Sommaire

• • ·Editorial board

    Page :iii-iii

    
  • ·Towards ICD-11 and DSM-V: Some current problems of diagnosis in psychiatry

    Page :1-1

    M. Maj

    
  • ·Prospects for the classification of mental disorders of the elderly

    Page :1-1

    J. Lindesay

    
  • ·Prospects for the classification of mental disorders of children and adolescents

    Page :1-1

    M.H. Schmidt

    
  • ·Prospects for the classification of mental disorders in women

    Page :1-2

    A. Riecher-Rossler

    Résumé Résumé Plan Plan
  • ·Should long-term outcome play a role in classification? considerations from european primary care research on affective disorders

    Page :2-2

    J. Ormel

    
  • ·Prospects for the classification of mental disorders for use in primary and general health care

    Page :2-2

    C. Dowrick

    
  • ·Individual and contextual predictors of burnout among mid-career Norwegian doctors: A ten-year follow-up nationwide study

    Page :2-2

    J.O. Rovik, R. Tyssen, T. Gude, Ø. Ekeberg, P. Vaglum

    
  • ·Results of one-year follow-up after participation in a burn-out prevention program for medical doctors at Villa Sana, Norway

    Page :3-3

    K.I. Ro, T. Gude, O.G. Aasland

    
  • ·Early recognition and help-seeking in burnout: Are psychiatrists any wiser?

    Page :3-3

    B. Schulze, W. Roessler

    
  • ·Burnout symptoms among impaired doctors treated in a spanish physicians programme

    Page :3-3

    P. Lusilla, C. Jacas

    
  • ·Gender differences in the symptoms of depression and anxiety. A comparison of interview and self-assessment data

    Page :3-4

    J. Angst, A. Gamma, V. Ajdacic, D. Eich, W. Roessler

    Résumé Résumé Plan Plan
  • ·Familial aggregation of mood disorders: Is there a sex of proband effect?

    Page :4-4

    M. Preisig, F. Ferrero

    
  • ·A community study on gender differences in mental health indicators and mediating effects of stalking victimization

    Page :4-4

    C. Kuehner, P. Gass, H. Dressing

    
  • ·Gender differences in caregiver burden and depression: A population-based study in Germany

    Page :4-5

    M. Schäufele, L. Köhler, S. Weyrerer

    Résumé Résumé Plan Plan
  • ·Sex differences in the occurrence of late-life dementia

    Page :5-5

    H. Bickel

    
  • ·Antipsychotics: Mode of action highlights

    Page :5-5

    C. Höschl, J. Horacek, M. Kopecek, V. Bubeníková-Valesová

    
  • ·The complexity of using D2-dopamine antagonists in the treatment of patients with schizophrenia

    Page :5-6

    F.-A. Wiesel, L. Bjerkenstedt, G. Edman, L. Flyckt, N. Venizelos

    Résumé Résumé Plan Plan
  • ·Why cannabis use is bad for schizophrenia

    Page :6-6

    R.S. Kahn, M. Rais, N. van Haren, H. Hulshoff Pol, E. Caspers, H. Schnack

    
  • ·Schizophrenia: A biologists perspective

    Page :6-6

    J. Vetulani

    
  • ·Introduction

    Page :6-6

    M.D. Waldinger

    
  • ·Diagnostic criteria of sexual dysfunctions: Need for a change

    Page :6-7

    R. Balon

    Résumé Résumé Plan Plan
  • ·Female sexual dysfunction

    Page :7-7

    R.T. Segraves

    
  • ·Drug treatment and psychotherapy of premature ejaculation

    Page :7-7

    M.D. Waldinger

    
  • ·The correlation of the endophenotypes to the at-risk haplotypes

    Page :7-7

    W. Maier, M. Wagner, O. Gruber, P. Falkai, S.G. Schwab

    
  • ·How to screen adolescents for cannabis dependence

    Page :7-7

    M. Reynaud

    
  • ·Cannabis abuse comorbidity with psychiatric disorders

    Page :7-8

    M. Casas, C. Roncero, M. Trasovares, A. Qureshi, E. Bruguera

    Résumé Résumé Plan Plan
  • ·An update on the neurobiology of cannabis addiction

    Page :8-8

    R. Maldonado

    
  • ·In vivo measurement of neuronal dopamine transporter in cannabis dependant subjects, with positron tomography and [11C]-PE2I

    Page :8-8

    C. Leroy, M. Lukasiewicz, C. Trichard, C. Comtat, R. Trébossen, M.J. Ribeiro, M. Reynaud, J.L. Martinot

    
  • ·An update on state of the art treatment of cannabis dependence

    Page :8-8

    A. Benyamina

    
  • ·Social cognition and theoretical framework

    Page :8-8

    F. Palha

    
  • ·Affect recognition in schizophrenia: impairments and treatment

    Page :8-9

    W. Woelwer, N. Frommann

    Résumé Résumé Plan Plan
  • ·Therapy of social cognition: Overview and empirical results

    Page :9-9

    N. Jimeno

    
  • ·Social cognition scale (SCS): A newly developed assessment instrument

    Page :9-9

    I. Fuentes, J.C. Ruiz, S. Garcia, M.J. Soler

    
  • ·Integrated neurocognitive therapy for schizophrenia patients (INT)

    Page :9-9

    V. Roder, M. Laechler, D. Mueller

    
  • ·Author index

    Page :1-18

    Résumé Résumé Plan Plan
  • ·Problems in the provision of psychiatric services in Europe

    Page :9-10

    G. Christodoulou, H. Sass

    Résumé Résumé Plan Plan
  • ·Imaginative death experience in hypochondriasis

    Page :10-10

    J. Prasko, H. Praskova

    
  • ·Placebo and nocebo effects: how the doctors words affect the patients brain

    Page :10-10

    F. Benedetti

    
  • ·Advances in pain research and therapy

    Page :10-10

    H. Flor

    
  • ·WHO European offices views and the European mental health plan

    Page :10-11

    M. Muijen

    Résumé Résumé Plan Plan
  • ·The views of European psychiatrists represented in the AEP

    Page :11-11

    C. Hoschl

    
  • ·The views of family organizations in Europe taking into account the recent developments in WHO Europe and the European community

    Page :11-11

    I. Nilsson

    
  • ·The EU strategy - Green/white paper

    Page :11-11

    J. Scheftlein

    
  • ·The views of the European Brain Council and the various disciplines represented in it

    Page :11-12

    J. Mendlewicz

    Résumé Résumé Plan Plan
  • ·Why it is sometimes difficult to generalize results from RCTs to everyday clinical practice

    Page :12-12

    W.W. Fleischhacker

    
  • ·Applying pragmatic outcome criteria in clinical trials

    Page :12-12

    R. Kahn

    
  • ·Adverse events beyond the ‘usual suspects'

    Page :12-12

    P. Mohr

    
  • ·Defining response, remission and recovery in schizophrenia

    Page :12-12

    S. Leucht

    
  • ·Psychosocial reintegration - an overambitious goal in schizophrenia patients?

    Page :12-13

    V. Roder

    Résumé Résumé Plan Plan
  • ·Update on lesbian, gay, bisexual and transgender (LGBT) mental health

    Page :13-13

    G.A. Nakajima, J.C. Navarro-Barrios, V.G. Carrion, D. Garza

    
  • ·Treatment of cognition and affect in schizophrenia

    Page :13-13

    G.M. Sachs, S. Robinson, B. Winklbaur, R.C. Gur, E. Moser, H. Katschnig

    
  • ·Social skills training and computerized cognitive training in patients with schizophrenia

    Page :13-14

    S. Galderisi, G. Piegari, A. Mucci, A. Acerra, L. Luciano, A.F. Rabasca, A. Valente, M. Volpe, M. Maj

    Résumé Résumé Plan Plan
  • ·Improvement of prefrontal brain function in schizophrenia under atypical neuroleptic treatment

    Page :14-14

    A.J. Fallgatter, M.J. Herrmann, A.C. Ehlis

    
  • ·Genetics and forensic psychiatric nosology

    Page :14-14

    H. Anckarsater

    
  • ·Neurobiological markers in conduct disorder

    Page :14-14

    S.H. Herpertz, B. Herpertz-Dahlmann

    
  • ·Neurobiological correlates of antisocial personality traits - research findings and treatment implications

    Page :14-15

    B.A. Vollm, M. Dolan, P. Richardson, S. McKie, R. Elliott, S. Williams, I. Anderson, J.F.W. Deakin

    Résumé Résumé Plan Plan
  • ·Ethical implications of neurobiological research findings in offender patients

    Page :15-15

    G.M. Adshead

    
  • ·Standards of expert opinion concerning criminal responsibility in Germany

    Page :15-15

    H. Sass

    
  • ·Statement on criminal prognosis and risk assessment in Switzerland

    Page :15-15

    V. Dittmann

    
  • ·Quality standards of expertise cocerning sexual offenders in Belgium

    Page :15-15

    P. Cosyns

    
  • ·Expert testimony in the context of preventive detention according to section sign 66 of the German penal code

    Page :15-16

    E. Habermeyer

    Résumé Résumé Plan Plan
  • ·Information processing in ADHD - what can we learn from ERP studies?

    Page :16-16

    T. Banaschewski

    
  • ·Effects of family environment on ADHD

    Page :16-16

    A. Miranda, R. Marco, D. Grau

    
  • ·Objective versus subjective assessment of MPH response

    Page :16-16

    I. Manor, S. Meidad, G. Zalsman, Z. Zemishlany, S. Tyano, A. Weizman

    
  • ·The influence of comorbid personality disorders on the outcome of CBT treatment of anxiety disorders

    Page :16-17

    A. Arntz, A. Weertman

    Résumé Résumé Plan Plan
  • ·Comorbidity of personality disorders and posttraumatic stress disorder

    Page :17-17

    R.I. Steil, A. Hinckers, M. Bohus

    
  • ·Comorbidity with affective disorders

    Page :17-17

    M. Backenstrass, K. Joest

    
  • ·Do premorbid personality disorders predict adult alcoholism? Results from a Danish Longitudinal High Risk Study

    Page :17-17

    J. Knop, E.C. Penick, E.J. Nickel, S. Murtaza, M.A. Sullivan, P. Jensen

    
  • ·Comorbidity of personality disorders and eating disorders

    Page :17-18

    U. Schweiger, V.R. Sipos

    Résumé Résumé Plan Plan
  • ·Parental perinatal psychopathology and infant development

    Page :18-18

    A.L. Sutter-Dallay

    
  • ·Comparison of mother-baby interactions of manic mothers and community mothers

    Page :18-18

    A.L. Sutter-Dallay, C. Bacholet, C. Galera, E. Glatigny-Dallay, H. Verdoux

    
  • ·Physical and psychosocial disturbances of the partners of women with severe postpartum psychiatric disorders

    Page :18-18

    C. Hornstein

    
  • ·Interactive regulation of affect in postpartum depressed mothers and their infants in the course of depression

    Page :18-18

    C. Reck, U. Stefenelli, E.Z. Tronick

    
  • ·To be advised

    Page :18-18

    P. Trautmann-Villalba

    
  • ·Co-aggregation of cognitive, personality and genetic risk indicators of schizophrenia in an ongoing Catalan family study

    Page :19-19

    N. Barrantes-Vidal, M. Fatjo-Vilas, M. Aguilera, S. Miret, M.E. Navarro, S. Campanera, M.J. Munoz, L. Fananas

    
  • ·Cognitive trait and state markers in subjects at genetic high risk

    Page :19-19

    S.M. Lawrie, J. Harris, D.C.G. Owens, E.C. Johnstone

    
  • ·Childhood victimization and developmental expression of sub-clinical psychosis

    Page :19-19

    I. Myin-Germeys, T. Lataster, J. van Os

    
  • ·Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level

    Page :19-20

    N.C. Stefanis, T.A. Trikalinos, D. Avramopoulos, N. Smyrnis, I. Evdokimidis, E.E. Ntzani, J.P. Ioannidis, C.N. Stefanis

    Résumé Résumé Plan Plan
  • ·Neurocognitive deficits in clinical high risk subjects: Relationship to symptoms and disease progression

    Page :20-20

    M. Wagner, I. Frommann, R. Pukrop, A. Bechdolf, S. Ruhrmann, J. Klosterkoetter, J. Brinkmeyer, W. Woelwer, P. Decker, W. Maier

    
  • ·Effects of cannabis on memory and response inhibition

    Page :20-20

    P. McGuire, J. Crippa, R. Martin-Santos, C. OʼCarroll, S. Bhattacharyya, S. Borgwardt, P. Fusar-Poli, Z. Atakan

    
  • ·Cannabidiol as an antipsychotic agent

    Page :21-21

    F.M. Leweke, D. Koethe, C.W. Gerth, B.M. Nolden, D. Schreiber, S. Gross, F. Schultze-Lutter, M. Hellmich, J. Klosterkotter

    
  • ·Anxiolytic effects of cannabidiol

    Page :21-21

    J.A. Crippa, A.W. Zuardi

    
  • ·CBD and the neural correlates of anxiety

    Page :21-21

    P. Fusar-Poli, S. Bhattacharyya, S. Borgwardt, K. Rubia, C. OʼCarroll, M. Seal, R. Martin-Santos, J. Crippa, Z. Atakan, P. McGuire

    
  • ·Cannabis and psychosis

    Page :21-22

    R.M. Murray

    Résumé Résumé Plan Plan
  • ·Neuropsychiatric symptoms management in HIV positive patients: a case discussion

    Page :22-22

    J. Blanch, M. Wainberg

    
  • ·Effect on outcomes of advance statements of patient preferences

    Page :22-22

    G. Szmukler, C. Henderson, C. Flood, M. Leese, K. Sutherby, G. Thornicroft

    
  • ·Deinstitutionalization in the Netherlands and the effectiveness of act to maintain contact with the severe mentally ill

    Page :22-22

    S. Sytema, J.W. Bloemers, L. Wunderink, L. Roorda

    
  • ·An overview of the Nordic comparative study on sectorized psychiatry 1987 - 2000

    Page :22-23

    O. Saarento, M. Kastrup

    Résumé Résumé Plan Plan
  • ·RCT on discharge planning for high utilisers of psychiatric services I: Background and first results

    Page :23-23

    B. Puschner, W. Gaebel, B. Janssen, M. Ramacher, H.E. Klein, C. Cording, H. Spießl, K. Sohla, H. Freyberger, C. Spitzer, B. Skoeries, T. Steinert, J. Bergk, J. Grempler, P. Schneider, R. Muche, T. Becker

    
  • ·RCT on discharge planning for high utilisers of psychiatric services II. Needs-oriented intervention

    Page :23-23

    S. Steffen, W. Gaebel, B. Janssen, H. Zimmer, H.E. Klein, C. Cording, H. Spiessl, A. Janner, H. Freyberger, C. Spitzer, K. Friesicke, T. Steinert, J. Bergk, U. Scheck, R. Kalkan, B. Puschner, T. Becker

    
  • ·The need for female leadership in international professional organisations

    Page :23-24

    M.C. Kastrup

    Résumé Résumé Plan Plan
  • ·Indication and impact of mentoring models

    Page :24-24

    A. Riecher-Rossler, R. Landmann

    
  • ·Gender and research trends in psychiatry

    Page :24-24

    B. Schrank, M. Amering

    
  • ·Gender-sensitive data and monitoring of international developments in psychiatry

    Page :24-24

    M. Amering, B. Schrank

    
  • ·Six-year prospective study of major depressive disorder: Remissions, relapses, and the effects of personality disorders

    Page :24-25

    C.M. Grilo, T.H. McGlashan, R.L. Stout, M.T. Shea, J.G. Gunderson, L.C. Morey, A.E. Skodol

    Résumé Résumé Plan Plan
  • ·Long-term outcome of depressive pseudodementia in the elderly

    Page :25-25

    J.A. Saez Fonseca, L. Lee, Z. Walker

    
  • ·Depression and HPA-axis dysregulation: A large cohort study

    Page :25-25

    F. Zitman, S. Vreeburg, B. Kruijtzer, H. van Pelt, R. van Dyck, R. de Rijk, W. Hoogendijk, B. Penninx

    
  • ·A triallelic serotonin transporter gene, life events and depression

    Page :25-26

    G. Zalsman, Y.Y. Huang, M.A. Oquendo, A.K. Burke, X. Hu, D.A. Brent, S.P. Ellis, D. Goldman, J.J. Mann

    Résumé Résumé Plan Plan
  • ·DAT binding and psychopathological features in depressed patients

    Page :26-26

    G. Camardese, D. Di Giuda, L. Mosca, A. Giordano, P. Bria

    
  • ·Long-term monitoring of HRV and activitiy with a new acquisition system: Preliminary data from a pilotstudy with depressive inpatients

    Page :26-26

    C. Norra, M. Arndt, M. Harris, E. Naujokat

    
  • ·Medical comorbidities in patients with recurrent depressive disorder

    Page :26-26

    V.R. Enatescu

    
  • ·Comorbidity of posttraumatic stress disorder and depression

    Page :27-27

    M.B. Simonovic, G.B. Grbesa

    
  • ·Diabetes and depression: The impact of fluoxetine on glycemic control

    Page :27-27

    M.K. Jallo, N.K. Toma

    
  • ·Ethical aspects of evidence based medicine (EBM)

    Page :27-27

    D. Goldberg

    
  • ·Ethics of art therapy and use of patient-produced art

    Page :27-28

    C. Carbonell

    Résumé Résumé Plan Plan
  • ·Ethical issues in the use of complementary and alternative medicine (CAM) in mental health

    Page :28-28

    F.J. Stone

    
  • ·Ethics of publication

    Page :28-28

    C. Hoschl

    
  • ·The scientific framework of personality research

    Page :28-28

    J.L. Carrasco

    
  • ·Posttraumatic stress and personality disorders

    Page :28-28

    J.J. Lopez-Ibor

    
  • ·Treatment of addiction: from abstinence programs to abstinence-supported treatment

    Page :28-29

    M. Musalek

    Résumé Résumé Plan Plan
  • ·Antagonists in the treatment of alcoholism: An update

    Page :29-29

    G. Rubio, M.A. Jimenez-Arriero

    
  • ·Towards an individual treatment in alcoholism: Project predict

    Page :29-29

    K.F. Mann, M. Smolka, A. Diehl, U. Zimmermann, A. Heinz

    
  • ·Prenatal famine exposure is an important risk factor for developing addiction in later life

    Page :29-29

    E.J. Franzek, B. Van De Wetering

    
  • ·The role of impulsivity, response inhibition and delay discounting in addictive behaviors

    Page :29-29

    W. Van Den Brink

    
  • ·Neural correlates of executive function and working memory in the ‘at risk mental state'

    Page :30-30

    M.R. Broome, P. Matthiasson, P. Fusar-Poli, J.B. Woolley, L.C. Johns, P. Tabraham, E. Bramon, L. Valmaggia, S.C. Williams, M. Brammer, X. Chitnis, P.K. McGuire

    
  • ·White matter changes from the prodrome to first psychotic episode

    Page :30-30

    J.B. Woolley, G.J. Barker, X. Chitnis, M. Broome, L. Valmaggia, L. Johns, P. Tabraham, P.K. McGuire

    
  • ·Cognitive capability of individuals at risk with and without transition to psychosis

    Page :30-30

    M.O. Pflueger, U. Gschwandtner, J. Aston, G. Berger, S. Borgwardt, M. Drewe, M. Dʼsouza, E. Rechsteiner, R.D. Stieglitz, A. Riecher-Roessler

    
  • ·Ventricle volumes in emerging psychosis. A cross-sectional and longitudinal MRI study

    Page :30-31

    G.E. Berger, S.J. Wood, D. Velakoulis, A. Ang, W.J. Brewer, L.J. Phillips, A.R. Yung, T.M. Proffitt, C. Pantelis, P.D. McGorry

    Résumé Résumé Plan Plan
  • ·Association of regional grey matter abnormalities with cognitive functions in the at risk mental state

    Page :31-31

    S.J. Borgwardt, E.W. Radue, P.K. McGuire, A. Riecher-Rössler

    
  • ·On capturing subjectivity in narrative

    Page :31-31

    T. Thornton

    
  • ·Subjectivity and cultures in psychiatry

    Page :31-31

    D. Moussaoui

    
  • ·Objective evidence and subjective narratives in medicine and psychiatry

    Page :31-32

    J. Lázaro

    Résumé Résumé Plan Plan
  • ·Psychiatric epistemology in Spain: ideas and models

    Page :32-32

    E. Novella

    
  • ·Autism: a molecular plasticity disorder

    Page :32-32

    N. Ramoz, A.M. Bestel-Lepagnol, G. Maussion, J.M. Moalic, J.D. Buxbaum, P. Gorwood, M. Simonneau

    
  • ·From mental retardation to autism: common aspects, common genes

    Page :32-32

    F. Laumonnier

    
  • ·Do autism and ocd have shared genetic vulnerability?

    Page :32-33

    J.D. Buxbaum, N. Ramoz, T. Sakurai, J. Silverman, E. Hollander

    Résumé Résumé Plan Plan
  • ·Do ADHD and autism have related traits considering the genes involved?

    Page :33-33

    L. Gallagher

    
  • ·Concepts of illness among addicted migrants

    Page :33-33

    M. Schouler-Ocak, J. Hein, A. Heinz

    
  • ·Addiction among Russian and Turkish migrants in Germany: developing prevention strategies

    Page :33-33

    A. Bondar, W. Machleidt

    
  • ·Substance use and schizophrenia among south Asian migrants to the UK

    Page :33-33

    I. Mirza

    
  • ·Hepatitis infection rates in addicted migrants

    Page :34-34

    J. Reimer, B. Fischer

    
  • ·The role of psychological pain in suicide victims. What do we make of it?

    Page :34-34

    M. Pompili, D. Lester, A. Leenaars

    
  • ·Programs and campaigns: introducing better understanding of suicide phenomenon

    Page :34-34

    Z. Rihmer, X. Gonda, A. Rihmer

    
  • ·Practical intervention for suicide survivors

    Page :34-34

    O. Grad

    
  • ·Do brain imaging and neurophysiology differentiate borderline personality disorder and depression?

    Page :35-35

    T. Zetzsche, J. Bobes, J.M. De la Fuente, O. Pogarell, C. Norra

    
  • ·Changing patterns of suicide attempts in Europe

    Page :35-35

    A. Schmidtke, D. Wasserman, C. Löhr

    
  • ·Changing suicide rates in western and central Europe

    Page :35-35

    Z. Rihmer

    
  • ·Suicides in the countries of the former Soviet Union

    Page :35-36

    V.A. Rozanov

    Résumé Résumé Plan Plan
  • ·Changes in male suicidality in a changing Europe

    Page :36-36

    W. Rutz, Z. Rihmer

    
  • ·Diminishing alcohol consumption is the most effective suicide preventive program in modern history for males

    Page :36-36

    D. Wasserman, A. Varnik, K. Kolves, L.M. Tooding

    
  • ·The phenomenology of impulse control disorders

    Page :36-36

    C. Mundt

    
  • ·Loss of impulse control in psychotic disorders

    Page :36-37

    M.L. Figueira

    Résumé Résumé Plan Plan
  • ·Loss of control in personality disorders

    Page :37-37

    M. Roca

    
  • ·Pathological gambling: Addiction or impulse control disorder

    Page :37-37

    M. Musalek

    
  • ·Comorbidity across the life span

    Page :37-37

    I.B. Crome

    
  • ·Policy and dual diagnosis

    Page :37-38

    A. Baldacchino

    Résumé Résumé Plan Plan
  • ·Innovations in pharmacological treatment of addiction

    Page :38-38

    F. Kiefer

    
  • ·Hidden comorbidity

    Page :38-38

    M. Casas, A. Ramos, R. Bosch, N. Gomez

    
  • ·The concept of quality of life in dementia in the different stages of the disease

    Page :38-38

    J.W. Leszek, R. Wojtynska

    
  • ·Suicide and attempted suicide in the elderly. Should the physician give support to patients wish to die?

    Page :38-39

    I. Icelli

    Résumé Résumé Plan Plan
  • ·Sanctions and suicide in the elderly

    Page :39-39

    A. Milicevic-Kalasic

    
  • ·Quality of life in the elderly mentally ill and the right to dye with dignity

    Page :39-39

    N. Tataru

    
  • ·Treating depression among HIV/AIDS patients: recent advances

    Page :39-39

    P. Ruiz

    
  • ·Treating depression in children and adolescents

    Page :40-40

    S. Kutcher

    
  • ·Treating depression in victims of disasters

    Page :40-40

    J.J. Lopez-Ibor

    
  • ·Treating depression in patients with organic brain disorders

    Page :40-40

    M.I. Lopez-Ibor

    
  • ·Birth during autumn is a risk for adolescent self-mutilative behaviour

    Page :40-40

    K. Riala, H. Hakko, P. Räsänen

    
  • ·Smoking predicts suicidality: findings from a prospective community study

    Page :40-40

    R. Lieb, M. Hoefler, H.U. Wittchen, T. Bronisch

    
  • ·Why is there an association between eczema and common mental disorders?

    Page :40-41

    M.K. Fremstad, K.G. Gotestam, A. Mykletun

    Résumé Résumé Plan Plan
  • ·Emotional burn-out in medical doctors in the Moscow region

    Page :41-41

    E.G. Starostina, E.N. Moshnyaga

    
  • ·Lay help to reduce dementia caregivers burden: results of a project in Goettingen, Germany and conclusions for a broader audience

    Page :41-41

    G. Stoppe, P. Geilfuss, G. Stiens

    
  • ·Filial maturity as predictor of caregiver burden in adult children of demented patients

    Page :41-41

    G. Stoppe, V. Linkersdörfer, L. Maeck, G. Stiens

    
  • ·Mothers, fathers and children with developmental problems

    Page :41-42

    Z. Lopicic, I. Perunicic, G. Knezevic, I. Derkovic

    Résumé Résumé Plan Plan
  • ·The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence

    Page :42-42

    E. Pinto, P. Gorwood, J. Reggers, D. Vaira, G. Scantamburlo, W. Pitchot, M. Ansseau

    
  • ·Psychiatric comorbidity of dependent tobacco smokers

    Page :42-42

    U. Havemann-Reinecke, C. Hein, S. Gorski, M. Wurche-Gier, S. Jacobs, U. Schneider

    
  • ·Somatic treatments in perinatal psychiatry

    Page :42-42

    S.V. Eranti

    
  • ·Advances in treatment in bipolar pregnant patients

    Page :43-43

    A.L. Sutter-Dallay

    
  • ·Antidepressant treatment during pregnancy: Pros and cons

    Page :43-43

    L. Garcia-Esteve, F. Botet, J. Perez, C. Soler, J. Figueras, P. Navarro, R. Martin-Santos, E. Gelabert, M.L. Imaz

    
  • ·Antidepressant treatment response of postpartum depression: Clinical and genetic factors

    Page :43-43

    R. Martin-Santos, E. Gelabert, A. Plaza, P. Navarro, R. Navines, C. Ascaso, C. Garcia, M. Gratacos, X. Estivill, L.L. Garcia Esteve

    
  • ·Treating postpartum depression in primary care in Santiago,Chile

    Page :44-44

    G. Rojas, R. Fritsch, J. Solis, E. Jadresic, R. Araya

    
  • ·Legislation and practice in the management of violent patients in Europe. A case vignette study

    Page :44-44

    T. Steinert, P. Lepping

    
  • ·The psychology of ‘takedown': Emotional and cognitive processes during the emergency management of violence by physical restraint on the floor

    Page :44-44

    R.C. Whittington

    
  • ·The need to develop alternative methods than seclusion and restraint

    Page :44-45

    A.M. Putkonen

    Résumé Résumé Plan Plan
  • ·Experiences with a training programme in the use of methods other than seclusion or restraint

    Page :45-45

    A.B. Bjorkdahl

    
  • ·Least restrictive interventions towards consensus

    Page :45-45

    B.A. Paterson

    
  • ·The clinical savoir-faire of ethnopsychiatry

    Page :45-45

    A.M. Ulman, N. Zajde, C. Grandsard

    
  • ·USA psychiatric educational perspectives

    Page :46-46

    P. Ruiz

    
  • ·CME courses system and accreditation process for CME

    Page :46-46

    H. Sass

    
  • ·European psychiatry. Perspectives on training and organisation

    Page :46-46

    A. Lindhardt

    
  • ·Explaining transitions over the psychosis continuum

    Page :46-46

    L. Krabbendam, J. van Os

    
  • ·Mapping silent spectrum predisposition: anomalous subjective experiences and schizotypy in unaffected genetic high-risk subjects

    Page :46-47

    A. Raballo, G. Castignoli

    Résumé Résumé Plan Plan
  • ·Three measures of schizotypality in a large sample of ultra-high risk patients

    Page :47-47

    M. Heinimaa, T. Ilonen, J. Huttunen, T. Svirskis, J. Korkeila, L. Vaskelainen, T. Ristkari, R.K.R. Salokangas, M. Birchwood, D. Lindszen, J. Klosterkötter

    
  • ·Psychopathological and neuropsychological data from first admitted and population-identified familial schizotypal disorders

    Page :47-47

    J. Parnas

    
  • ·The psychosis continuum and the Cardiff Anomalous Perceptions Scale (CAPS): Are there multiple factors underlying anomalous experience?

    Page :47-47

    V. Bell, P.W. Halligan, H.D. Ellis

    
  • ·Improving quality of treatment decision of emergency room. The case of borderline patients

    Page :47-48

    O. Dufour, P. Ohlendorf, G. Hourton, C. Damsa, A. Andreoli

    Résumé Résumé Plan Plan
  • ·Crisis hospitalisation outcome among borderline patients. A 1-year follow-up

    Page :48-48

    P. Ohlendorf, A.M. Berrino, L. Ligorio, D. Maire, A. Andreoli

    
  • ·Time-limited psychodynamic psychotherapy and venlaxafine among acutely suicidal bordeline patients

    Page :48-48

    Y. Burnand, D. Maire, P. Ohlendorf, M.F. Cochennec, A. Andreoli

    
  • ·Nature and nurture in suicidal behaviour; the role of genetics: Some novel findings

    Page :48-48

    D. Wasserman, M. Sokolowski, J. Wasserman, V. Rozanov

    
  • ·Risk factors and vulnerability to suicidal behavior

    Page :48-49

    M. Sarchiapone, A. Marusic, V. Carli, C. Cuomo

    Résumé Résumé Plan Plan
  • ·The link between the serotonin system and suicidality

    Page :49-49

    P.A. Saiz

    
  • ·Decision making as an endophenotype in suicidal behaviour

    Page :49-49

    P. Courtet

    
  • ·Genetic association studies of aggression-related genes

    Page :49-49

    D. Rujescu

    
  • ·SSRIs versus tricyclics

    Page :49-50

    K.B. Stage

    Résumé Résumé Plan Plan
  • ·The fate of moclobemide

    Page :50-50

    K. Martiny

    
  • ·Dose-effect relationships for antidepressants

    Page :50-50

    L.F. Gram

    
  • ·Placebo-controlled relapse prevention trials in unipolar depression

    Page :50-50

    P. Bech

    
  • ·Prophylaxis in bipolar disorder: methodological implications of an almost completed lamotrigine-vs-lithium study

    Page :50-50

    R.W. Licht

    
  • ·Management of psychomotor agitation in the ER: Evidence based medicine, between guidelines and clinical practice

    Page :51-51

    M. Allen, C. Damsa

    
  • ·Factors Influencing Depression Endpoints Research (finder) - A European study in depression

    Page :51-51

    M. Bauer

    
  • ·Finder: Baseline results and caseness of depression

    Page :51-52

    K. Demyttenaere

    Résumé Résumé Plan Plan
  • ·Pain in depression

    Page :52-52

    N. Dantchev, M. Bauer, K. Demyttenaere, A. Garcia-Cebrian, L. Grassi, A.L. Montejo, B. Monz, D. Perahia, D. Quail, C. Reed, A. Tylee

    
  • ·Prescribing patterns in the Finder study

    Page :52-52

    A.T. Tylee

    
  • ·The use of legal substances by persons with schizophrenia

    Page :52-53

    R.G. McCreadie, A. Dervaux, J. de Leon, M. Gurpegui

    Résumé Résumé Plan Plan
  • ·Who are the patients with schizophrenia who drink alcohol?

    Page :53-53

    A. Dervaux

    
  • ·Does duration of depression predict suicidality?

    Page :53-53

    J. Spijker, M. ten Have, R. de Graaf

    
  • ·Transition probability form attempted to completed suicide: A thirty year follow-up study

    Page :53-53

    H. Katschnig, M. Freidl

    
  • ·Mortality and mental disorders

    Page :53-54

    C. Lauber, V. Ajdacic-Gross, W. Rössler

    Résumé Résumé Plan Plan
  • ·General mortality from anxiety and depression (the HUNT study)

    Page :54-54

    A. Mykletun, O. Bjerkeset, R. Stewart, M. Dewey, S. Overland, M. Prince

    
  • ·Anxiety, depression and cause - specific mortality. The HUNT historical cohort study

    Page :54-54

    A. Mykletun, O. Bjerkeset, M. Dewey, M. Prince, S. Overland, R. Stewart

    
  • ·The role of adherence to medication in the effectiveness of long-term treatment of schizophrenia

    Page :54-55

    J. Volavka, J.P. Lindenmayer, H. Liu-Seifert, P. Kulkarni, B.J. Kinon, V. Stauffer, B. Edwards, L. Chen, D.H. Adams, P.F. Buckley, L. Citrome

    Résumé Résumé Plan Plan
  • ·Long-term outcomes of schizophrenia: Does psychosocial treatment make a difference?

    Page :55-55

    L. Motlova, E. Dragomirecka, J. Cermak, M. Rodriguez, D. Holub

    
  • ·Large pragmatic long term clinical trials in schizophrenia

    Page :55-55

    W.W. Fleischhacker

    
  • ·Real-world effectiveness of pharmacological treatments in schizophrenia

    Page :55-56

    J. Tiihonen, K. Wahlbeck, J. Lönnqvist, T. Klaukka, J.P.A. Ioannidis, J. Volavka, J. Haukka

    Résumé Résumé Plan Plan
  • ·Treatment strategies for psychotic geriatric depression

    Page :56-56

    L. Agüera

    
  • ·Care needs of functional psychotic patients in late life. the situation of elderly patients at psychiatric hospitals versus nursing homes

    Page :56-56

    R. Mateos, M. Puime

    
  • ·The paraspectrum study: searching for a valid paranoid psychotic phenotype

    Page :56-57

    J. Cervilla, E. de Portugal, N. González, V. Villalta-Gil, M. Vilaplana, M. Dolz, S. Ochoa, J. Usall, J.M. Haro

    Résumé Résumé Plan Plan
  • ·Long-term outcome of schizophrenia

    Page :57-57

    M. Martin-Carrasco

    
  • ·The short-term treatment of narcissistic and other self-disorders

    Page :57-57

    M. Trujillo

    
  • ·Mentalizing techniques in the treatment of borderline personality disorder

    Page :57-57

    A.W. Bateman

    
  • ·Short term psychotherapy in borderline personality disorders

    Page :57-58

    B. Reneses

    Résumé Résumé Plan Plan
  • ·Results of a brief crisis program for people with borderline personality disorders

    Page :58-58

    J. Guimón, C. Maruotolo, A. Mascaró, A. Boyra

    
  • ·Dysgyrification in psychotic disorders: Its functional significance and molecular foundations

    Page :58-58

    P. Falkai

    
  • ·Automatic assessment of brain gyrification in patients

    Page :58-58

    J.L. Martinot, P. McGuire, T. Kircher, D. Hubl, P. Allen, M.L. Paillere-Martinot, A. Galinowski, F. Bellivier, D. Januel, R. De Beaurepaire, M. Plaze, E. Artiges, J.F. Mangin, A. Cachia

    
  • ·What is the functional consequence of disturbed gyrification of the human brain?

    Page :58-59

    S.M. Lawrie, J. Harris, A. Stanfield, H. Bonnici, T.W. Moorhead, E.C. Johnstone

    Résumé Résumé Plan Plan
  • ·Drug addiction comorbidity with borderline personality disorder and attention deficit hyperactivity disorder in adults

    Page :59-59

    M. Casas

    
  • ·Schematherapy: personality disorders and schema processes

    Page :59-59

    H. Berbalk

    
  • ·Dysfunctional interactional styles of clients with narcissistic and histrionic personality disorders

    Page :59-59

    R. Sachse

    
  • ·Evaluation of a new integrative therapy program for patients with personality disorder - results of a multi-center study

    Page :59-60

    P. Zorn, V. Roder, M. Thommen, D. Müller, W. Tschacher

    Résumé Résumé Plan Plan
  • ·Time series analysis of therapy process in groups of clients with personality disorders

    Page :60-60

    W. Tschacher, P. Zorn, M. Thommen, D. Müller, V. Roder

    
  • ·Cultural identity, cultural congruity and distress

    Page :60-60

    D. Bhugra

    
  • ·The challenge of cultural diversity and psychiatric assessment

    Page :60-60

    S. Baarnhielm

    
  • ·The Rif-project delivery of psychiatric care to Dutch-Moroccan migrants in Morocco during summer

    Page :60-61

    P. Van Loon, J. Lamé, F. Saarloos

    Résumé Résumé Plan Plan
  • ·Culturally sensitive psychopharmacological research

    Page :61-61

    F. Collazos, A. Qureshi, M. Ramos

    
  • ·A road map for European collaborative research in schizophrenia

    Page :61-61

    S. Frangou, P. Falkai, P. McGuire, N. Van Haren, S. Lawrie

    
  • ·Is stepped care the right format for internet delivered cognitive behavioural therapy for anxiety disorders and depression?

    Page :61-61

    G. Andersson

    
  • ·Can we benefit from internet to increase accessibility to an effective non-pharmacological treatment for major depression and anxiety disorders?

    Page :61-62

    N. Lindefors

    Résumé Résumé Plan Plan
  • ·Psychotherapy on the internet: How does it work concretely?

    Page :62-62

    T. Berger, F. Caspar

    
  • ·Association of response to methylphenidate in adults with ADHD with a polymorphism in SLC6A3 (DAT1)

    Page :62-62

    J.S. Kooij, A.M. Boonstra, S.H. Vermeulen, J.A. Heister, H. Burger, J.K. Buitelaar, B. Franke

    
  • ·Attention-deficit/hyperactivity disorder endophenotypes - an overview

    Page :62-62

    T. Banaschewski

    
  • ·Genes and neurocognitive performance: are the two related in adult ADHD?

    Page :62-63

    A.M. Boonstra, J.S. Kooij, J.K. Buitelaar, J. Oosterlaan, J.A. Sergeant, J.G. Heister, B. Franke

    Résumé Résumé Plan Plan
  • ·The possible association, in adolescence, between attention deficit and hyperactivity disorder and attempted suicide - a pilot study

    Page :63-63

    I. Manor, I. Gutnik, S. Meidad, D. Ben-Dor, A. Apter, Y. Sever, G. Zalsman, A. Weizman, S. Tyano

    
  • ·A 6 month study of the adherence, effectiveness and safety with methylphenidate adults with ADHD

    Page :63-63

    J.A. Ramos-Quiroga, R. Bosch, X. Castells, S. Valero, M. Nogueira, S. Yelmo, E. Garcia, I. Martinez, M. Casas

    
  • ·The European prediction of psychosis study - concept and design

    Page :63-64

    J. Klosterkötter, R.K. Salokangas, M. Birchwood, D. Linszen, S. Ruhrmann, G. Juckel, S. Lewis, H. Graf von Reventlow

    Résumé Résumé Plan Plan
  • ·EPOS - sample characteristics, transition rates and psychopathological predictors

    Page :64-64

    S. Ruhrmann, R.K.R. Salokangas, D. Linzen, M. Birchwood, G. Juckel, F. Schultze-Lutter, H. Graf, V. Reventlow, A. Morrison, S. Lewis, J. Klosterkötter

    
  • ·Premorbid adjustment in persons at high risk for psychosis

    Page :64-64

    R.K. Salokangas, M. Heinimaa, J. Klosterkoetter, S. Ruhrman, H. Graf von Reventlow, D. Linszen, P. Dingemans, M. Birchwood, P. Patterson

    
  • ·Drug and alcohol abuse as risk factors

    Page :65-65

    D. Linszen

    
  • ·Neurobiological characteristics of the at-risk mental state

    Page :65-65

    G. Juckel

    
  • ·First episode psychosis. The Danish National Schizophrenia project

    Page :65-65

    A. Lindhardt

    
  • ·The Danish National Schizophrenia project. Outcome and treatment modalities

    Page :65-65

    B. Rosenbaum, S. Harder, M. Lajer, A. Koester, A. Lindhardt, P. Knudsen, K. Valbak, G. Winther

    
  • ·The Danish National Schizophrenia project: Treatment as usual (TAU) in FEP with focus on continuity of treatment

    Page :65-65

    M. Lajer, A. Køster, A. Lindhardt

    
  • ·Gender differences in first episode psychosis (FEP)

    Page :66-66

    A. Koester, M. Lajer, A. Lindhardt

    
  • ·The Danish National Schizophrenia project (DNS): Interpersonal self-image as predictor for outcome in first-episode psychosis (FEP)

    Page :66-66

    S. Harder

    
  • ·Depression and anxiety during pregnancy: The role of light therapy

    Page :66-66

    G. Tavormina

    
  • ·The assessment of postpartum depression and satisfaction from husband

    Page :66-67

    K.H. Sharifi, Z. Sooky, Z. Tagharrobi, H. Akbari

    Résumé Résumé Plan Plan
  • ·Sex differences in hospitalised depressed patients

    Page :67-67

    H. Hausner, M. Wittmann, S. Poljansky, E. Haen, H. Spiessl

    
  • ·The cultural pattern of suicidal behaviour in different ethnic groups in Romania

    Page :67-67

    D. Cozman, M. Gheorghiu

    
  • ·Doing well: Implementing stepped care for depression

    Page :67-67

    J. Brooks, M. Smith, D. Young, K.J. Sutherland, L. Ackland, H. Sandbach

    
  • ·Importance of social relations for development of depression among pregnant women in urban and rural areas of Pakistan

    Page :67-68

    Z. Fatmi, A. Kazi

    Résumé Résumé Plan Plan
  • ·Neuropsychology of remitted bipolar patients

    Page :68-68

    H.J. Assion, G. Studentkowski, F. Balkau, P. Calabrese, G. Juckel

    
  • ·Cognitive behavioural psychoeducation in bipolar patients: results at 3 months-follow-up of a randomised controlled trial

    Page :68-68

    B. Bernhard, E. Severus, M. Riedel, H.J. Moeller

    
  • ·The man from Papyrus 3024: Did he meet the criteria?

    Page :68-68

    F. Versonnen, S. Tuinier, P. Verhaeghe

    
  • ·Factors associated to resistant depression

    Page :69-69

    D. Souery, P. Oswald, I. Massat, U. Bailler, J. Bollen, K. Demyttenaere, S. Kasper, Y. Lecrubier, S. Montgomery, A. Serretti, J. Zohar, J. Mendlewicz

    
  • ·Antidepressants - do they decrease or increase the risk of suicidality?

    Page :69-69

    H.-J. Moeller

    
  • ·Ten possible explanations for resistant depression

    Page :69-69

    J. Zohar

    
  • ·New methods of evaluation the cognition in schizophrenia

    Page :69-70

    M. Cuesta, E. Rojo, O. Pino, S.E. Purdon, P. McKenna

    Résumé Résumé Plan Plan
  • ·Prevention of neonaticide and abandonment from a prenatal stage in France

    Page :70-70

    C.J. Bonnet

    
  • ·Female offender patients in Germany

    Page :70-70

    C. Hornstein

    
  • ·Clinical and social factors contributing female offending in Russia

    Page :70-71

    M.A. Kachaeva

    Résumé Résumé Plan Plan
  • ·Female patients in a high secure hospital in Britain

    Page :71-71

    M. Orr

    
  • ·Female offender patients in Portugal

    Page :71-71

    L. Vicente

    
  • ·Vulnerability-stress-coping model: implications for the treatment of first-episode schizophrenia

    Page :71-71

    W. Wölwer, M. Riesbeck, J. Brinkmeyer, W. Gaebel

    
  • ·Dysfunction of the neuroendocrine system: Implications for the treatment of schizophrenia

    Page :72-72

    F. Mueller-Spahn

    
  • ·Therapeutic Drug Monitoring and its implications on acute and long-term treatment with neuroleptics

    Page :72-72

    F. Bengtsson

    
  • ·Pharmacogenetics in first-episode patients with schizophrenia

    Page :72-72

    W. Maier

    
  • ·Contemporary approaches for an optimal treatment of major depression

    Page :72-72

    P. Blier, M.H. Trivedi, A.A. Nierenberg, M. Hyman Rapaport

    
  • ·Long-term treatment of schizophrenic patients

    Page :72-73

    H.J. Moeller

    Résumé Résumé Plan Plan
  • ·Long-term treatment of unipolar depression

    Page :73-73

    S. Kasper

    
  • ·Long-term treatment of bipolar depression

    Page :73-73

    E. Vieta, J.M. Goikolea

    
  • ·Long term treatment of anxiety disorders

    Page :73-73

    B. Bandelow

    
  • ·Trait aggression and hostility in recovered alcoholics

    Page :74-74

    S. Ziherl, Z. Cebasek - Travnik, B. Zalar

    
  • ·Effects of multiple drug abuse on attentional functioning - the impact of substance abuse, psychiatric disorder and time of abstinence

    Page :74-74

    H.J. Kunert, F. Loehrer

    
  • ·Social exclusion and substance dependency: new models of care and interventions?

    Page :74-74

    W. Fakhoury, S. Priebe

    
  • ·Factors related to the use of drugs among medical students

    Page :74-75

    D.X. Da Silveira, L.Q. Rosa-Oliveira, M.P. Oliveira, E. Doering-Silveira, M.C. Di Pietro

    Résumé Résumé Plan Plan
  • ·Predicting an effective treatment for alcohol dependent patients

    Page :75-75

    D.X. Da Silveira, M.B. Terra, M.R. Jorge

    
  • ·Heroin assisted treatment for opioid-dependence: a randomized controlled trial in germany

    Page :75-75

    J. Reimer, U. Verthein, C. Haasen

    
  • ·Reasons for increased rates of violence among persons with schizophrenia

    Page :75-75

    J. Vevera, A. Hubbard, H. Papezova

    
  • ·Posttraumatic stress disorder in a Swiss offender population

    Page :75-76

    A. Rossegger, F. Urbaniok, J. Endrass, T. Noll, S. Vetter

    Résumé Résumé Plan Plan
  • ·Results of the German Research Network on Schizophrenia: Early intervention in the initial prodromal phase

    Page :76-76

    J. Klosterkoetter, A. Bechdolf, S. Ruhrmann

    
  • ·The OPUS trial: Transition from schizotypal disorder to psychotic disorder. A RCT of integrated treatment and standard treatment

    Page :76-76

    M. Nordentoft, A. Thorup, P. Jeppesen, L. Petersen, J. Øhlenschlaeger, G. Krarup, T. Christensen, P. Jørgensen

    
  • ·Results of the German Research Network on Schizophrenia (GRNS): Prodorme-based treatment in first-episode schizophrenia

    Page :76-76

    W. Gaebel, M. Riesbeck

    
  • ·The MESIFOS-trial: Treatment strategies in remitted first episode psychosis

    Page :76-77

    D. Wiersma, A. Wunderink, F.J. Nienhuis, S. Sytema

    Résumé Résumé Plan Plan
  • ·Job opportunities for young psychiatrists in Europe

    Page :77-77

    D. Eraslan, O. Ozturk

    
  • ·Workplace bullying and burn-out syndromes among young psychiatrists in Italy

    Page :77-77

    U. Volpe, G. Piegari, A. Fiorillo

    
  • ·Maximising job satisfaction for young psychiatrists and trainees: Innovative approaches as a way out of the crisis?

    Page :77-78

    J.N. Beezhold

    Résumé Résumé Plan Plan
  • ·Possibilities of young psychiatrists for private practice in Europe

    Page :78-78

    M. Zittis, E. Tzavellas, A. Zachariades, T. Piachas

    
  • ·Intercultural mediation in psychiatry

    Page :78-78

    A. Qureshi, M. Ramos, F. Collazos

    
  • ·Recent clinical advances in cultural psychiatry

    Page :78-78

    R. Bennegadi

    
  • ·Religion and migration : curse or opportunity?

    Page :78-78

    D. Moussaoui

    
  • ·Utilization of psychiatric services among ethnic groups. Results from a nationwide register study

    Page :79-79

    M.C. Kastrup

    
  • ·Outcome of first episode psychosis in the United Arab Emirates: a 5 year retrospective study

    Page :79-79

    M.O. Salem

    
  • ·First Episode Psychosis (FEP): Factors associated with delayed access to care in a rural Egyptian setting

    Page :79-80

    M. El-Adl, M. El-Mahdy, M. Anis

    Résumé Résumé Plan Plan
  • ·First Episode Psychosis: Primary care experience and implications to service development

    Page :80-80

    M. El-Adl, J. Burke, K. Little

    
  • ·The wheel of compliance in schizophrenia

    Page :80-80

    A. Shoka

    
  • ·Autobiographical memory: What have we learned from brain imaging studies

    Page :80-81

    P. Fossati

    Résumé Résumé Plan Plan
  • ·Evidence of long-term memory impairment in schizophrenia

    Page :81-81

    J.M. Danion

    
  • ·Long-term memory and visuospatial navigation

    Page :81-81

    A.A. Ledoux, F.L. Rousseau

    
  • ·Exploring long-term memory and the hippocampus using functional magnetic resonance imaging

    Page :81-81

    J.L. Phillips

    
  • ·The clinical implications of the long-term memory impairment of schizophrenia

    Page :81-81

    P. Boyer

    
  • ·Impulse control disorders: association with obsessive compulsive disorder, addiction and impulsivity

    Page :81-82

    I. Iancu, K. Lowengrub, P.N. Dannon, G. Anholt, C. Alter

    Résumé Résumé Plan Plan
  • ·Networking in psychiatry, towards a new adventure!

    Page :82-82

    V.J. Buwalda, C. Hanon

    
  • ·The situation of training in psychiatry in south eastern europe and the relevance of young psychiatrists networks: Experiences from Croatia

    Page :82-82

    M. Rojnic Kuzman, N. Jovanovic

    
  • ·HPA axis dysfunction in psychiatry: Genetic background

    Page :83-83

    S.J. Claes, F. Van Den Eede, D. van West, J. Del-Favero, C. Van Broeckhoven

    
  • ·Transmission diseqilibrium of chromosome 22q11-13 marks in Chinese Han mixed pedigrees of schizophrenia and mood disorder

    Page :83-83

    Z.H. Yi, Y.R. Fang, S.Y. Yu, W. Hong, Z.W. Wang, J.R. Kelsoe

    
  • ·Attitudes of nurses towards schizophrenia

    Page :83-84

    M. Bras, J. Topic, M. Andelic

    Résumé Résumé Plan Plan
  • ·The Danish OPUS-trial: RCT of standard treatment versus integrated treatment in first episode psychosis. 5 years follow-up

    Page :84-84

    M. Nordentoft, M. Bertelsen, A. Thorup, L. Petersen, J. Ahlenschleger, T. Christensen, G. Krarup, P. LeQuack, P. Jorgensen

    
  • ·Outcome and its predictors in schizophrenia - The northern Finland 1966 birth cohort

    Page :84-84

    E. Lauronen, J. Miettunen, J. Veijola, G. Murray, P. Jones, J. McGrath, M. Isohanni

    
  • ·Familial risk and prodromal features of psychosis in adolescents aged 15-16 years in the northern Finland 1986 birth cohort

    Page :84-85

    P.H. Maki, J. Miettunen, A. Taanila, I. Moilanen, H. Ebeling, M. Joukamaa, E. Lauronen, M.R. Jarvelin, P.B. Jones, G. Murray, M. Heinimaa, J.M. Veijola

    Résumé Résumé Plan Plan
  • ·The efficacy of weight management training in patients with schizophrenia

    Page :85-85

    J. Cordes, J. Thünker, S.J. Kim, D. Geßner-Ozokyay, A. Klimke, H. Hauner

    
  • ·Near-infrared spectroscopy for the guidance of inhibitory rTMS treatment of auditory verbal hallucinations in schizophrenic patients

    Page :85-85

    A.J. Fallgatter, A.-C. Ehlis, M.M. Richter, M.M. Plichta

    
  • ·The effect of long term treatment with olanzapine on neuropsychological prefrontal test in schizophrenia

    Page :85-85

    A. Borkowska, W. Drozdz, A. Roszkowska, J.K. Rybakowski

    
  • ·Schizophrenia research: Ethical questions

    Page :86-86

    L. Nabelek, J. Vongrej, J. Demianova

    
  • ·An objective diagnostic decision support for schizophrenia

    Page :86-86

    S. Nielzen

    
  • ·Encoding deficit during face processing within the fusiform face area in schizophrenia

    Page :86-86

    S. Walther, A. Federspiel, H. Horn, P. Bianchi, R. Wiest, M. Wirth, W.K. Strik, T.J. Muller

    
  • ·Cognitive remediation in schizophrenia: An evidence-based treatment approach?

    Page :86-87

    M. Pfammatter, U.M. Junghan, H.D. Brenner

    Résumé Résumé Plan Plan
  • ·ECT practice in Australia

    Page :87-87

    W. Chanpattana

    
  • ·ECT practice in Asia

    Page :87-87

    W. Chanpattana, B.A. Kramer, G. Kunigiri, B.N. Gang, R. Kitphatic, C. Andrade

    
  • ·A prospective study of metabolic disease and monitoring practices in antipsychotic-treated community psychiatric patients

    Page :87-87

    P. Mackin, D.R. Bishop, H.M. Watkinson

    
  • ·Assessing the needs of pregnant women and mothers with severe mental illness

    Page :87-88

    L.M. Howard, K. Hunt, G. Thornicroft, M. Slade, M. Leese, G. Seneviratne, V. O'Keane

    Résumé Résumé Plan Plan
  • ·Nicotinic cholinergic mechanisms in the regulation of brain DNA-methyltransferase 1 (DNMT1) expression

    Page :88-88

    E. Maloku, R. Satta, A. Zhubi, M. Veldic, B. Kadriu, A. Guidotti, E. Costa

    
  • ·Correlation between serum androgen levels and neuropsychological functions in schizophrenia

    Page :88-88

    A. Elias, A.G. Alias, T. Abraham, E.S. Gilza, S. Sreekumari, E. Mohandas, J.T. Antony, M. Elias

    
  • ·Functional dissection of SLITRK1 signaling

    Page :88-88

    D.E. Grice, Y. Kajiwara, T. Sakurai, J.D. Buxbaum

    
  • ·What does agitation mean in the acute setting?

    Page :89-89

    F. Canas

    
  • ·Sedation is not the opposite of agitation

    Page :89-89

    S. Kasper

    
  • ·Appropriate treatments for agitation associated with schizophrenia: Control of acute agitation and maintenance of efficacy

    Page :89-90

    A. Fagiolini

    Résumé Résumé Plan Plan
  • ·Pharmacological treatment of anxiety disorders - is there a state of the art?

    Page :90-90

    B. Bandelow

    
  • ·Requires severe depression a specific treatment?

    Page :90-90

    S.H. Kennedy

    
  • ·OCD quo vadis? The Cape Town consensus statement

    Page :90-91

    H.G.M. Westenberg

    Résumé Résumé Plan Plan
  • ·Escitalopram - a new option in OCD treatment

    Page :91-91

    N.A. Fineberg

    
  • ·Effective management of depressed mood with agomelatine, a melatonergic antidepressant

    Page :91-91

    G.M. Goodwin

    
  • ·A new pharmacological step: The melatonergic approach

    Page :91-92

    G. Racagni

    Résumé Résumé Plan Plan
  • ·How the internal clock interacts with mood and depression

    Page :92-92

    C. Guilleminault

    
  • ·Beyond efficacy on the core symptoms of depression: Sex and sleep benefits

    Page :92-92

    A.L. Montejo

    
  • ·Impact of medical comorbidities on patients with severe mental illness

    Page :92-92

    S. Leucht

    
  • ·Considerations in the treatment of severe mental illness: Differential profiles of antipsychotics

    Page :92-93

    J.W. Newcomer

    Résumé Résumé Plan Plan
  • ·Toward the reintegration of psychiatry and medicine in patients with mental illness

    Page :93-93

    W.W. Fleischhacker

    
  • ·Dementia with Lewy bodies: A comparison of clinical diagnosis, DaTSCAN imaging and neuropathological diagnosis

    Page :93-93

    Z. Walker

    
  • ·Results of a multi-centre study of DaTSCAN in dementia with Lewy bodies

    Page :93-93

    I. McKeith

    
  • ·The impact of DATscan can have on dementia patients: Case studies

    Page :93-94

    D. Aarsland

    Résumé Résumé Plan Plan
  • ·Schizophrenia and overweight/obesity: Pathophysiology and medical consequences

    Page :94-94

    J. Bobes

    
  • ·Impact of antipsychotic treatment on physical health

    Page :94-94

    M. De Hert

    
  • ·Psychosocial consequences of physical health impairment in schizophrenia

    Page :94-95

    P. Thomas

    Résumé Résumé Plan Plan
  • ·Problem solving in psychopharmacotherapy using pharmacokinetic and pharmacogenetic tests

    Page :96-96

    P. Baumann, E. Jaquenoud Sirot, C. Hiemke, F. Bengtsson

    
  • ·Psychometric evaluation in psychiatry

    Page :96-96

    P. Bech, G. Bech-Andersen

    
  • ·Clinical management of physicians with addictive and mental disorders

    Page :96-97

    P. Lusilla, A. Gual, R. Tyssen, M. Casas

    Résumé Résumé Plan Plan
  • ·Complexity of posttraumatic reactions

    Page :97-97

    T. Franciskovic, R. Gregurek, L. Moro, B. Droždek

    
  • ·Interpersonal psychotherapy of depression

    Page :97-97

    T. Gruettert

    
  • ·Mental health care of migrants

    Page :97-98

    A. Qureshi, F. Collazos

    Résumé Résumé Plan Plan
  • ·Infant psychiatry, its relevance for adult psychiatry

    Page :98-98

    M. Keren, S. Tyano

    
  • ·Delusions - diagnosis and treatment

    Page :98-98

    M. Musalek

    
  • ·Cognitive behavior therapy in anxiety disorders

    Page :98-98

    L-G. Ost

    
  • ·Taking care of ourselves: Managing stress, preventing burnout

    Page :98-99

    W. Roessler, B. Schulze

    Résumé Résumé Plan Plan
  • ·Clinical management of suicidal behaviour: From genetic to therapeutic approach

    Page :99-99

    P.A. Saiz, P. Courtet, M. Bousono, J.P. Soubrier

    
  • ·How to set up an anti-stigma program

    Page :99-99

    H. Stuart, N. Sartorius, J. Arboleda-Florez

    
  • ·Principles of psychiatric interview: How to examine and assess personal experiences

    Page :99-100

    G. Stanghellini

    Résumé Résumé Plan Plan
  • ·How to set up and evaluate a community mental health service for people with severe mentally illness

    Page :100-100

    M. Tansella, G. Thornicroft

    
  • ·The management of eating disorders

    Page :100-100

    J.L. Treasure

    
  • ·Evaluation of compliance with mems in schizophrenic patients and its relationship with clinical and psychopathological variables. Preliminary data

    Page :101-101

    F. Acosta, E. Bosch, G. Sarmiento, N. Juanes, A. Caballero, T. Mayans

    
  • ·Factors associated to persistence of negative symptoms in psychotic patients: Results from the CLAMORS study

    Page :101-101

    C. Arango, J. Bobes, P. Aranda, R. Carmena, M. Garcia-Garcia, J. Rejas

    
  • ·Mental health and dental health: Severe and chronic mental disorders and odontostomatological health. Clinical and care implications

    Page :101-102

    A. Arnaiz, J.J. Uriarte

    Résumé Résumé Plan Plan
  • ·Neuropsychology of schizoaffective disorders

    Page :102-102

    H.J. Assion, F. Balkau, G. Studentkowski, P. Calabrese, G. Juckel

    
  • ·Aripiprazole in child and adolescent psychiatric disorders: Effectiveness preliminary report

    Page :102-102

    P. Auby, M. Nyilas, S. Mallikaarjun, A. Forbes, W.H. Carson

    
  • ·A long term group for patients with psychosis in partial remission

    Page :102-102

    B. Avgustin, N. Perovsek Solinc, M. Blinc Pesek

    
  • ·The importance of long term group therapy for diminishing the stigma of patients with psychosis

    Page :102-103

    B. Avgustin, N. Perovsek Solinc, M. Blinc Pesek

    Résumé Résumé Plan Plan
  • ·A long term group for patients with psychosis - the personal view of a resident of psychiatry

    Page :103-103

    B. Avgustin

    
  • ·Neuropsychological remediation in schizophrenia

    Page :103-103

    C. Guerin-Langlois, A. Mondoloni, B. Beaufils

    
  • ·Effect of clozapine and olanzapine on cortical excitability in schizophrenia

    Page :103-103

    C. Ben Amor, A. Galinowski, B. Gueguen, M.C. Bourdel, R. Waismann, B. Granger, Q. Debray, J.P. Olie, M.O. Krebs

    
  • ·The lactate provocation test to investigate the relationships between panic attacks and delusional disorder: A two case report

    Page :103-104

    G. Bertschy, F. Deshusses-Epelly

    Résumé Résumé Plan Plan
  • ·The assessment of adherence using a questionnaire in patients suffering from schizophrenia

    Page :104-104

    A. Meszaros, I. Bitter

    
  • ·Sertindole: A newly available atypical antipsychotic with placebo level EPS

    Page :104-104

    E. Lindström, A. Björck-Linné, J. Eberhard

    
  • ·Persistence of negative symptoms in psychotic patients: Results from the CLAMORS study

    Page :104-105

    J. Bobes, C. Arango, P. Aranda, R. Carmena, M. Garcia-Garcia, J. Rejas

    Résumé Résumé Plan Plan
  • ·Consensus guideline for the evaluation of physical health in patients with schizophrenia

    Page :105-105

    J. Bobes, J. Saiz-Ruiz, M. Bernardo, M. Gutiérrez, M. Bousoño, J. Sanjuan, E. Baca-García, J. Mostaza

    
  • ·The appearance of negative symptoms in schizophrenic patients with onset in old age

    Page :105-105

    P.O. Bomov, V.G. Budza

    
  • ·Theoretical model of insight

    Page :105-105

    R.G. Bota, D.A. Bota

    
  • ·Empathy as method toward identification the debut of the prodrome of schizophrenia

    Page :105-106

    R.G. Bota, W.F. Ricci, D.A. Bota

    Résumé Résumé Plan Plan
  • ·Induced 49 Hz gamma and event-related coherence in deficit and nondeficit schizophrenia

    Page :106-106

    P. Bucci, A. Mucci, E. Merlotti, U. Volpe, M. Piccirillo, S. Galderisi, M. Maj

    
  • ·Schizophrenia, structural violence and human rights

    Page :106-106

    J.K. Burns

    
  • ·Physical health monitoring in a scottish cohort of schizophrenia patients - the role of ECG and blood pressure monitoring

    Page :106-107

    C. Bushe, O'Neil J., C. Wood, A. Bradley, M. Farren, M. Turner

    Résumé Résumé Plan Plan
  • ·Categorical prevalence of hyperprolactinaemia in schizophrenia and bipolar outpatients in UK recieving antipsychotics

    Page :107-107

    C.J. Bushe, M. Shaw, N. Lidder

    
  • ·Aripiprazole in schizophrenia: Dosing and switching in clinical practice

    Page :107-107

    F. Canas, R. Sanchez

    
  • ·Analysis of the clinical profile of patients with schizophrenia and schizoaffective disorder at the acute care unit (profile 3 study)

    Page :107-107

    L. San, M. Bernardo, A. Gomez de la Camara, C. Puig, C. Castillo, A. Rodriguez

    
  • ·Insight as a predicting factor in the early phases of schizophrenia (Eiffel project)

    Page :108-108

    R. Segarra, I. Eguiluz, M. Gutierrez, I. Ruiz, A. Rodriguez, C. Castillo

    
  • ·Therapeutic adherence and treatment strategies: Registry in mental disease (Adhere study)

    Page :108-108

    F. Canas, J.R. Gutierrez Casares, L.M. Tejeda, A. Rodriguez, C. Castillo

    
  • ·Olanzapine-induced metabolic side effects, switching from olanzapine to ziprasidone: A pilot study

    Page :108-108

    M. Cetin, M. Karagozoglu

    
  • ·Ariprazole in acute schizophrenics

    Page :108-109

    A. Chinchilla Moreno, M. Vega Piñeiro, D. Crespo Hervas, M.F. Pando Velasco, R. Gonzalez Lucas, J. Perez Templado, M. Lazaro Redondo

    Résumé Résumé Plan Plan
  • ·Efficacy and safety with long-acting risperidone at medium high doses

    Page :109-109

    A. Chinchilla Moreno, M. Vega Piñero, M.D. Crespo Hervás

    
  • ·Descriptive analysis of the activity performed at a Depot Clinic

    Page :109-109

    J. Correas-Lauffer

    
  • ·Long-term adherence and health outcomes study with risperdal consta and oral atypicals in the treatment of schizophrenia patients (interim-analysis RIS-SCH-4023)

    Page :109-110

    J. Czekalla, B. Ibach, L. Hargarter, M. Gerwe

    Résumé Résumé Plan Plan
  • ·Diagnostic stability of early-onset psychosis over a two-year follow-up

    Page :110-110

    M.J. de Castro, D. Fraguas, M. Parellada, D. Moreno, A. Ruiz-Sancho, J. Merchan, C. Arango

    
  • ·Frequency of diabetes in 114 French patients with schizophrenia

    Page :110-110

    A. Dervaux, M. Grohens

    
  • ·Olanzapine and pregnancy

    Page :110-110

    A. Dervaux, P. Ichou, F. Pierron, F. Devianne, F. Bavoux

    
  • ·COMPARING risperidone long-acting injection (RLAI) with oral antipsychotics in Spanish patients with schizophrenia using propensity scoring

    Page :110-111

    J. Diels, J.M. Olivares, A. Rodriguez-Morales, S. Caleo

    Résumé Résumé Plan Plan
  • ·Cardiac risk factors and schizophrenia: An analysis of 18,094 patients enrolled in an international comparative trial of olanzapine and ziprasidone

    Page :111-111

    B.L. Strom, G. Faich, S.M. Eng, R.F. Reynolds, F. Rappard, J.M. Kane

    
  • ·The impact of psychoeducational intervention on relatives' views on schizophrenia: Results from an Italian multicenter study

    Page :111-111

    M. Bassi, G. de Girolamo, F. Catapano, A. Fiorillo, F. Romeo

    
  • ·Valuating objectives and effectiveness in psychiatric rehabilitation today: I.C.F. usefulness

    Page :111-112

    V. Fricchione Parise, M.R. Landolfi

    Résumé Résumé Plan Plan
  • ·Emotion recognition and schizophrenia

    Page :112-112

    P. Jaramillo, I. Fuentes, J.C. Ruiz

    
  • ·Premorbid adjustment and neurocognitive functioning in first episode psychosis

    Page :112-112

    E. Garcia de Jalon, M.S. Campos, V. Peralta, M.J. Cuesta

    
  • ·Reflection of psychotic symptoms in paintings

    Page :112-112

    A.G. Nejad, F. Pouya

    
  • ·Affective priming in paranoid schizophrenia treated with olanzapine or risperidone

    Page :112-113

    M. Kuklinska, K. Rataj, E.J. Gorzelanczyk

    Résumé Résumé Plan Plan
  • ·Effects of cigarette smoking on cognitive deficits in first-episode psychosis

    Page :113-113

    M. Gutierrez, S. Enjuto, A. Zabala, C. Fernandez, R. Segarra, A. Gonzalez Pinto, I. Eguiluz

    
  • ·Open-label assessment of the long-term tolerability, safety, and efficacy of sertindole in patients with schizophrenia

    Page :113-113

    A. Hale, R.M. Murray, J.M. Azorin, E. Maehlum

    
  • ·Childhood behavioral and psychological characteristics in schizophrenia - a questionnaire-based retrospective study

    Page :113-113

    Y. Hamasaki, M. Okubo, F. Miyagi, H. Misawa, T. Murai

    
  • ·Assessment of sociodemographic characteristics including employment, income and usual residence of European patients with schizophrenia: results from the Star study

    Page :114-114

    L. Hanssens, L'Italian G., K. Pugner

    
  • ·Oculomotor deficits in schizophrenia: Validation of endophenotypes in a genetically homogenous Icelandic sample

    Page :114-114

    M. Haraldsson, U. Ettinger, B.B. Magnusdottir, T. Sigmundsson, E. Sigurdsson, H. Petursson

    
  • ·Conceptual problems with early detection of prodromal psychosis

    Page :114-114

    M. Heinimaa

    
  • ·Acute phase proteins and personality disorders in schizophrenia

    Page :114-115

    M. Henry, A.L. Morera, A. Garcia-Hernandez, A. Orozco, E. Diaz, T. Rodriguez-Martos, M. Martin, L. Fernandez, C.R. Morales, M. Sangines, R. Gracia

    Résumé Résumé Plan Plan
  • ·Study of the COMT gene in Spanish patients with schizophrenia

    Page :115-115

    J. Hoenicka, L. Espana, X. Alvira-Botero, R. Rodriguez-Jimenez, J. Diez, M.A. Jimenez-Arriero, T. Palomo

    
  • ·The high prevalence of undiagnosed metabolic complications in people with severe mental illness

    Page :115-115

    R.I.G. Holt, R.C. Peveler

    
  • ·New functional single nucleotide polymorphism (Ala72Ser) in the comt gene is associated with aggressive behavior in male schizophrenia

    Page :115-115

    J.P. Hong, S.H. Chung, C.Y. Kim

    
  • ·Time to clinical stabilization and discharge from hospital treatment of patients with schizophrenia after conversion to long-acting risperidone (RIS-CONSTA), ris-siv-401

    Page :115-116

    B. Ibach, L. Hargarter, M. Gerwe, J. Czekalla

    Résumé Résumé Plan Plan
  • ·Plasma glutathion peroxidase in chronic schizophrenics

    Page :116-116

    A. Intxausti, A.L. Morera, P. Abreu, M. Henry, A. Orozco, E. Díaz-Mesa

    
  • ·Psychopathology and global functioning in schizophrenic patients on depot antypsychotics and long-acting injectable risperidone: A six month comparative study

    Page :116-116

    A. Intxausti, A.L. Morera, C.C. González-Hernández, D. Alonso-Diaz, N. González-Brito, D. Hernández-García, M. Henry, A. Orozco, E. Díaz-Mesa, E. de Diego-Herrero

    
  • ·Reduced polypharmacy in patients enrolled in the electronic schizophrenia adherence registry (E-STAR) and treated with risperidone long-acting injection (RLAI) for 6 months

    Page :116-117

    J. Peusekens, J.M. Olivares, H. Hustig, M. Povey, A. Jacobs

    Résumé Résumé Plan Plan
  • ·Substance abuse (SA) does not compromise significant improvements in spanish patients with schizophrenia treated with risperidone long-acting injection (RLAI)

    Page :117-117

    J.M. Olivares, A. Rodriguez, J.A. Buron, A. Rodriguez-Morales, M. Povey, A. Jacobs

    
  • ·Improvements in illness severity and functioning in Australian schizophrenia patients treated with risperidone long-acting injection (RLAI) for 12 months

    Page :117-117

    H. Hustig, T. Lambert, B. Emmerson, M. Povey, A. Jacobs, C. Methven

    
  • ·Duration of untreated psychosis and stigma in psychotic patients - a family view

    Page :117-118

    D.B. Jovanovic

    Résumé Résumé Plan Plan
  • ·Efficacy and tolerability of once-daily quetiapine sustained release in patients with acute schizophrenia: A randomised, double-blind, 6-week, placebo-controlled study

    Page :118-118

    R. Kahn, C. Schulz, V. Palazov, E. Reyes, D. Meulien, M. Brecher, O. Svensson, H.M. Andersson

    
  • ·Reconciling previous DTI studies in schizophrenia

    Page :118-118

    R.A.A. Kanaan, G.J. Barker, X. Chitnis, S.S. Shergill, M. Picchioni, J. Woolley, P.K. McGuire

    
  • ·Correlation indexes between quality of life (QoL) and the current psychopathology in Greek chronic schizophrenics

    Page :118-119

    D. Kandylis, St. Kaprinis, V. Iliadou, M. Magiria-Routsoni, D. Skrimba

    Résumé Résumé Plan Plan
  • ·Wellness program: One-year experiences from the Czech and Slovak Republics

    Page :119-119

    E. Kitzlerová, L. Motlová, E. Dragomirecká, P. Korczog, J. Vránová

    
  • ·The differences between autistic and schizophrenic stereotype: Case report

    Page :119-119

    M.E. Ceylan, F. Ozgun-Roubey, A. Turkcan, A. Kol-Akinci

    
  • ·Continuous attention in dual diagnosis patients

    Page :119-119

    K. Krysta, I. Krupka-Matuszczyk, A. Klasik, M. Matuszczyk, M. Sygut

    
  • ·Facial expression recognition deficits in schizophrenia

    Page :119-120

    F. Laroi, H. Mourad, B. Fonteneau

    Résumé Résumé Plan Plan
  • ·Observational study of patients with schizophrenia in Spain: ACE 2005 study

    Page :120-120

    C. Leal, E. Baca, M. Roca, Y. Riesgo

    
  • ·Specificity of autobiographical memory in schizophrenia: Retrospective and prospective deficits

    Page :120-120

    D. Lecompte, H. Nachtergael, A. Neumann, S. Blairy, P. Philippot

    
  • ·Catatonia after abrupt discontinuation of chronic clozapine treatment

    Page :120-121

    A. Kalogeropoulou, C. Leotsakou, I. Fotara, C. Karkatzouli, K. Loulakaki, E. Datsi, M. Giovanoglou, P. Paterakis

    Résumé Résumé Plan Plan
  • ·First diagnoses in schizophrenic patients

    Page :121-121

    I. Lerma-Carrillo, M. Leonor, F. Pascual, F. Mora, S. de Pablo, T. Cuevas-Duran, J.D. Molina

    
  • ·The role of long-acting risperidone in antipsychotic polypharmacy: Retrospective study in a brief hospitalization unit

    Page :121-121

    I. Lerma-Carrillo, J.D. Molina, S. de Pablo, F. Mora, M. Leonor, F. Pascual, T. Cuevas-Duran

    
  • ·The role of psychiatrist on prescription of psychotropic drugs in schizophrenic patients in a psychiatric brief hospitalization unit

    Page :121-121

    I. Lerma-Carrillo, F. Mora Minguez, S. de Pablo, M. Leonor, F. Pascual, T. Cuevas-Duran, J.D. Molina

    
  • ·Predicting the revolving door phenomenon in schizophrenic patients

    Page :121-122

    I. Lerma-Carrillo, F. Pascual, F. Mora, S. De Pablo, M. Leonor, T. Cuevas-Duran, J.D. Molina

    Résumé Résumé Plan Plan
  • ·Challenges and options in the treatment of schizophrenia

    Page :122-122

    S. Leucht, J. Loughran, J. Van Os, M. Davidson, P. Munk-Jorgensen

    
  • ·Akathisia in schizophrenia patients treated with aripiprazole, haloperidol, or olanzapine - analysis of three double-blind, long-term trials

    Page :122-122

    J. Loze, S. Talbott, J. Eudicone, R.D. McQuade, P.F. Buckley

    
  • ·A clinical trial with olanzapine in schizophrenia with allele variation of the DRD4 and maoa gene

    Page :122-123

    F.W. Lung, T.S. Cheng

    Résumé Résumé Plan Plan
  • ·PSIC - early intervention community program for schizophrenia

    Page :123-123

    T. Maia, B. Lopes, S. Jorge, J. Alexandre, G. Cardoso

    
  • ·An audit of risperidone long acting injection in clinical practice

    Page :123-123

    B.G. Mangan, C. Gilmurray

    
  • ·What is the aim when the psychiatrist is treating a person suffering schizophrenia?

    Page :123-124

    M.A. Franco, E. González-Pablos, J.C. Velasquez, E. Gaitero, D. Moreno, J.L. De la Serna, R. Barba, T. Orihuela, A. Valenzuela

    Résumé Résumé Plan Plan
  • ·Comorbidity of schyzophrenia and disorders due to psychoactive substance use

    Page :124-124

    M. Perez Garcia, S. Martinez Formoso, M. Tajes Alonso, M. Paramo Fernandez

    
  • ·Intramuscular aripiprazole for the treatment of acute agitation associated with schizophrenia: Sub-analysis of a double-blind, controlled, dose-ranging study

    Page :124-124

    D.A. Oren, G. Manos, O. Markovic, R.D. McQuade

     
  • ·Transitioning from intramuscular (IM) to oral aripiprazole in patients with schizophrenia

    Page :124-125

    D.G. Daniel, O. Markovic, D. Crandall, G. Manos, R.D. McQuade, R. Gutierrez-Esteinou, A. Pikalov, D.A. Oren

    Résumé Résumé Plan Plan
  • ·Treatment of obsessive-compulsive symptoms in schizophrenic patients

    Page :125-125

    M. Maroufi, F. Kianvash, M. Marofi

    
  • ·Psychogenic psychosis: Validity of diagnosis

    Page :125-125

    S. Formoso Martinez, M. Tajes Alonso, R. Lamas Naveira

    
  • ·Negative symptoms predict functional outcome of early-onset psychosis

    Page :125-125

    J. Merchan-Naranjo, D. Fraguas, M.J. De Castro, M. Parellada, D. Moreno, A. Ruiz-Sancho, A. Cifuentes, M. Leiva, C. Arango

    
  • ·Health professionals and misconceptions associate with patients with schizophrenia

    Page :126-126

    A. Mihai, M. Toma, M. Pop

    
  • ·Factors associated with caregiver psychological distress in chronic schizophrenia

    Page :126-126

    C.I. Mitsonis, N.K. Pagkalis, N.P. Dimopoulos, K.I. Liolios, K.E. Stamatopoulou, N.M. Andriotis, N.K Kariki, F.E. Tsakiris, E.E. Maragkoudaki, M.E. Katsanou

    
  • ·Survey of reasons to switch to sertindole in the treatment of schizophrenia

    Page :126-126

    A. Mittoux, P. Tanghoj, J. Peuskens

    
  • ·Continued efficacy and tolerability in clinically stable patients switched from quetiapine immediate release (IR) to quetiapine sustained release (SR)

    Page :126-127

    H.J. Moeller, S. Johnson, T. Mateva, D. Meulien, M. Brecher, O. Svensson, F. Miller

    Résumé Résumé Plan Plan
  • ·Repetitive transcranial magnetic stimulation and rehabilitation of cognitive functions in schizophrenia

    Page :127-127

    P. Mohr, M. Rodriguez, T. Novak, M. Kopecek, J. Horacek, Y. Hendrychova, R. Zalesky, R. Kawaciukova, M. Preiss, D. Seifertova

    
  • ·Interventions in a fringe patient

    Page :127-127

    E. Botzakis, E. Chourdaki, A. Pontikaki, A. Vardiabasis, S. Monezis, N. Paritsis

    
  • ·Volumetric reduction of the corpus callosum and interhemispheric transfer in subjects with first-episode psychoses: A voxel-based morphometry

    Page :127-128

    T.M. Chaim, F.L. Duran, M.S. Schaufelberger, A.M. Ayres, M. Scazufca, P.R. Menezes, E.J. Amaro, C.C. Leite, R.M. Murray, P.K. McGuire, T.M. Rushe, G.F. Busatto

    Résumé Résumé Plan Plan
  • ·Does the legal status affect the outcome of inpatients with schizophrenia?

    Page :128-128

    A. Nawka, J. Raboch, L. Kuklova, E. Kitzlerova, L. Kalisova, M. Cerny, L. Cihal, T.W. Kallert

    
  • ·The frontal assessment battery (FAB) compared to the stroop test in schizophrenia

    Page :128-128

    S. Spyridi, I. Nimatoudis, S. Kantartzis, S. Sokolaki, P. Panagiotidis, Z. Nassika, G. Kaprinis

    
  • ·The frontal assessment battery at bedside (FAB) in patients with schizophrenia

    Page :128-128

    I. Nimatoudis, S. Spyridi, S. Kantartzis, S. Sokolaki, P. Panagiotidis, Z. Nassika, G. Kaprinis

    
  • ·Stroop color word test performance in first episode and chronic psychotic patients

    Page :128-129

    I. Nimatoudis, S. Spyridi, S. Kaprinis, P. Panagiotidis, S. Siamouli, K. Fountoulakis, A. Iacovides, G. Kaprinis

    Résumé Résumé Plan Plan
  • ·The efficacy and safety of clozapine therapy for the community-based management of psychotic disorders

    Page :129-129

    A.M. Ni Mhaolain, W. Afolabi, J.S. Butler, J.H. Thakore

    
  • ·Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the opus trial. A randomized clinical trial of integrated treatment and standard treatment

    Page :129-129

    M. Nordentoft, P. Jeppesen, L. Petersen, A. Thorup, J. Øhlenschlaeger, T. Christensen, G. Krarup, P. Jørgensen

    
  • ·Executive dysfunction and insight in schizophrenic patients

    Page :129-130

    C. Silveira, R. Curral, A. Norton, S. Costa, I. Domingues, F. Barbosa, A. Palha

    Résumé Résumé Plan Plan
  • ·Number needed to treat (NNT) for all-cause medication discontinuation in catie compared to the schizophrenia outpatients health outcomes (SOHO) study

    Page :130-130

    D. Novick, D. Suarez, H. Ascher-Svanum, J. Karagianis, E. Perrin, J.M. Haro, J. Alonso, I. Gasquet, J.M. Haro, P.B. Jones, J. Lepine

    
  • ·Aripiprazole in child and adolescent psychiatric disorders: Safety, tolerability, and pharmacokinetics

    Page :130-130

    M. Nyilas, P. Auby, S. Mallikaarjun, A. Forbes, W.H. Carson

    
  • ·The "C.A.P. 13": A new clinical assesment of psychosis

    Page :130-130

    B. Odier, S. Gauthier, V. Souffir

    
  • ·Long-term effect of olanzapine on caudate volume in schizophrenic patients

    Page :130-131

    G. Okugawa, K. Takase, K. Nobuhara, Y. Saito, T. Kinoshita

    Résumé Résumé Plan Plan
  • ·Once-year experience with aripiprazole in acute care units. Recommendations for use

    Page :131-131

    J. Orta, R. Dueñas, A. Arévalo

    
  • ·First psychotic episode - a descriptive study

    Page :131-131

    A. Marques, S. Pereira, M. Martins

    
  • ·Antipsychotic treatment and the need for hospitalization: advantages of long-acting neuroleptics

    Page :131-132

    M. Perez Garcia, M. Paramo Fernandez, V. Prado Robles, J. Alonso San Gregorio, J. Perez Perez, I. Tortajada Bonasselt

    Résumé Résumé Plan Plan
  • ·Belgian schizophrenia outcome survey (SOS)

    Page :132-132

    J. Peuskens, B. Gillain, D. De Graeve, B. Van Vleymen, A. Albert

    
  • ·Randomised, placebo-controlled, relapse-prevention study with once-daily quetiapine sustained release in patients with schizophrenia

    Page :132-132

    J. Peuskens, J.K. Trivedi, S. Malyarov, M. Brecher, O. Svensson, F. Miller, I. Persson, D. Meulien

    
  • ·Contributions of psychopatology and cognitive impairment to social functioning in patients with schizophrenia

    Page :132-133

    G. Piegari, A. Mucci, S. Garramone, F. Maddalena, M. Capuano, S. Galderisi, M. Maj

    Résumé Résumé Plan Plan
  • ·Semantic fluency in schizophrenia

    Page :133-133

    C.A. Popescu, I.V. Miclutia, R. Macrea, I. Craciun, A. Zaharia

    
  • ·Anomalous subjective experiences as a tentative new direction for a youth-targeted psychometric high-risk approach

    Page :133-133

    A. Raballo, C. Cattaneo, G. Castignoli

    
  • ·Anomalous incipiency in self-narratives: A naturalistic, qualitative exploration of self-experienced liability in prodromal patients

    Page :133-133

    A. Raballo, E. Semrov

    
  • ·Prevalence of the metabolic syndrome (MS) in psychotic patients using two proposed NCEP-ATP-III definitions: Results from the clamors study

    Page :134-134

    J. Rejas, J. Bobes, C. Arango, P. Aranda, R. Carmena, M. Garcia-Garcia

    
  • ·An alternative approach to measuring treatment persistence with antipsychotic agents among patients with schizophrenia

    Page :134-134

    X.S. Ren, S. Qian, L.E. Kazis

    
  • ·Assessment of akathisia in acute schizophrenia and schizoaffective disorder patients: A pooled analysis of 5 placebo-controlled, double-blind studies with aripiprazole

    Page :134-135

    Y. Riesgo, S. Talbott, J. Eudicone, R. Owen, Q. Tran, A. Pikalov, J. Kane

    Résumé Résumé Plan Plan
  • ·Profile of the schizophrenic patient treated with aripiprazole in Spain. REA study

    Page :135-135

    F. Cañas, M. Camacho, S. Ros, M. Serrano, Y. Riesgo, J. Luque

    
  • ·Retrospective, observational, post-authorization study to obtain a second profile of schizophrenic patients treated with aripiprazole in Spain. Study REA II

    Page :135-135

    F. Cañas, M. Camacho, S. Ros, M. Serrano, Y. Riesgo, P. Hernanz, P. Vieitez

    
  • ·Clinical and treatment features of patients with schizophrenia in Spain: ACE 2004 study

    Page :135-135

    M. Roca, C. Leal, E. Baca, Y. Riesgo

    
  • ·Correlation between cognitive functions and the PANSS cognitive factor in schizophrenic patients

    Page :135-136

    R. Rodriguez-Jimenez, I. Martinez, M.A. Jimenez-Arriero, G. Ponce, A. Bagney, M. Aragues, A. Koeneke, P. Carretero, G. Rubio, T. Palomo, P.A.R. Group

    Résumé Résumé Plan Plan
  • ·Clinical and neuropsychological differences in schizophrenia according to negative symptom PANSS scores

    Page :136-136

    M.A. Jimenez-Arriero, R. Rodriguez-Jimenez, G. Rubio, I. Martinez, M. Aragues, A. Koeneke, A. Bagney, P. Carretero, G. Ponce, T. Palomo, P.A.R. Group

    
  • ·Efficacy and tolerability of switching from conventional and atypical antipsychotics to ziprasidone in acute schizophrenic patients

    Page :136-136

    C. Mencacci, A. Filippo, F. Rappard, P. Tiradritti, F. Romeo

    
  • ·Efficacy and tolerability of intramuscular and oral ziprasidone in acute and agitated schizophrenic patients: An 8-week, open-label trial

    Page :136-137

    C. Munizza, A. Mautone, F. Rappard, P. Tiradritti, F. Romeo

    Résumé Résumé Plan Plan
  • ·Remission in psychotic chronic patients. Is it really possible?

    Page :137-137

    S.L. Romero Guillena, J.L. Vélez Noguera

    
  • ·Disability and social cognicion in schizophrenia

    Page :137-137

    S.L. Romero Guillena, N. Casas Barquero, I. Garcia Ramirez

    
  • ·ESPASS study: Baseline characteristics of the included schizophrenic patients

    Page :137-138

    F. Rouillon, J. Loze, D. Leguay, I. Gasquet, R. Arnaud, J. Azorin

    Résumé Résumé Plan Plan
  • ·Frequency of sexual dysfunction in patients with schizophrenia

    Page :138-138

    H. Salvan, M. Stanculete, R. Macrea

    
  • ·Incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder

    Page :138-138

    R. Sanchez, E. Kim, J. Eudicone, A. Pikalov, E. Vester-Blokland, D.D. Miller

    
  • ·Prevalence of the metabolic sindrome among schizophrenic patients

    Page :138-139

    T. Sanchez-Araña Moreno, J.L. Hernandez Fleta, M. Terres Ruiz, J.M. Brito Jinorio, A. Salesansky Davidovsky, E. Zerek Benitez, A. Dominguez Santana

    Résumé Résumé Plan Plan
  • ·High prevalence PF metabolic syndrome in schizophrenic patients: A review of the literature

    Page :139-139

    T. Sanchez-Araña Moreno, J.L. Hernandez Fleta, M.E. Terres Ruiz, J.M. Brito Jinorio, A. Salesansky Davidovsky, A. Dominguez Santana, E. Zerek Benitez

    
  • ·Are European psychiatrists concerned about the physical health of their patients suffering from schizophrenia?

    Page :139-139

    D. Saravane, H. Millar, L. Hanssens, F. Moutard-Martin

    
  • ·Remission, functioning and treatment adherence in psychotic patients

    Page :139-139

    M.M. Serrano Carton, M. Serrano Vazquez, M.C. Serrano Carton

    
  • ·Affective disorders in the elderly: Descriptive study in acute psychiatric unit for 10 years

    Page :139-140

    M. Serrano Vazquez, M.M. Serrano Carton

    Résumé Résumé Plan Plan
  • ·Information technology aided relapse prevention in schizophrenia: ITAREPS

    Page :140-140

    F. Spaniel, L. Motlova

    
  • ·Cognitive deficits in relatives of patients with schizophrenia

    Page :140-140

    M. Stanculete, I. Miclutia, A. Zaharie

    
  • ·Denial of stigma

    Page :140-140

    M. Strbad, S. Demsar, V. Svab

    
  • ·How to reduce discrimination of patients with severe mental illness among future doctors?

    Page :140-141

    V. Svab

    Résumé Résumé Plan Plan
  • ·Identification of potential predictors of sertindole response in patients with schizophrenia

    Page :141-141

    C. Tamminga, P. Tanghoj, J. Eberhard

    
  • ·Cross-sectional remission of schizophrenia symptoms with quetiapine compared with haloperidol: An analysis of four randomised, controlled trials

    Page :141-141

    K. Timdahl, G. Stening

    
  • ·Contribution to the autoimmunity and immune system dysregulation theory of schizophrenia: Case report of the patient with four autoimmune diseases and psychosis schizoaffectiva

    Page :141-141

    S.M. Todorovic, Z. Vinkovic

    
  • ·Remission in schizophrenia application of a "new concept" on an "old study"

    Page :141-142

    J. Tolna, M. Farkas, B. Petho

    Résumé Résumé Plan Plan
  • ·The autolytic risk at the pacients with schizophrenia

    Page :142-142

    M. Toma, A. Mihai

    
  • ·Socio-demographic and clinical characteristics of 2040 schizophrenic outpatients in Greece (The Greek ‘ACE' study)

    Page :142-142

    E.C. Tsiolka, V.G. Mavreas, I.A. Chatzimanolis, A.A. Karavatos

    
  • ·Treatment patterns of schizophrenic outpatients in Greece (The Greek ‘ACE' study)

    Page :142-143

    E.C. Tsiolka, I.A. Chatzimanolis, A.A. Karavatos, V.G. Mavreas

    Résumé Résumé Plan Plan
  • ·Most frequently observed adverse events among schizophrenic outpatients in Greece (The Greek 'ACE' study)

    Page :143-143

    E.C. Tsiolka, A.A. Karavatos, V.G. Mavreas, I.A. Chatzimanolis

    
  • ·Contribution of extramural psychiatric care units in the treatment of psychosis in rural population

    Page :143-143

    P. Panagoutsos, I. Syros, D. Tzavaras, A. Tourka

    
  • ·Extramural psychiatric care units in the treatmenta of psychosis in rural population: Investigation of the number and duration of relapses in a 5-year study

    Page :143-144

    P. Panagoutsos, D. Tzavaras, A. Tourka, I. Syros

    Résumé Résumé Plan Plan
  • ·Functional adjustment of patients with first episode of schizophrenia - one year follow up

    Page :144-144

    L. Vavrusova

    
  • ·Analisys of the adherence of schizophrenic patients to therapeutic programmes

    Page :144-144

    J.C. Villalobos Vega

    
  • ·Hyperprolactinaemia in patients with schizophrenia treated with risperidone or olanzapine, correlations with age of patients and lengh of treatment

    Page :144-145

    A. Wyszogrodzka-Kucharska, J. Rabe-Jablonska

    Résumé Résumé Plan Plan
  • ·Subjective attitude towards antipsychotics and neurocognitive functions in schizophrenic inpatients

    Page :145-145

    B.H. Yoon, A. Bae, Y.H. Sea, K.J. Kim, S.H. Park, W.M. Bahk

    
  • ·Neuropsychological functioning in early-onset first-episode psychosis: lack of differences among diagnostic subgroups

    Page :145-145

    A. Zabala, I. Bombin, M. Rapado, P. Andres, C. Gonzalez, M. Mayoral, O. Robles, J.M. Rodriguez, E. de la Serna, C. Arango

    
  • ·Cognitive functioning in schizophrenic patients and their siblings

    Page :145-145

    A.M. Zaharie, I.V. Miclutia, C.A. Popescu, M. Stanculete

    
  • ·Use of antipsychotic drugs in lithuanian clinical practice

    Page :145-146

    V. Adomaitiene, E. Kadusevicius, L. Katajceva

    Résumé Résumé Plan Plan
  • ·Evaluation study on patient's attitude towards the psychiatric treatment

    Page :146-146

    J.A. Aguado, O. Segurado, R.M. San Miguel

    
  • ·Being widowed - a high risk period for suicide

    Page :146-146

    V. Ajdacic-Gross, E. Gadola, C. Lauber, M. Bopp, F. Gutzwiller, W. Rossler

    
  • ·Prediction of antipsychotics gene targets by integration of genomic, evolutionary, and gene expression data

    Page :146-147

    A. Ambesi-Impiombato, F. Panariello, A. de Bartolomeis, G. Muscettola

    Résumé Résumé Plan Plan
  • ·Validation of a 'satisfaction from psychiatric training' questionnaire

    Page :147-147

    G.D. Giaglis, K. Mantziava, G.F. Angelidis

    
  • ·Emotional profile of women victims of domestic violence

    Page :147-147

    E. Avdibegovic, O. Sinanovic

    
  • ·Attitudes toward the mentally ill in a sample of professionals working in general and clinical praxis

    Page :147-147

    E. Avdibegovic, M. Brkic, Z. Selimbasic

    
  • ·Sucide of people with mental disorders in war and peace circumstances

    Page :147-148

    E. Avdibegovic, M. Jarakovic, O. Sinanovic

    Résumé Résumé Plan Plan
  • ·Understanding crisis: First steps of validation of crisis integration scale (CIS)

    Page :148-148

    J.P. Bacchetta, A. Zanello, M. Varnier, A. Zinetti Bertschy, A. Fredenrich-Muehlebach, M.C.G. Merlo

    
  • ·What do they think of us? Opinions of general hospital ward staff on a CLP service

    Page :148-148

    V. Barbanti Silva, S. Ferrari, M. Rigatelli

    
  • ·Associations between demographic and other factors and outcomes of formal assessment for compulsory admission in Norfolk, UK

    Page :148-148

    J.N. Beezhold, G. Mosa

    
  • ·Safety and effectiveness of intramuscular psychotropic drugs in acutely agitated patients - a Pan-European study

    Page :148-149

    E. Bonnett-Perrin, A. Ballerini, Y. Dyachkova, S. Godanci, S. Reiter, T. Wagner

    Résumé Résumé Plan Plan
  • ·Schizophrenia and substance use disorders: Effects of zyprasidone treatment

    Page :149-149

    J. Canete, I. Alonso, F. Baron, G. Gonzalez

    
  • ·Changes in prolactin in olanzapine-treated adolescents with schizophrenia or bipolar mania: A pooled analysis of 4 studies

    Page :149-149

    C. Robertson-Plouch, G. Carlson, M. DelBello, R. Findling, R. Kowatch, S.C. Schulz, L. Kryzhanovskaya, W. Xu, J. Carlson, M. Tohen

    
  • ·Changes in metabolic parameters in olanzapine-treated adolescents with schizophrenia or bipolar I disorder: A pooled analysis of 4 studies

    Page :149-150

    L. Kryzhanovskaya, G. Carlson, M. DelBello, R. Findling, R. Kowatch, S.C. Schulz, C. Robertson-Plouch, W. Xu, G. Sethuraman, J. Carlson, M. Tohen

    Résumé Résumé Plan Plan
  • ·Olanzapine-induced metabolic abnormalities, switching from olanzapine to aripiprazole

    Page :150-150

    M. Cetin, M. Karagozoglu

    
  • ·Adherence to treatment and risperidone metabolism phenotypes

    Page :150-150

    A. Ceverino, E. Baca-Garcia, M.M. Perez-Rodriguez, I. Basurte, A. Fernandez del Moral, M.A. Jimenez Arriero, A. Llerena, P. Dorado, R. Alamis, J. De Leon

    
  • ·Effect of nice guidance on treatment of outpatients with schizophrenia in a uk depot clinic

    Page :150-151

    A. Crockett, M. Goldstein

    Résumé Résumé Plan Plan
  • ·Long-acting risperidone improves negative symptoms in stable psychotic patients

    Page :151-151

    V.A. Curtis, K. Katsafouros, H.J. Moeller, R. Medori, E. Sacchetti

    
  • ·Patients attending a psychiatric emergency service: What do they really want?

    Page :151-151

    J. De Fruyt, H. Vervaeke, M. Haspeslagh, S. Aneca, H. van den Ameele

    
  • ·Trp64Arg beta3 adrenergic polymorphism in antipsychotic-induced weight gain and obesity: A meta-analysis

    Page :151-152

    V. De Luca, L. Sickert, C. Rothe, D.J. Mueller, M. Romona-Silva, A. de Bartolomeis, J.L. Kennedy

    Résumé Résumé Plan Plan
  • ·Weight gain in patients with risperidone injection

    Page :152-152

    A. De Sebastián, I. Ramos

    
  • ·Psychiatry and culture: A journey througout mental disorders and its socio-cultural context

    Page :152-152

    V. Domingues, M. Santos, M. Roque

    
  • ·Psychopharmacologic evaluation in a group of psychotic patients

    Page :152-153

    J.A. Dorado Primo, C. Balmon Cruz

    Résumé Résumé Plan Plan
  • ·Acceptability and impact of partial smoking ban, followed by a total smoking ban in a psychiatric hospital

    Page :153-153

    M. Etter, N. Khan, J.F. Etter

    
  • ·Characteristics of the handling of amisulpride in a brief internment unit

    Page :153-153

    A. Vispe, J.G. Valdecasas, D. Diaz, E. Diaz, M. Sangines

    
  • ·The impact of total calories and fat content on steady-state serum ziprasidone concentrations in patients receiving oral ziprasidone

    Page :153-153

    K. Gandelman, J. Alderman, P. Glue, M. Versavel, S. Preskorn

    
  • ·It is a correlation between the pharmacological heterogeneity and clinical effect of atypicals?

    Page :153-154

    M.D. Gheorghe, G. Grigorescu

    Résumé Résumé Plan Plan
  • ·Neuroleptics and cancer

    Page :154-154

    G.J. Gómez-Bernal, A. Reboreda, M. Bernal, F. Romero, E. Esteban

    
  • ·Prolactin serum blood levels in patients on antipsychotic treatment: A prevalence study

    Page :154-154

    E. Gonzalez Pablos, L. Minguez Martin, F.J. Garcia Sanchez, C.F. Salgado Pascual, I. Herreros Gilaber, M. Esteban Iglesias, F. Primo Herrero, M.C. Bombim Puyo

    
  • ·Attitude of nurses and nursing students towards sexual minorities

    Page :154-154

    V. Grigaliuniene, J. Gedgaudaite, B. Burba, O. Jankuviene, A. Jaras

    
  • ·Olazepine (Zalasta) treatment of residual phenomenology in patients with long-term schizophrenic disorder

    Page :154-155

    G. Hadzi-Angelkovski, S. Arsova, V. Vujovic, N. Simonovski, L. Aleksovska, M. Stanoevska

    Résumé Résumé Plan Plan
  • ·Metabolic risk of atypical antipsychotics: Individualising treatment to improve mental and physical wellness

    Page :155-155

    C.U. Correll, L. Hanssens

    
  • ·Costs of out-of-area treatment: Patterns in 5 London boroughs

    Page :155-155

    A. Hassiotis, C. Parkes, B. Fitzgerald, R. Romeo

    
  • ·Experience about therapeutic adherence and clinical remission in patients with severe mental disease in a community mental health center

    Page :155-155

    J.L. Hernandez Fleta, M.E. Terres Ruiz, T. Sanchez-Araña Moreno, A. Salesansky Davidovsky, A. Dominguez Santana, E. Zerek Benitez

    
  • ·Experience with out-patients treated with long-acting injectable risperidone

    Page :155-156

    P.M. Holgado Madera, J. Diez Martin, E. Bermudez Vazquez, R. Lopez Mateos

    Résumé Résumé Plan Plan
  • ·Mean change in panss positive subscale during hospitalization in patients treated with risperidone

    Page :156-156

    C. Huergo, G. Fernandez

    
  • ·Risk of violence in hooligans using the PFAV scale

    Page :156-156

    L. Jimenez-Trevino, M. Navio-Acosta, C. Larena, L. Villoria, P.A. Saiz-Martinez, M.P. Garcia-Portilla, M.T. Bascaran, M. Bousono-Garcia, J. Saiz-Ruiz, J. Bobes

    
  • ·The impact of food on absorption of ziprasidone

    Page :156-156

    A. Jina, J. Alderman, J. Miceli, K. Wilner

    
  • ·Psychiatric disorders in homeless Iranian adolescent girls

    Page :156-157

    S. Karami, M.R. Eskandari

    Résumé Résumé Plan Plan
  • ·Metabolic and inflammatory parameters changes in schizophrenic patients during three months of treatment with long acting risperidone

    Page :157-157

    D. Karlovic, V. Solter, J. Potkonjak

    
  • ·Long-term efficacy of aripiprazole to treat psychosis in schizophrenia: Sub-analysis of two double-blind, haloperidol controlled studies

    Page :157-157

    S. Kasper, R.D. McQuade, W.H. Carson, R.N. Marcus

    
  • ·Arsenic trioxide and olanzapine co-administration: Case analysis

    Page :157-158

    K.R. Kaufman, S. Chhabra, H. Suss, R. Sotsky, M.J. Levitt, S.S. Rose

    Résumé Résumé Plan Plan
  • ·Themes in cultural competence: II. impaired access to mental health treatment with acetaminophen overdose

    Page :158-158

    K.R. Kaufman, H. Suss, E.S. Hwang, J.F. Schiltz, C.E. Skotzko

    
  • ·A novel electronic continuous medical education system for clinical psychiatry and neuroimaging

    Page :158-158

    S.A. Kofteros, G.J. Konnis, M. Behr, P. Bitsios, P. Brambila, S. Frangou, S. Poulimenos

    
  • ·Young medical professionals' attitudes towards assisted death activities

    Page :158-158

    V.P. Kontaxakis, K.G. Paplos, P.P. Ferentinos, M.I. Kontaxaki, M.D. Dasopoulou, G.N. Christodoulou

    
  • ·The differentiated medicament correction of psychoemotional infringements at the induced pregnancy

    Page :159-159

    S. Kulchimbayeva, N. Mamedalieva, Y. Djangildin

    
  • ·Switching to long-acting injectable risperidone: Beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia

    Page :159-159

    M.A. Latif, P. Saleem, P. Glue, W.J. Arnoldussen, R. Teijeiro, A. Lex, T. De Marinis

    
  • ·Risperidon vs haloperidol in treatment of schizophrenia

    Page :159-159

    P. Maksuti, V. Kola, E. Roshi

    
  • ·Dosing patterns in Europe: Efficacy and safety of RLAI in doses 25-50mg

    Page :159-160

    M.C. Mauri, M. Turner, L.S. Volonteri, R. Medori, W. Maier

    Résumé Résumé Plan Plan
  • ·Attitudes towards suicidal behaviours among health science students

    Page :160-160

    I. Menendez, E. Garcia, M.P. Garcia-Portilla, M.T. Bascaran, S. Martinez, L. Jimenez, P.A. Saiz, M. Bousono, J. Bobes

    
  • ·Risperidone long acting injection: One year experience

    Page :160-160

    N. Mercadillo, N. Mathur, S. Sundaresh, S.I. Aslam, R.H. Giridhar

    
  • ·Topographic and tomographic EEG changes after a single oral dose of antipsychotic drugs in healthy young subjects

    Page :160-161

    E. Merlotti, A. Mucci, P. Bucci, U. Volpe, V. Montefusco, S. Galderisi, M. Maj

    Résumé Résumé Plan Plan
  • ·Preliminary results of the Belgian lifestyle program ENERGIE on weight in patients with psychiatric disorders

    Page :161-161

    C. Mertens, M. De Hert, M. Floris, C. Matton

    
  • ·Migration and schizophrenia spectrum disorders: Evidence from Romania

    Page :161-161

    I.V. Miclutia, V. Junjan, C.A. Popescu, S. Tigan

    
  • ·Akathisia: Old challenge for new antipsychotic agents

    Page :161-161

    M. Mihanovic, D. Bodor, P. Filakovic, M. Grah, S. Devčic, D. Sago, I. Sain

    
  • ·2nd generation antipsychotics for refractory generalized anxiety disorder

    Page :161-162

    V. Psarra, N. Dimopoulos, C. Mitsonis

    Résumé Résumé Plan Plan
  • ·Do extrapyramidal syndromes influence the patients' mortality?

    Page :162-162

    J. Modestin, M. Vogt Wehrli, P. Agarwalla, P.L. Stephan

    
  • ·Insomnia and excessive daytime sleepiness in psychotic patients taking traditional or atypical antipsychotic medications

    Page :162-162

    S. Montaldo, A.R. Collu, V. Nonnoi, A. Campus, G.L. Pillai, M. Pinna, D. Primavera, B. Carpiniello

    
  • ·QT interval and dispersion in very young children treated with antipsychotic drugs

    Page :162-162

    E. Nahshoni, S. Spitzer, M. Berant, G. Shoval, G. Zalsman, A. Weizman

    
  • ·Acutely disturbed behaviour in psychiatry: A survey of current practice

    Page :162-162

    I. Wimalaratne, K.S. Naidoo

    
  • ·Status epilepticus in a patient treated with olanzapine and mirtazapine

    Page :163-163

    S. Spyridi, S. Sokolaki, M. Siamouli, I. Nimatoudis, A. Iacovides, G. Kaprinis

    
  • ·The increased need for liaison psychiatry in surgical patients due to the high prevalence of undiagnosed anxiety and depression

    Page :163-163

    A.M. Ni Mhaolain, J.S. Butler, P.F. Magill, A.E. Wood, J. Sheehan

    
  • ·Improvement of tardive dyskinesia with aripiprazol use. Case report and review of 4 cases

    Page :163-163

    R. Osorio, A. Hurtado-Mendoza, L. Agüera, I. Ramos

    
  • ·Survey of facilities available in psychiatric clinics to check blood pressure, ECG and associated training requirements

    Page :163-164

    R. Paranthaman, F. Alam, P. Mbaya

    Résumé Résumé Plan Plan
  • ·Coercion and antipsychotic medication for voluntary out-patients: Depot versus oral

    Page :164-164

    M.X. Patel, N. De Zoysa, M. Bernadt, J. Bindman, A.S. David

    
  • ·Depression - Causes and remedies

    Page :164-164

    M. Popa

    
  • ·Ziprasidone in hospitalized patients with schizophrenia: Evidence supporting rapid dose titration

    Page :164-164

    F. Rappard, D. Vanderburg, L. Warrington, R. Yang

    
  • ·Use of long lasting risperidone in hospitalized patients

    Page :164-165

    M.N. Rodriguez, F. Romero Marmaneu, I. Zaera Cuadrado, C. Ramos Vidal, M. Villar Garcia

    Résumé Résumé Plan Plan
  • ·Long-term efficacy of ziprasidone in treatment-resistant schizophrenia: Results from the 1-year, open-label mozart extension study

    Page :165-165

    E. Sacchetti, A. Galluzzo, F. Romeo, B. Gorini, F. Rappard

    
  • ·Adverse events of antypsychotics during therapy of patients with schizophrenia

    Page :165-165

    I. Sain, D. Sago, A. Bogovic, A. Silic, A. Slavicek, M. Mihanovic, D. Bodor

    
  • ·Descriptive study about long-acting injectable risperidone (RLAI) in outpatients

    Page :165-166

    R. Sala Cassola, O. Sobrino Cabra, C. Moreno Menguiano

    Résumé Résumé Plan Plan
  • ·Womens mental health needs in Bosnia and Herzegovina in the context of community mental health care

    Page :166-166

    D. Salcic, S. Popovic

    
  • ·Suicide-related adverse events and antipsychotic use: An analysis of data from the WHO and FDA AERS database

    Page :166-166

    S. Niemcryk, A.J. Parker, J. Parris, R. Sanchez

    
  • ·Reversible myocarditis in a patient receiving clozapine: A reported case.

    Page :166-166

    M. Sangines, M. Henry, J. Garcia-Valdecasa, C.R. Morales, T. Rodriguez-Martos, F. Trujillo, J. Monzon, R. Gracia

    
  • ·Quetiapine use in manic episode during pregnancy: A case report

    Page :166-167

    D.F. Kaya, A. Sayin, A. Biri

    Résumé Résumé Plan Plan
  • ·Acute psychiatric inpatient treatment: An observational study

    Page :167-167

    N. Segrec, M. Delic, U. Groleger

    
  • ·Who responds to aripiprazole? An observational study

    Page :167-167

    P. Shajahan, A. MacCrae, M. Bashir, M. Taylor

    
  • ·Who responds to risperidone and zuclopenthixol long-acting injections? A comparative observational study

    Page :167-167

    P. Shajahan, J. Crighton, M. Bashir, M. Taylor

    
  • ·Patient satisfaction with psychiatric care in the rehabilitation ward - Lincolnshire, UK

    Page :167-168

    A.N. Singh

    Résumé Résumé Plan Plan
  • ·An audit of risperidone long acting injection in Lincolnshire, UK

    Page :168-168

    A. Singh, S. Lugg

    
  • ·Ethnicity and detention in the UK: A systematic review and meta-analysis

    Page :168-168

    S.P. Singh, N. Greenwood, S. White, R. Churchill

    
  • ·Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses

    Page :168-168

    D.W. Stewart, M.S. Turner

    
  • ·Pisa syndrome during risperidone treatment: Review and case report

    Page :169-169

    H. Strauss, W. Homri, J. Houenou

    
  • ·Forensic-psychiatric war and peacetime comparison of homicide - timing, psychiatric diagnoses and mental accountability

    Page :169-169

    A. Sutovic, R. Hodzic, O. Sinanovic

    
  • ·Aripiprazole in practice: A 6 month follow-up

    Page :169-169

    D.M. Taylor, J. Atkinson, C. Fischetti, A. Sparshatt

    
  • ·The particularities to active behavior defendants with personality disorders in process of protection of their own rights and legal interest

    Page :169-170

    O. Tsehmistro

    Résumé Résumé Plan Plan
  • ·Long acting injectable risperidone in the treatment of schizophrenia: 6 month preliminary results in E-star project in Czech Republic

    Page :170-170

    I. Tuma, M. Povey, A. Lam

    
  • ·Weight increase and psychotropic medication: The international amsp project

    Page :170-170

    J.W. van der Velden, R. Grohmann

    
  • ·Metabolic adverse events of antipsychotics treatment in chronic schizophrenia

    Page :170-171

    D. Vasile, O. Vasiliu, S. Paraschiv, P. Ivanov, M. Terpan, M. Vasile

    Résumé Résumé Plan Plan
  • ·Psychotic patients addicted to cannabis and other substances treated with risperidone long acting injectable: Follow-up and reintegration

    Page :171-171

    A. Viala, M.N. Vacheron, C. Baldacci, H. Bardou, M. Choudey, A. Ekbatani, P. Martin, L. Masclet, I. Rousset, O. Ruetsch, P.O. Smagghe, F. Caroli

    
  • ·Rhabdomyolysis associated with correction of hyponatremia and clozapine use in a patient with schizophrenia paranoid type

    Page :171-171

    V. Voros, P. Osvath, S. Fekete, T. Tenyi

    
  • ·Inpatient psychiatric treatment: EFFECT of organization on clinical outcome

    Page :171-172

    I. Vucko-Miklavcic, U. Groleger

    Résumé Résumé Plan Plan
  • ·Impact of staffs smoking status on attitude changes following a smoking ban in a Swiss psychiatric hospital

    Page :172-172

    D.F. Zullino, R. Bilancioni, N. Kaufmann, D. Knoble, Y.A. Kaufmann, B. Broers, Y. Khazaal

    

• Poster Session 1: PERSONALITY DISORDERS

  • ·The predictive value of saliva cortisol for remission of major depressive disorder

    Page :172-172

    E. Biringer, J. Egeland, K.I. Stordal, A. Lund

    
  • ·Olanzapine for the treatment of borderline personality disorder: A flexible-dose 12-week randomized double-blind placebo-controlled study

    Page :172-172

    S.C. Schulz, M.C. Zanarini, H.C. Detke, Q. Trzaskoma, D. Lin, W. DeBerdt, S. Corya

    
  • ·A dose comparison of olanzapine for the treatment of borderline personality disorder: A 12-week randomized double-blind placebo-controlled study

    Page :172-173

    M.C. Zanarini, S.C. Schulz, H.C. Detke, Y. Tanaka, F. Zhao, D. Lin, W. DeBerdt, S. Corya

    Résumé Résumé Plan Plan
  • ·Personality disorders in a Tunisian psychiatric outpatient unit: A descriptive study

    Page :173-173

    Y. El Kissi, M. Ayachi, S. Ben Nasr, A. Mansour, B. Ben Hadj Ali

    
  • ·Cluster B personality disorders: A comparative study in a Tunisian psychiatric outpatient unit

    Page :173-173

    Y. El Kissi, S. Ben Nasr, N. Ben Salah, A. Mansour, B. Ben Hadj Ali

    
  • ·Accuracy of personality disorder screening tools

    Page :173-174

    M. Garriz, F. Gutierrez

    Résumé Résumé Plan Plan
  • ·A case report: Medical helplessness in the treatment of histrionic personality

    Page :174-174

    K. Gintalaite

    
  • ·Psychological personality characteristics of children suffreing from stomach pain

    Page :174-174

    V. Grigaliuniene, B. Burba, O. Jankuviene, A. Jaras, A. Stolygaite

    
  • ·Treatment with ect is associated with an increase of nitric oxide

    Page :174-174

    R. Hoekstra, D. Fekkes, A.J. Loonen, S. Tuinier, W.M. Verhoeven

    
  • ·The future of depressive personality disorder in the diagnostic manuals

    Page :174-175

    S.K. Huprich

    Résumé Résumé Plan Plan
  • ·Bordeline personality disorder in primary care: Characteristics and patterns of comorbidity

    Page :175-175

    M. Iza, L. Mata, J. Iglesias, L. de Ugarte, P. Garcia-Parajua, E. Baca

    
  • ·The Trebol study. Quetiapine in the bordeline personality disorder: Patient's attitude and compliance

    Page :175-175

    J.C. Ortigosa, E. Sotomayor, S. Majadas, P. Garcia-Portilla, J. Bobes

    
  • ·Personality disorders-neurotic disorders and somatic illnesses

    Page :175-175

    P. Papadopoulos, D. Malidelis, A. Drositi, E. Panagoulias

    
  • ·Quetiapine improves depressive and anxiety symptom but not impulsivity in cluster b personality disorder: An open label prospective trial

    Page :176-176

    S. Roepke, A. Merkl, A. Dams, A. Ziegenhorn, I.G. Anghelescu, I. Heuser, C.H. Lammers

    
  • ·The influence of aesthetic surgery on the emotional profile

    Page :176-176

    T. Tic-Bacic, G. Rubeša, H. Svesko-Visentin, G. Bacic

    
  • ·Gender differences, impulsivity and attention measures in BPD patients

    Page :176-176

    S. Subira, L. Ferraz, M. Vallez, J. Vicens

    
  • ·Mental illness: An automatic, learned and stylized stimulus- response

    Page :176-177

    J.M. Vargas Ponciano

    Résumé Résumé Plan Plan
  • ·Personality disorders in a cross-cultural perspective

    Page :177-177

    I.T. Calliess, W. Machleidt, M. Ziegenbein

    

• Poster Session 1: EATING DISORDERS

  • ·New therapeutic strategies for new eating disorders

    Page :177-177

    J.A. Aguado, O. Segurado

    
  • ·The comparison with Japanese and Indonesian adolescent women's wishes to be slender and mental health GHQ score showed

    Page :177-178

    M. Aoki, R. Setiyani, S. Aoki

    Résumé Résumé Plan Plan
  • ·Anorexia nervosa: A probable factitious disorder by proxy

    Page :178-178

    M. Catalina Zamora, L. de Ugarte Postigo

    
  • ·A clinical sample of children and adolescents with eating disorders in Brazil: Comorbidities and socio-demographic characteristics

    Page :178-178

    B. Fleitlich-Bilyk, V. Pinzon, A. Cobelo, A.P. Gonzaga, P. Belluzzo, M. Nicoletti, A. Scharff, A. Sousa, L. Carvalho, M.A. Mangiacavalli

    
  • ·Toward next (editions of DSM and ICD) classifications of mixed mania/state (a dipolar, non bipolar, structure/disorder)

    Page :178-178

    E.M. Gonçalves

    
  • ·Atypical antipsychotic drugs in severe anorexia nervosa: A case study

    Page :178-179

    M. Jasovic-Gasic, D. Britvic, N. Maric, O. Vukovic, T. Cvetic, M. Zebic

    Résumé Résumé Plan Plan
  • ·Self-harming behavior, pain and body perception in patients with eating disorder

    Page :179-179

    V. Kmoch, H. Papezova, A. Yamamotova

    
  • ·Mental bulimia and paroxetine treatment - monitoring CYP2D6 activity (preliminary results)

    Page :179-179

    I. Palcíková, A. Zourková, D. Valentová, E. Hadasová, B. Ravcuková

    
  • ·Personality disorders in eating disorders: Analisys of clinical, psycopatological and personality differences

    Page :179-179

    E. Tedeschini, L. Forcano, X. Aguera, D. Bussolotti, G. Guaraldi, F. Fernandez-Aranda

    
  • ·Using latent growth curve modeling in clinical treatment research: Comparing guided self-change and cognitive behavioral therapy treatments for bulimia nervosa

    Page :180-180

    S.A. Hardy, C. Thiels

    
  • ·Psychopathological characterization of morbid obese patients proposed for bariatric surgery

    Page :180-180

    S. Timóteo, I. Domingues, I. Brandão, A.R. Torres, A. Palha

    
  • ·3111t/c polymorphism of the clock gene confers a predisposition to a lifetime lower body weight in anorexia and bulimia nervosa

    Page :180-180

    A. Tortorella, P. Monteleone, C. Di Filippo, A. Di Cerbo, S. Mansueto, M. Maj

    
  • ·Eating disorders in males, a general population study in Norwegian males

    Page :180-181

    E. Vedul-Kjelsaas, V. Vedul-Kjelsaas, K.G. Gotestam

    Résumé Résumé Plan Plan
  • ·The association between eating disorders and level of physical activity among norwegian women

    Page :181-181

    E. Vedul-Kjelsaas, G. Braein, K.G. Gotestam

    
  • ·Eating disorders and psychopathological comorbidity in obesity patients

    Page :181-181

    E. Vedul-Kjelsaas, S.A. Sandnes, J.K. Dahl, K.G. Gotestam, M. Strommen, B. Kulseng, R. Mårvik

    
  • ·The influence of the study profile on early anorexia symptoms expression in women

    Page :181-182

    R.W. Wojciak

    Résumé Résumé Plan Plan
  • ·The assessment of hair trace elements level in the early onset of anorexia

    Page :182-182

    R.W. Wojciak, Z. Krejcpio, D. Olejnik

    

• Poster Session 1: ALCOHOLISM AND OTHER ADDICTIONS

  • ·Effectiveness of daily outpatient alcohol detoxification by an Irish public psychiatric hospital

    Page :182-182

    V.O. Agyapong, J. Benbow, R. Browne

    
  • ·A baseline audit of opiate substitution therapy and 12-week retention in treatment

    Page :182-182

    A. Akioye, R. Cohen

    
  • ·Pathological gambling - Case series

    Page :182-183

    S. Alcaz, S. Vucetic, G. Popadic

    Résumé Résumé Plan Plan
  • ·Testing the self-medication hypothesis of depression and aggression in cannabis dependent subjects

    Page :183-183

    M. Arendt, R. Rosenberg, L. Fjordback, J. Brandholdt, L. Foldager, L. Sher, P. Munk-Jørgensen

    
  • ·Attention deficit and hiperactivity disorder in cocaine addiction

    Page :183-183

    M.L. Barrigon Estevez, A. Fontalba-Navas, M. Ruiz Martinez, J. Joya Redondo, O. Andres Ricoy, A. Sanchez Viñas, G. Jurado de Flores Yepes

    
  • ·Subjective classification of drug craving cues responses: Comparison of fmri findings to self report study

    Page :183-184

    A. Behzadi, H. Ekhtiari, A. Mokri, H. Edalati, M.A. Oghabian

    Résumé Résumé Plan Plan
  • ·Comorbidity and therapy of affective disturbances in associated forms of alcoholism

    Page :184-184

    N.A. Bokhan

    
  • ·Impulsivity, personality disorders and the engagement in addiction treatment

    Page :184-184

    D.A. Charney, K.J. Gill

    
  • ·Pathological internet use among Romanian children and teenagers

    Page :184-184

    V. Chirita, R. Chirita, C. Stefanescu, M. Ilinca, G. Chele

    
  • ·Specific rehabilitative and psychotherapeutic groups for cocaine addicted patients: A new model of treatment

    Page :184-185

    G. Conte, L. Angelicola Nizza, B. Cassiani, M. Di Paolo, F. Focà, E. Rigino, C. Villella, P. Bria

    Résumé Résumé Plan Plan
  • ·Changes of the populations of patients in an addictive disorders service in Rome: 2001-2006

    Page :185-185

    G. Conte, E. Righino, E. Maniccia, L. Angelicola Nizza, M. Di Paolo, M. Pomponi, C. Villella, P. Bria

    
  • ·Description of a population of pathological gamblers acceding a group therapy program in rome

    Page :185-185

    G. Conte, R. Franza, A. Gericitano, L. Allegretti, F. D'Amico, A. Di Gioia, C. Villella, P. Bria

    
  • ·Alcohol consuption situation among drivers and citizens delivered in a republican narcological clinic on survey for infringement of the legislation in dynamics

    Page :185-186

    M. Dalsaev, R. Dalsaeva

    Résumé Résumé Plan Plan
  • ·Safe consumption rooms - A project for the future?

    Page :186-186

    I. Domingues, A. Horta, M. Esteves, A. Palha

    
  • ·New drugs in the treatment of tobacco addiction

    Page :186-186

    I. Domingues, A. Norton, C. Torres, A. Coelho, J. Barreto

    
  • ·Quantitative EEG after activation methods in chronic patients with alcohol dependence

    Page :186-186

    J. Dragasek, M. Drimalova, M. Martinove, E. Palova, D. Breznoscakova, B. Bodnar, P. Jankovic

    
  • ·Designing and evaluation of reliability and validity of a visual cue - induced craving assessment task for intravenous heroin users

    Page :186-187

    H. Ekhtiari, A. Mokri, H. Edalati, H. Safaei, A. Jannati, M.E. Razzaghi

    Résumé Résumé Plan Plan
  • ·Impulsive personality characteristics of homeless HIV(+) iv heroin users (IHU) in comparison with homeless HIV(-) IHUs and non-homeless HIV(-) IHUs

    Page :187-187

    H. Ekhtiari, A. Mokri, M.R. Jahani, H. Shirzad, S. Mahin Torabi, B. Elahi, M.E. Razzaghi

    
  • ·Efficacy of olanzapine in antisocial opioid substance abusers

    Page :187-187

    M.R. Eskandari, S. Karami

    
  • ·Influence of drug misuse in psychiatric inpatientsacute; evolution

    Page :187-187

    O. Euba, N. Sánchez, M.M. López, E. Zallo, E. Garnica, A. Sarasola, A. Arnaiz, E. Pinilla, M. Torreblanca, F. Chicharro

    
  • ·Alcohol and psychiatric co-morbidity

    Page :187-188

    A.S. Costa, V.T. Sousa, C. Costa, M.G. Mota, S. Fonseca, R. Grangeia, A.P. Palha

    Résumé Résumé Plan Plan
  • ·Resilient of adolescents from alcoholic families

    Page :188-188

    S. Filipovic, R. Panoski, P. Nastasic, I. Mladenovic

    
  • ·Dual diagnosis in a psychiatric hospital

    Page :188-188

    E. Garnica, A. Arnaiz, E. Zallo, O. Euba, N. Sánchez, A. Sarasola, M.M. López, E. Pinilla, M. Torreblanca, F. Chicharro

    
  • ·Physician drug addictions: Additional data support the gold hypothesis

    Page :188-188

    M.S. Gold, R.J. Melker, B.A. Goldberger

    
  • ·Cocaine abuse in 2006

    Page :188-189

    M.D. Gold, B.A. Goldberger

    Résumé Résumé Plan Plan
  • ·Differential comorbidity between ADHD with substance use disorder and ADHD without substance use disorder group

    Page :189-189

    B. Gonzalez Vigo, A. Ortin Peralta, M. Morais-Nogueira, R. Bosch Munso, Y. Martinez Ortega, N. Gomez Barros, S. Valero Ventura, A.J. Ramos-Quiroga, M. Casas Brugue

    
  • ·Erectile dysfunction in alcoholic patients. Results of an observational study carried out in an alcohol treatment centre

    Page :189-189

    L. Ortega, E.F. Santoyo, A. Gual

    
  • ·The COMT Val158Met polymorphism is associated with novelty seeking in czech methamphetamine abusers: Preliminary results

    Page :189-190

    L. Hosak, J. Libiger, J. Cizek, M. Beranek, E. Cermakova

    Résumé Résumé Plan Plan
  • ·The management of psychiatric comorbidity in an outpatient individual therapeutic program of addiction

    Page :190-190

    L. Iliopoulou, V. Koutras, P. Georgakas, T. Chajoudi

    
  • ·Expression and communication through body in withdrawal attempt

    Page :190-190

    L. Iliopoulou, P. Georgakas, T. Chajoudi, C. Vasiliou, V. Koutras

    
  • ·Educating high school teachers in applying programs for the prevention of drug abuse

    Page :190-190

    L. Iliopoulou, V. Koutras, E. Fidi, V. Basogianni, S. Gonta, K. Komninou, D. Lagou, S. Thomos

    
  • ·A combination of the narcotic antagonist therapy and a special psychotherapy

    Page :190-191

    T.T. Iosebadze, N.D. Dzagania

    Résumé Résumé Plan Plan
  • ·Ondansetron for the treatment of stimulant addiction

    Page :191-191

    B.A. Johnson

    
  • ·Anxiety in addicted patients in different therapeutic units in greece

    Page :191-191

    M. Stiga, K. Katsigiannopoulos, K. Nikolaou, E. Kazantzidou, N. Theodorides, I. Drenos, E. Alagiozidou, K. Sgourou, V. Kioseoglou, D. Dyntsikou, G. Papazisis, C. Rongotis

    
  • ·Depression in addicted patients in different therapeutic units in greece

    Page :191-191

    K. Katsigiannopoulos, M. Stiga, K. Nikolaou, N. Theodorides, E. Kazantzidou, A. Georganaki, V. Kioseoglou, E. Alagiozidou, K. Sgourou, D. Dyntsikou, G. Papazisis, C. Rongotis

    
  • ·Impact of internet abuse on human relationships

    Page :192-192

    A. Kwiatkowska, E. Ziolko, K. Krysta, M. Muc-Wierzgon, I. Krupka-Matuszczyk

    
  • ·VIH+ status: indication or contra-indication for liver transplantation?

    Page :192-192

    A. Lligoña, N. Freixa, M. Monras, A. Rimola, J.M. Miró, M. Walther

    
  • ·Does substance abuse significantly risk of relapse after treatment of first episode psychosis despite adherence to medication?

    Page :192-192

    A. Malla, R. Norman, L. Bechard, N. Schmitz, R. Manchanda, C. Cassidy

    
  • ·Cognitive impairment expressed in drawings of healthy alcoholics serves as diagnostic and therapeutical instrument

    Page :192-193

    G.I. Mandic-Gajic, P.P. Gajic, Z. Spiric, R. Samardzic, T. Sabo, Z. Jovic

    Résumé Résumé Plan Plan
  • ·The changes of sex hormones among male alcoholics in the early abstinention

    Page :193-193

    G.I. Mandic-Gajic, P.P. Gajic, Z. Spiric, M. Radovanovic, G. Dedic, J. Antonijevic

    
  • ·Correlates of nicotine dependence in a non-psychiatric sample

    Page :193-193

    J.M. Martinez-Ortega

    
  • ·Role of methadone in post-war society

    Page :193-193

    N. Mehic-Basara, I. Ceric, H. Hasecic, M. Grabovica

    
  • ·Suicide in dual diagnosis patients

    Page :193-194

    Y. Gimelfarb, Z. Natan, Y. Baruch

    Résumé Résumé Plan Plan
  • ·Risperidone versus haloperidol treatment in dual diagnosis inpatients: preliminary results from a 6 week, randomized controlled, open label pilot trial

    Page :194-194

    Y. Gimelfarb, Z. Natan, M. Mashiah, Y. Dlayahu

    
  • ·Prevalence of dual diagnosis elderly inpatients: Is the phenomenon rare?

    Page :194-194

    Z. Natan, Y. Gimelfarb, Y. Barak, Y. Baruch

    
  • ·The impact of feedback and punishment on the decisions of male heroin addicts

    Page :194-195

    C.G.J. Newman, I. Crome, M. Frisher

    Résumé Résumé Plan Plan
  • ·What predicts illicit drug use and drug offending? The Finnish 'from a boy to a man' follow-up study

    Page :195-195

    S. Niemela, A. Sourander, P. Wu, K. Poikolainen, H. Elonheimo, H. Helenius, J. Piha

    
  • ·Verbal working memory and executive dysfunctions in patients with alcohol addiction

    Page :195-195

    K. Nowakowska, K. Jabłkowska, A. Borkowska

    
  • ·Addiction and depression diseases in primary families of young women dependents of several psychoactive substances

    Page :195-195

    R. Panoski, G. Lazetic, I. Mladenovic, P. Nastasic, S. Filipovic

    
  • ·Minorities in a detoxififcation unit in Greece: I. Socio-demographic characteristics

    Page :195-196

    G. Papazisis, K. Katsigiannopoulos, K. Nikolaou, N. Theodorides, E. Kazantzidou, A. Kefalas, V. Papadopoulou, G. Kesidis, E. Danana, D. Dyntsikou, C. Rongotis

    Résumé Résumé Plan Plan
  • ·Minorities in a detoxification unit in Greece: II. Clinical characteristics

    Page :196-196

    K. Nikolaou, G. Papazisis, K. Katsigiannopoulos, E. Kazantzidou, A. Kefalas, V. Papadopoulou, G. Kesidis, P. Alektoridis, N. Theodorides, D. Dyntsikou, C. Rongotis

    
  • ·Nonspecific treatment response in alcoholics

    Page :196-196

    J.K. Penberthy

    
  • ·Multimodal treatment of alcoholic patients in a day hospital setting: A preliminary study of retention

    Page :196-197

    A. Frustaci, G. Martinotti, G. Pozzi, L. Janiri

    Résumé Résumé Plan Plan
  • ·Positivity of borna disease virus (BDV) in patients with substance abuse

    Page :197-197

    S. Rackova, L. Janu

    
  • ·Alexithymia in patients with substance addiction being treated by cognitive-behavioural psychotherapy within Minnesota model treatment

    Page :197-197

    O. Razlog, S. Longbottom, L. Marcoci, F. Seidel, I. Razlog

    
  • ·Aggregate - level beverage - specific effect of alcohol on alcoholism and alcohol psychoses rate

    Page :197-197

    Y. Razvodovsky

    
  • ·Influence of childhood adhd history on personality traits of pathological gamblers

    Page :197-198

    R. Rodriguez-Jimenez, G. Ponce, M.A. Jimenez-Arriero, A. Bagney, I. Martinez, M. Aragues, G. Rubio, T. Palomo, P.A.R. Group

    Résumé Résumé Plan Plan
  • ·Neuropsychology and alcoholism: Influence of childhood ADHD history

    Page :198-198

    R. Rodriguez-Jimenez, M.A. Jimenez-Arriero, A. Bagney, A. Koeneke, I. Martinez, M. Aragues, G. Rubio, G. Ponce

    
  • ·Smoking prevalence in the different psychiatric diagnoses in a hospitalisation unit

    Page :198-198

    R. Rodriguez-Jimenez, A. Bagney, G. Ponce, M. Aragues, M.A. Jimenez-Arriero

    
  • ·Heavy drinkers with recreational cocaine use: Who does become a cocaine or alcohol dependent 4 years later?

    Page :198-199

    G. Rubio, M. Jiménez-Giménez, M. Iribarren, R. Rodriguez, M.A. Jiménez-Arriero, F. López-Muñoz, C. Alamo

    Résumé Résumé Plan Plan
  • ·Varieties of impulsivity in males with alcohol dependence: The role of cluster-B personality disorder

    Page :199-199

    G. Rubio, M. Jiménez-Giménez, M. Iribarren, I. Martinez, R. Rodriguez, M.A. Jiménez-Arriero, G. Ponce

    
  • ·When attachement trauma and addiction both influence the brain: Combination of pharmaco- and psychotherapy can cope the problem efficiently

    Page :199-199

    M. Rus-Makovec, Z. Cebasek-Travnik, I. Rahne-Otorepec

    
  • ·Psychiatric adverse event profile of interferon therapy in drug abusers

    Page :199-199

    D. Sago, I. Sain, A. Silic, A. Bogovic, S. Zanic, M. Mihanovic, A. Slaviček

    
  • ·Towards a phenomenological understanding of addiction

    Page :199-200

    J.E. Schlimme

    Résumé Résumé Plan Plan
  • ·Alcohol-related problem and adolescence crisis

    Page :200-200

    M.V. Stankovic

    
  • ·Youths binge drinking - the pathways to be dependent

    Page :200-200

    M.V. Stankovic, N. Dostanic

    
  • ·The relationship between development identity and internet addiction

    Page :200-200

    C. Stefanescu, G. Chele, R. Chirita, V. Chirita, M. Ilinca

    
  • ·Occupational stress and alcohol use: A study of two nationwide samples of operational ambulance personnel and police in norway

    Page :201-201

    T. Sterud, E. Hem, A. Ekeberg, B. Lau

    
  • ·Alcohol dependence ambulatory clinic in Hospital de São João

    Page :201-201

    V. Teixeira Sousa, A. Costa, C. Costa, S. Fonseca, M. Mota, R. Grangeia, A. Pacheco Palha

    
  • ·Different psychiatric profile for the alcohol and paramiloidosis transplant groups

    Page :201-201

    D. Telles-Correia, A. Barbosa, I. Mega, E. Barroso, E. Monteiro

    
  • ·Impact of quetiapine in the treatment of insomnia associated with addictive pathologies: a retrospective study

    Page :201-202

    A. Teran, S. Majadas

    Résumé Résumé Plan Plan
  • ·Evolution of drug use after enforcing a new protocol in a medium stay unit

    Page :202-202

    M. Torreblanca, E. Zallo, A. Sarasola, E. Garnica, N. Sánchez, O. Euba, A. Arnaiz, M.M. López, E. Pinilla, F. Chicharro

    
  • ·Behavioural inhibition and behavioural activation systems in cocaine dependent patients

    Page :202-202

    M.V. Trasovares, O. Andion, C. Roncero, E. Bruguera, M. Casas, R. Torrubia

    
  • ·Impact of various psychopharmacological agents on anxiety, depressive symptoms and global functioning during alcohol detoxification

    Page :202-203

    T.J. Paparrigopoulos, E.O. Tzavellas, A.P. Komporozos, J.A. Liappas, C.R. Soldatos

    Résumé Résumé Plan Plan
  • ·Addiction and pregancy

    Page :203-203

    S.S. Vucetic, S.R. Alcaz

    
  • ·Mechanisms of addiction and relapse: Startling evidence for lingering appetitive effects of drug-cues in smokers and former smokers

    Page :203-203

    M. Wagner, A.K. Rehme, I. Frommann, S. Peters, J. Bludau, R. Mucha, K. Mogg, B. Bradley, W. Maier, C. Schütz

    
  • ·Quality of life in patients undergoing opioid maintenance therapy - A comparative study of slow release morphine versus methadone treatment

    Page :203-204

    B. Winklbaur, N. Ebner, R. Jagsch, K. Thau, G. Fischer

    Résumé Résumé Plan Plan
  • ·The characteristics of nicotine addiction among mentally ill persons

    Page :204-204

    E.J. Wojtyna, M.M. Dosiak, M. Zagrodnik

    
  • ·Adolescents addressed to an addiction liaison team after alcohol-intoxication related emergency room admittance

    Page :204-204

    M. Alvarez, M. Suchet, M. Caflisch, D. Aladjem, R. Manghi, R. Khan, D. Zullino

    

• Poster Session 1: PSYCHOTHERAPIES

  • ·Early change in maladaptive defense style and development of the therapeutic alliance

    Page :204-204

    G. Ambresin, Y. de Roten, M. Drapeau, J.N. Despland

    
  • ·The Bologna multiethnic mental health centre

    Page :204-205

    D. Berardi, I. Tarricone, F. Poggi, F. Salvatori, M. Morri, C. Fini, A. Amadori

    Résumé Résumé Plan Plan
  • ·A structured group psychotherapy programme improves adjustment to lipodistrophy in HIV+ patients: Preliminary data

    Page :205-205

    J. Blanch, A. Rousaud, A. Milinkovic, E. Martinez, J.M. Peri, J.M. Gatell

    
  • ·The effect of groupcoaching in adult ADHD

    Page :205-205

    I. Bloemen, W. Verbeeck, S. Tuinier

    
  • ·The "V.I.T.A. project": An experimental study for psychotherapeutic interventions in telemedicine

    Page :205-205

    E. Caroppo, G. Di Maria, C. Camerino, G. Ruggeri

    
  • ·Electronical communication in psychotherapy

    Page :206-206

    Z. Cebasek-Travnik, M. Rus Makovec

    
  • ·Delivering CBT to a community: The 'Living Life to the Full courses'

    Page :206-206

    I. Day, M. McAuley, C. Williams, L. Rafferty, A. Wood

    
  • ·Short term psychotherapy for the soldier in crisis following estimation for military duty

    Page :206-206

    G.J. Dedic, S.S. Djurdjevic

    
  • ·Pregnancy, aripiprazole and psychotherapy

    Page :206-206

    G. Doulgeraki, D. Karadima, G. Kalogiratos, A. Grekiotis, K. Magoula

    
  • ·Cognitive behavior therapy: Treatment of choice for somatic presentations

    Page :206-207

    J.I. Escobar

    Résumé Résumé Plan Plan
  • ·Parent oriented psycho-education for under 5 years age children with stubbornness

    Page :207-207

    M.R. Eskandari, S. Karami, H. Sharifi, F. Taheri

    
  • ·Directly observed therapy (DOT) in a psychiatric consulting dispensary, long term practice and retrospective study of patients coming every day

    Page :207-207

    C. Ducroix, M. Choudey, F. Cornic, J. Gauillard, M.N. Vacheron

    
  • ·Efficacy of medication and combined medication and cognitive behavior therapy in the treatment of obsessive compulsive disorder

    Page :207-207

    N.A. Giasuddin, J.S. Nahar

    
  • ·Effects of group psychoeducational psychotherapy on inpatients with chronic psychoses

    Page :207-208

    G. Gómez-Bernal, F. Romero, S. Reboreda, M. Bernal, E. Esteban

    Résumé Résumé Plan Plan
  • ·My new Alfa Romeo GT is not in the garage any more

    Page :208-208

    E.N. Gruber, V. Dordevic, S. Martic-Biocina, M. Agius

     
  • ·The rebild trial: An intervention for challenging behaviour in intellectual disabilities

    Page :208-208

    A. Hassiotis, A. Canagasabey, D. Langridge, D. Robotham, M. King

    
  • ·The effects of touch therapy and physiotherapy on pain in females refer to physiotherapy ward of hafez hospital

    Page :208-209

    M. Hazrati

    Résumé Résumé Plan Plan
  • ·Using our model of fairy-tale CBT (FCBT) at the psycho-social rehabilitation center

    Page :209-209

    T.T. Iosebadze, N.D. Dzagania

    
  • ·The influence of physical activities on happiness of female studants of medical sciences of Isfahan university

    Page :209-209

    J. Karimian, P. Shekarchizadeh Isfahani

    
  • ·The effectiveness of long-term and short-term psychodynamic psychotherapy on psychiatric symptoms - A randomized trial

    Page :209-209

    P. Knekt, O. Lindfors, M. Laaksonen, M. Valikoski

    
  • ·PTSD

    Page :209-209

    T.J. Kozarov

    
  • ·Experiences of using neurofeedback in clinical practice

    Page :209-210

    M. Sygut, K. Czech, K. Krysta, I. Krupka-Matuszczyk, A. Klasik

    Résumé Résumé Plan Plan
  • ·Unresolved grief in boy depression in young man

    Page :210-210

    M. Kudumija Slijepcevic, I. Manestar

    
  • ·Cogntive behaviour therapy for autism spectrum disorders: Modifications and applicability

    Page :210-210

    K. Laskaridou, E. Tagouli

    
  • ·Influence of the group psychodynamic psychotherapy on negative affect, somatization and general psychological distress

    Page :210-210

    K. Malyszczak, T. Pawlowski, P. Pacan, A. Kiejna

    
  • ·Empathy in psychiatric setting. the contribution of self psychology

    Page :210-211

    M. Mazzariol

    Résumé Résumé Plan Plan
  • ·Group psychotherapy in the acute cases department of psychiatry clinic

    Page :211-211

    E. Chourdaki, E. Botzakis, S. Monezis, A. Vardiabasis, N. Paritsis

    
  • ·Description of elements of psychoanalytic technique in a mental health center

    Page :211-211

    D. Malidelis, P. Papadopoulos, A. Drositi, E. Panagoulias

    
  • ·Anxiety disorder - Treatment with psychopharmacotherapy and cognitve and behavioural therapies

    Page :211-211

    J. Petkovic, E. Tupkovic

    
  • ·Art-therapy in theory and practice of humanistic education

    Page :212-212

    N.M. Popova

    
  • ·Using multimedial tools, role playing and videofeedback in the training of case management

    Page :212-212

    J. Prasko, C. Hoschl

    
  • ·Presentation of a French mental health promotion project aimed at promoting parental skills and enhancing attachment in early childhood

    Page :212-212

    D. Purper-Ouakil, R. Dugravier, T. Greacen, N. Guedeney, A. Haddad, D. Mahieu-Caputo, T. Saias, R.E. Tremblay, B. Topuz, F. Tubach, B. Welniarz, A. Guedeney

    
  • ·Adapting assertive community treatment (ACT) for use among hard-to-treat people with severe mental illness in S- Hertogenbosch, The Netherlands

    Page :212-213

    H.V. Saez, E.S. Valencia

    Résumé Résumé Plan Plan
  • ·Therapeutic factors in group psychotherapy: Different perpectives of patients and psychiatrists

    Page :213-213

    A. Sayın, E.H. Karslıoğlu, A. Sürgit, T. Aslan, S. Şahin

    
  • ·Salvation with art in personological interpretation

    Page :213-213

    V.Y. Semke

    
  • ·User involvement in commisioning mental health services for multi ethnic population in UK

    Page :213-213

    A.N. Singh, U. Kumar

    
  • ·Investigating the effectiveness of enhancing optimism skills on high school students' locus of control

    Page :214-214

    F. Sohrbi, A. Javanbakhsh

    
  • ·Food, life, and death. The film la grande bouffe of marco ferreri in an art psychological point of view

    Page :214-214

    F. Tury, O. Peter

    
  • ·Drug-addicted adults: Their self-concept, self-esteem and their role in treatment

    Page :214-214

    S. Ucman, S. Prosen

    
  • ·The efficiency of application physical factors in rehabilitation of children in conditions psychiatric clinic

    Page :214-214

    T.G. Vyetrila

    
  • ·Psychological risk factors in anxiety and depression symptoms in patients with cardio-vascular diseases

    Page :214-215

    L. Aleksovska, V. Vujovic, V. Gerazova, S. Arsova, T. Ristovska-Dimova, I. Dojcinovski, G. Hadzi-Angelkovski, Z. Mitrev

    Résumé Résumé Plan Plan
  • ·Treatment in obsessive - compulsive disorder with high dosage of sertraline (asentra) and low dosage of olanzepine(zalasta)

    Page :215-215

    S. Arsova, V. Vujovic, G. Hadzi-Angelkovski, V. Gerazova, A. Novotni, M. Stanoevska, L. Aleksovska, N. Simonovski, Z. Babinkostova

    
  • ·Medical students' attitudes towards mental illness

    Page :215-215

    M. Burgic-Radmanovic

    
  • ·Needs of persons with different psychiatric disorders, satisfaction with services, social functioning and quality of life

    Page :215-215

    E. Dobrzynska, J. Rymaszewska, A. Kiejna

    
  • ·Psychiatry in the community: one year experience

    Page :215-216

    A.S. Costa, M.G. Mota, V. Sousa, C. Torres, C. Costa, R. Grangeia, A.P. Palha

    Résumé Résumé Plan Plan
  • ·To a question of optimization of the medical and psycological help to patients with GID

    Page :216-216

    T.N. Grigorieva

    
  • ·Mother of courage

    Page :216-216

    E.N. Gruber, D. Poredos, V. Cerancevic, E. Koic

    
  • ·Since I have my case manager, I am back to life

    Page :216-216

    E.N. Gruber, S. Ivezić-Štrkalj, M. Agius, V. Djordjevic

    
  • ·Genetic consultation in psychiatry: Family histories and picture tests

    Page :217-217

    E.V. Gutkevich, L.A. Rjadovaja

    
  • ·The international legion of humanists awarded psychiatry clinic in tuzla with the golden award for peace

    Page :217-217

    I. Pajevic, M. Hasanovic, A. Kopric

    
  • ·Supporting family members of people with severe mental illness

    Page :217-217

    F. Hisanaga, M. Nishio, J. Ito

    
  • ·Improving nursing documentation. Action research in a north-Norwegian psychiatric hospital

    Page :217-218

    R. Karlsen

    Résumé Résumé Plan Plan
  • ·Dopamine transporter density of basal ganglia in obsessive-compulsive disorder, measured with SPECT before and after treatment with serotonin reuptake inhibitors

    Page :218-218

    M.S. Koo, C.H. Kim, K.A. Cheon

    
  • ·Clinical characteristics of obsessive compulsive disorder with schizophrenia

    Page :218-218

    M.S. Koo, K.A. Cheon, J.Y. Jun, C.H. Kim

    
  • ·SMS communication and identity

    Page :218-218

    D. Krasic, M. Stankovic, O. Milojkovic, J. Vukicevic

    
  • ·Investigation into the quality of life of psychiatric patients

    Page :218-219

    M. Mihanovic, I. Sain, B. Restek-Petrovic, S. Zanic, S. Kezic, S. Devcic, M. Grah, A. Silic, V. Grosic, S. Vuk-Pisk, A. Bogovic, S. Jelavic, D. Bodor

    Résumé Résumé Plan Plan
  • ·Socio-psychological problems in the families of patients with mental illnesses in republic of belarus

    Page :219-219

    K. Mironova

    
  • ·Psychiatrist and social dialogue

    Page :219-219

    E. Koic, V. Djordjevic, S. Nadj, E.N. Gruber, D. Poredos

    
  • ·An investigation on spouses' mutual abuse behavior

    Page :219-220

    M. Nasiri

    Résumé Résumé Plan Plan
  • ·A randomised study comparing seclusion and mechanical restraint in people with serious mental illness

    Page :220-220

    T. Steinert, J. Bergk

    
  • ·Trends in the use of antidepressant drugs in Lithuania

    Page :221-221

    V. Adomaitiene, E. Kadusevicius, L. Kataiceva

    
  • ·Low episodic memory performance as a premorbid marker of depression: Evidence from a 3-year follow-up

    Page :221-221

    E. Airaksinen, Å. Wahlin, Y. Forsell, M. Larsson

    
  • ·Risk factors for postpartum depression: A preliminary study

    Page :221-222

    A. Algul, U.B. Semiz, M. Cetin, O. Dundar, M.A. Ates, C. Basoglu, S. Ebrinc, H. Gunay, S. Iyisoy

    Résumé Résumé Plan Plan
  • ·Depressive disorder in patients with multiple sclerosis

    Page :222-222

    A. Alajbegovic, N. Loga, N. Tiro, E. Mehmedika-Suljic, S. Alajbegovic

    
  • ·Health-related quality of life in patients with pain related to depression (Results from UK subsample of the European Finder study)

    Page :222-222

    A. Azough, R.D.A.S. Gupta, B. Wong, C. Barradell, Y. Jogessar, L. Poole, J. Watkins, A. Tylee, R. Peveler, P. Gandhi

    
  • ·Effect of the depressive symptoms and life events to the quality of life in a school population

    Page :222-222

    I. Baji, L. Mayer, E. Kiss, D. Skulteti, K. Boda, J. Gadoros, A. Vetro

    
  • ·Depression in patients with coronary heart disease

    Page :223-223

    A. Baloescu, G. Grigorescu, M. Miclos, E. Badescu, M.D. Gheorghe

    
  • ·Testing ters and madrs on 567 pre-OLTx patients

    Page :223-223

    V. Barbanti Silva, M. Ferrara, S. Ferrari, M. Rigatelli

    
  • ·Efficacy of fluoxetine compared to amitriptyline in patients with premenstrual dysphoric disorder

    Page :223-223

    L.M. Bardenshteyn, A.V. Ershova, D.O. Sorokina, A.S. Bychkova

    
  • ·Relationship between depression and hostility among teachers

    Page :223-224

    G. Barekhat, A.A. Bayani, A.M. Kocheki

    Résumé Résumé Plan Plan
  • ·Analysis of individual items of the Hamilton depression scale in a study of eszopiclone/fluoxetine co-therapy

    Page :224-224

    P. Bech, A. Krystal, J. Walsh, R. Rubens, J. Caron, T. Wessel, D. Amato, T. Roth, W.V. McCall, M. Fava

    
  • ·Psychical disorder and chest pain

    Page :224-224

    A. Beheshti, G. Irajian, M. Darabian

    
  • ·Maternal depression and its impact in children

    Page :224-224

    F. Berberi, F. Elezi, E. Petrela, E. Xhumari, A. Braho, E. Sotiri

    
  • ·The course of coronary artery disease in relation to personality traits and symptoms of depression in hospitalized male patients

    Page :224-225

    A. Borkowska, J. Pulkowska, W. Drozdz, M. Bielinski

    Résumé Résumé Plan Plan
  • ·Relation between depression and some clinical and biochemical parameters in patients undergoing chronic hemodialysis

    Page :225-225

    C.I. Bornivelli, P.A. Alivanis, I.E. Giannikouris, A.N. Arvanitis, I.G. Choustoulakis, N.C. Karvouniaris

    
  • ·Efficacy of duloxetine in the treatment of unspecific pain associated with depression

    Page :225-225

    S. Brecht, C. Courtecuisse, C. Debieuvre, J. Croenlein, D. Desaiah, J. Raskin, K. Demyttenaere

    
  • ·The comorbidity depression and coronary disease - the differences between male and female

    Page :225-226

    D. Breznoscakova, E. Palova, J. Dragasek, P. Moscovic

    Résumé Résumé Plan Plan
  • ·A day treatment programme on mood disorders: One-year activity outcomes

    Page :226-226

    G. Camardese, A. Picello, G. Di Carlo, C. Morelli, L. Mosca, P. Bria

    
  • ·Effectiveness of a consultation-liaison psychiatry intervention in a coronary intensive care unit

    Page :226-226

    G. Cardoso

    
  • ·Temperament and character profile as risk factor of depression and anxiety syndromes induced by interferon and ribavirin treatment in chronic hepatitis c patients

    Page :226-227

    P. Castellvi, R. Navinés, C. Díez-Quevedo, D. Jiménez, C. Márquez, J.A. Galeras, S. Subirà, R. Solà, R. Martín-Santos

    Résumé Résumé Plan Plan
  • ·Follow-up of brain-derived neurotrophic factor (BDNF) during a one-year antidepressant treatment.

    Page :227-227

    M. Catena, D. Marazziti, A. Piccinni, A. Del Debbio, G. Consoli, A. Veltri, F. Golia, E. Schiavi, A. Palla, M. Picchetti, A. Mariotti, C. Bianchi, I. Roncaglia, S. Baroni, L. Dell'Osso

    
  • ·Stimulation of the subthalamic nucleus in parkinson's disease and mood disorders, one-year follow-up

    Page :227-227

    I. Chereau-Boudet, I. de Chazeron, P. Derost, M. Ulla, J.J. Lemaire, F. Durif, P.M. Llorca

    
  • ·Sexual dysfunctions in men with depressive disorders

    Page :227-227

    G.D. Dremov, V.Y. Semke, E.D. Schastnyy

    
  • ·The influence of depressive symptoms on quality of life in coronary artery disease inpatients after the successful coronary angioplasty

    Page :228-228

    D. Dudek, W. Datka, M. Siwek, A. Wróbel, A. Zięba

    
  • ·Depressive symptoms in coronary artery disease inpatients after the successful coronary angioplasty

    Page :228-228

    D. Dudek, M. Siwek, W. Datka, A. Wróbel, A. Zięba

    
  • ·Urinary steroid metaboilites in patients with violent suicidal and nonsuicidal depressive disorders

    Page :228-228

    S. Fekete, P. Osvath, V. Voros, V. Poor

    
  • ·Fatigue in major depression: The role of anxiety and somatisation

    Page :228-229

    P.P. Ferentinos, V.P. Kontaxakis, B.J. Havaki-Kontaxaki, C.R. Soldatos

    Résumé Résumé Plan Plan
  • ·Long-term treatment of severe major depression (MDD) with escitalopram or paroxetine

    Page :229-229

    J.P. Boulenger, A.K.T. Huusom, E. Weiller, I. Florea

    
  • ·Meta analysis of randomised controlled trials describing the effectiveness of venlafaxine in the treatment of major depressive disorder

    Page :229-229

    N. Freemantle, P. Tharmanathan

    
  • ·Alexithymia and winter seasonal affective disorder: Prevalence, sociodemographic and clinical correlates

    Page :229-230

    S. Friedman, M. Oumaya, C. Even, J. Thuile, J.D. Guelfi, F. Rouillon

    Résumé Résumé Plan Plan
  • ·Antidepressant treatment during pregnancy: Pros and cons

    Page :230-230

    L. Garcia-Esteve, F. Botet, J. Pérez, C. Soler, J. Figueras, P. Navarro, R. Martín-Santos, E. Gelabert, M.L. Imaz

    
  • ·Escitalopram in clinical practice: The Greek experience- efficacy and tolerability

    Page :230-230

    A. Liakouras, T. Hamogeorgakis, A. Zouganelli, D. Giailoglou, I.A. Parashos

    
  • ·The spinal cord injuries and depression symptoms relation

    Page :230-230

    V. Grigaliuniene, A. Stolygaite, B. Burba, O. Jankuviene

    
  • ·Escitalopram in patients with recurrent unipolar major depression: 6-month clinical follow-up

    Page :230-231

    M. Grigoroiu-Serbanescu, R. Mihailescu, M. Gherlghel

    Résumé Résumé Plan Plan
  • ·Are depressive and seasonal symptoms associated?

    Page :231-231

    S. Grimaldi, T. Partonen, J. Lönnqvist

    
  • ·Depression on late life: Epidemiologycal data, risk factors and therapeutic approach

    Page :231-231

    J.L. Hernandez Fleta, M.E. Terres Ruiz, T. Sanchez-Araña Moreno, A. Salesansky Davidovsky, E. Zerek Benitez, A. Dominguez Santana

    
  • ·Update on the treatment for refractary depression

    Page :231-232

    J.L. Hernandez Fleta, M.E. Terres Ruiz, T. Sanchez-Araña Moreno, A. Salesansky Davidovsky, A. Dominguez Santana, E. Zerek Benitez

    Résumé Résumé Plan Plan
  • ·Association of depressive symptoms with overactive bladder

    Page :232-232

    D.E. Irwin, I. Milsom, Z. Kopp

    
  • ·St. John's wort versus depression

    Page :232-232

    C. Istikoglou, O. Mikirditsian, K. Michelidakis, T. Nikolaou, D. Vlissides, V. Mavreas, D. Damigos, M. Stathaki

    
  • ·Solving the problem of antidepressant selection

    Page :232-233

    B. Burba, O. Jankuviene, V. Grigaliuniene, A. Jaras, D. Gudiene

    Résumé Résumé Plan Plan
  • ·Gender differences of teenagers suicidal behavior: Correlation with depression, personal peculiarities

    Page :233-233

    A. Jaras, V. Arbaciauskas, D. Gudiene, O. Jankuviene, B. Burba, V. Grigaliuniene

    
  • ·Anhedonia in patients with depression

    Page :233-233

    K. Katsigiannopoulos, M. Stiga, G. Garyfallos, C. Zagora, M. Lombtzianidou, I. Drenos, M. Voikli, A. Adamopoulou

    
  • ·What are users views as regards the acceptability and usefulness of overcoming depression cdrom

    Page :233-233

    C. Kent, G. Crawford, M. Selkirk, C. Williams

    
  • ·Effect of ADHD and other comorbidity on the life quality of depressed children and adolescents

    Page :233-234

    E. Kiss, D. Skulteti, A. Vetro

    Résumé Résumé Plan Plan
  • ·Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression

    Page :234-234

    M. Kluge, P. Schuessler, A. Steiger

    
  • ·Stress hormones and anabolic balance in depression: Influence of antidepressants.

    Page :234-234

    Y.A. Kochetkov, L.N. Gorobets, K.V. Beltikova

    
  • ·Role of psychological suitability factors in the choice between short and long-term therapy for treatment of depressive and anxiety disorders

    Page :234-234

    M.A. Laaksonen, P. Knekt, O. Lindfors

    
  • ·Depressive symptoms and sport activity among college students

    Page :234-235

    M. Zuljan Cvitanovic, D. Duplancic, D. Lasic, I. Stipetic, M. Tripkovic, V. Capkun

    Résumé Résumé Plan Plan
  • ·Effect of pallidotomy on depression in patients with Parkinson's disease

    Page :235-235

    I. Laskowska, P. Rolinska, P. Andryszak, K. Żukiewicz, A. Stachowiak, E.J. Gorzalańczyk

    
  • ·Depression and self-esteem in adolescence:a study of senior high school students in Greece

    Page :235-235

    H. Lazaratou, D.G. Dikeos, D.C. Anagnostopoulos, C.R. Soldatos

    
  • ·Prophylaxis in bipolar disorder: Implications of a randomised, open lamotrigine-vs-lithium study

    Page :235-236

    R.W. Licht, P. Vestergaard, L.F. Gram

    Résumé Résumé Plan Plan
  • ·Influences of personality traits on depressive tendency among adolescents in Eastern Taiwan

    Page :236-236

    C.C.H. Lin, S.J. Chen, H.J. Yang, C.H. Wang

    
  • ·The intensity dependence of auditoy ERP components in unmedicated patients with major depression. an analysis of group differences.

    Page :236-236

    T. Linka, G. Sartory, M. Gastpar, B.W. Mueller

    
  • ·Suicidal ideation and depressive disorders in primary care: The role of comorbidity

    Page :236-237

    J.J. Carballo, P. Garcia-Parajua, M. Magarinos, L. de Ugarte, L. Giner, L. Sher

    Résumé Résumé Plan Plan
  • ·Neuroticism and life adversity in the development of depressive symptoms

    Page :237-237

    K. Malyszczak, T. Pawlowski, A. Pyszel, M. Inglot, A. Kiejna

    
  • ·Conventional EEG as predictor to mood stabilisers choice?

    Page :237-237

    D.J. Marinkovic, O.O. Marinkovic, S.D. Totic, M.D. Marjanovic

    
  • ·Early screening of risk factors of postpartum depression at the obstetric ward

    Page :237-238

    E. Gelabert, P. Navarro, A. Plaza, M.L. Imaz, S. Subira, L.L. Garcia-Esteve, R. Martin-Santos

    Résumé Résumé Plan Plan
  • ·Trazodone in the treatment of the depressed patient with insomnia

    Page :238-238

    J. Martinovic, A. Miljatovic, L. Trikos

    
  • ·Relationship of socio-demographic characteristics of seizure types in epileptics with depression present as comorbid condition

    Page :238-238

    E. Mehmedika-Suljic, A. Alajbegovic, N. Loncarevic, A. Kulenovic Dzubur, A. Bravo, S. Alajbegovic, A. Kucukalic

    
  • ·Anxiety and depression of patients with diabetes

    Page :238-238

    K. Michelidakis, J. Myriokefalitakis, S. Bousboulas, C. Istikoglou, O. Mikirditsian, T. Nikolaou, M. Stathaki, D. Vlissides

    
  • ·Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia

    Page :238-239

    S. Montgomery, G. Kinrys, A. Krystal, W.V. McCall, T. Roth, R. Rubens, K. Schaefer, J. Roach, H. Huang, R. Krishnan, M. Pollack

    Résumé Résumé Plan Plan
  • ·Prevalence, incidence and risk of depression in the Spanish cohort within the predict study

    Page :239-239

    B. Moreno, C. Montón, M.J. Gil De Gómez, M. Sánchez-Celaya, B. Oliván, M.S. Sánchez

    
  • ·Refractory pain-depression syndrome treated with tianeptine

    Page :239-239

    P.S. Muniz, A.E. Nardi

    
  • ·Two years of maintenance treatment with venlafaxine xr 75-225 mg/d: Efficacy in patients with recurrent unipolar major depression

    Page :239-240

    J.H. Kocsis, S.G. Kornstein, S. Ahmed, T. Ferdousi, J. Musgnung, M. Thase, E. Friedman, B.W. Dunlop, B. Yan, R. Pedersen, P.T. Ninan

    Résumé Résumé Plan Plan
  • ·Predictors of clinical outcome in panic disorder: Analysis of venlafaxine XR short-term treatment studies

    Page :240-240

    M. Pollack, D.J. Stein, R. Mangano, J. Musgnung, R. Entsuah, N. Simon

    
  • ·Efficacy of venlafaxine XR and placebo in social anxiety disorder: Effects of gender and physical symptoms

    Page :240-240

    M. Liebowitz, J. Davidson, C. Blanco, J. Musgnung, R. Tummala, Q. Jiang

    
  • ·Recurrence prevention in patients with recurrent major depression receiving 12 months of treatment with venlafaxine XR

    Page :240-241

    M. Keller, B. Yan, J. Musgnung, D. Dunner, J. Ferguson, E. Friedman, A. Gelenberg, R. Hirschfeld, J. Kocsis, S. Kornstein, C. Nemeroff

    Résumé Résumé Plan Plan
  • ·Two-year placebo-controlled maintenance study to assess recurrence prevention with venlafaxine XR in patients with recurrent unipolar major depression

    Page :241-241

    M. Keller, B. Yan, J. Musgnung, D. Dunner, J. Ferguson, E. Friedman, A. Gelenberg, R. Hirschfeld, J. Kocsis, S. Kornstein, C. Nemeroff

    
  • ·Treatment of depressive syndrome in patients with psychosomatic disorders

    Page :241-241

    B.V. Mykhaylov

    
  • ·Use of antiepileptic drugs in psychiatry

    Page :241-242

    C. Silveira, R. Curral, A. Norton, I. Domingues, A. Palha

    Résumé Résumé Plan Plan
  • ·Child neurodevelopment following exposure to venlafaxine in utero, unexposed siblings as comparison groups: Preliminary results

    Page :242-242

    I. Nulman, D. Knittel-Keren, S. Valo, R. Sussman, M. Barrera, G. Koren

    
  • ·Correlation of functioning level with level of anxiety, depression and hopelessness in patients under the treatment with psychopharmacotherapy

    Page :242-242

    J. Petkovic, E. Tupkovic

    
  • ·Duloxetine in major depressed patients resistant to SSRIs or venlafaxine

    Page :242-242

    W. Pitchot, E. Pinto, G. Scantamburlo, M. Ansseau

    
  • ·Affective patients in residential setting

    Page :242-243

    A. Placentino, L. Pedrini, N. Di Tommaso, C. Giovannini, P. Basso, S. Bignotti, J. Perez

    Résumé Résumé Plan Plan
  • ·Pospartum depression and early life events: Influences of the dysregulation of the pituitary-thyroid axis

    Page :243-243

    A. Plaza, P. Navarro, L.L. Garcia-Esteve, C. Ascaso, J. Aguado, R. Martin-Santos, E. Gelabert

    
  • ·The efficiency of atypical antidepressants in late life depression

    Page :243-243

    D.M. Podea, R.M. Chenderes

    
  • ·Suicide and antidepressants: risk, benefits and response to treatment

    Page :243-244

    M. Pompili, P. Girardi, E. De Pisa, R. Tatarelli

    Résumé Résumé Plan Plan
  • ·Depression in hemodialysis patients: association with inflammatory and nutritional markers

    Page :244-244

    V.R. Popovic, J.R. Popovic, N.B. Dimkovic, Z.T. Paunic, A.A. Jovanovic

    
  • ·Affective temperament-types and suicidal behaviour

    Page :244-244

    A. Rihmer, S. Rozsa, Z. Rihmer, X. Gonda, K.K. Akiskal, H.S. Akiskal

    
  • ·The relationships between the severity of depression and behavioral attitudes

    Page :244-245

    V.S. Rotenberg, A. Cholostoy, P. Gurwitz, E. Shamir, Y. Baruch

    Résumé Résumé Plan Plan
  • ·Behavioral attitudes and subjective sleep estimation in depression

    Page :245-245

    V.S. Rotenberg, P. Gurwitz, A. Cholostoy, E. Shamir, Y. Baruch

    
  • ·Pharmacological validation of a chronic social stress model in rats: effects of citalopram, reboxetine, haloperidol and diazepam

    Page :245-245

    R. Rygula, N. Abumaria, C. Hiemke, E. Ruther, G. Flugge, E. Fuchs, U. Havemann-Reinecke

    
  • ·Painful physical symptoms (PPS) in depressed patients: how is the correlation between physician- and patient assessment?

    Page :245-245

    M. Linden, E. Schneider, A. Schacht, M. Grigat, U. Hegerl

    
  • ·Relationship between kind of delivery and postpartum depression

    Page :245-246

    K.H. Sharifi, Z. Sooky, Z. Tagharrobi, H. Akbari

    Résumé Résumé Plan Plan
  • ·Cardic parasympathetic dysfunction in depressed coronary heart disease patients:what is the response to treatment with sertaline?

    Page :246-246

    F.M. Sherif, M.M. Abdel Samei

    
  • ·The depression prevalence and its related factors in teenagers in Kashan-Iran 2006

    Page :246-246

    Z. Sooky, K.H. Sharifi, Z. Tagharrobi

    
  • ·48 week follow-up study of venlafaxine extended release and fluoxertine hydrochloride treatment for first-episode depression

    Page :246-246

    H. Su, K.D. Jiang, Y.F. Xu, F. Li, Y.L. Liu, G.H. Pan

    
  • ·Psychiatric disorder and Parkinson's disease

    Page :246-247

    I. Tazi, F. Manoudi, F. Asri

    Résumé Résumé Plan Plan
  • ·Venlafaxine XR versus fluoxetine in the treatment of major depressive disorder and generalized anxiety disorder dual diagnosis

    Page :247-247

    D. Vasile, O. Vasiliu, P. Ivanov, D. Ojog, M. Sarmache, M. Vasile

    
  • ·5-httlpr polymorphism in patients with depression and the treatment response to citalopram.

    Page :247-247

    L. Vavrusova, V. Repiska, T. Braxatorisova

    
  • ·Sexual disturbances associated with use of SSRI's and other antidepressants

    Page :247-247

    M. Vucic Peitl, G. Rubesa, D. Ljubicic, V. Peitl

    
  • ·Treatment with sertraline(asentra) in patients with cardio-vascular difficulties after cardio-surgical interventions

    Page :247-248

    V. Vujovic, S. Arsova, A. Novotni, G. Hadzi-Angelkovski, V. Gerazova, M. Stanoevska, L. Aleksovska

    Résumé Résumé Plan Plan
  • ·The effects eszopiclone 3mg on next day driving ability, cognitive and psychomotor function in patients with primary insomnia

    Page :248-248

    T. Wessel, J. Caron, L. Trick, R. Rubens, J. Roach, J. Boyle

    
  • ·The impact of a novel computerized CBT CD-Rom (overcoming depression) offered to patients referred to clinical psychology

    Page :248-248

    C.J. Williams, G. Whitfield, R. Hinshelwood, A. Pashley, L. Campsie

    
  • ·Association between quality of life and self-stigma, insight, and adverse effects of medication in patients with depressive disorders

    Page :248-249

    C.F. Yen, C.C. Chen, Y. Lee, T.C. Tang, C.H. Ko, J.Y. Yen

    Résumé Résumé Plan Plan
  • ·Depression during hospitalization for acute coronary syndrome predicts physical function one year later

    Page :249-249

    B.D. Thombs, R.C. Ziegelstein, D.E. Stewart, S.E. Abbey, S.L. Grace

    
  • ·Both depression and self-reported physical health during hospitalization for an acute coronary syndrome predict mortality one year later

    Page :249-249

    B.D. Thombs, R.C. Ziegelstein, D.E. Stewart, S.E. Abbey, S.L. Grace

    
  • ·Mixed (bipolar) depression and suicide attempts

    Page :249-250

    J. Balazs, F. Benazzi, Z. Rihmer, H.S. Akiskal

    Résumé Résumé Plan Plan
  • ·Metabolic syndrome among patients with bipolar disorder: Current perspectives of European psychiatrists

    Page :250-250

    M. Bauer, Y. Lecrubier, T. Suppes

    
  • ·Trends in psychopharmacological approach to bipolar disease in the last 20 years - A retrospctive study-

    Page :250-250

    P. Cintra, A.N. Ramos, P.F. Varandas

    
  • ·The treatment of rapid cycling bipolar disorder (RCBD)

    Page :250-250

    A.M. Ciobanu

    
  • ·Attribution style and social functioning of ADHD vs non-referred children

    Page :250-251

    M.I. Dabkowska, M.R. Dabkowski

    Résumé Résumé Plan Plan
  • ·Bipolar disorder-mixed episode: adding mood stabilizer to antipsychotics

    Page :251-251

    I.A. Dan, G. Marian, A. Varghes

    
  • ·Mania following stroke. A case report

    Page :251-251

    A. Dervaux

    
  • ·Changes in cortical activation during sad facial affect recognition with lamotrigine monotherapy in patients with bipolar disorder

    Page :251-251

    S. Frangou, J. Jogia, M. Haldane, V. Kumari

    
  • ·The prevalence of the metabolic syndrome in bipolar patients

    Page :252-252

    M.P. Garcia-Portilla, P.A. Saiz, I. Menendez, P. Sierra, L. Livianos, A. Benabarre, J. Perez, A. Rodriguez, J. Valle, F. Sarramea, R. Fernandez-Villamor, J.M. Montes, M.J. Muñiz

    
  • ·Investigation of child-family relations using family drawing in kindergarten children in Kaunas

    Page :252-252

    V. Grigaliuniene, A. Gonak, A. Krisciukaityte, G. Stonyte

    
  • ·Gender-related effect of parental age on age-at-onset in bipolar disorder

    Page :252-252

    M. Grigoroiu-Serbanescu, P. Wickramaratne, M.M. Noethen

    
  • ·Differences in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with lamotrigine monotherapy

    Page :252-253

    M. Haldane, J. Jogia, A. Cobb, E. Kozuch, V. Kumari, S. Frangou

    Résumé Résumé Plan Plan
  • ·Transition from immediate-release methylphenidate (ir-mph) to extended-release methylphenidate (OROS-MPH) improves quality of life of patients with adhd -a naturalistic study

    Page :253-253

    L. Hargarter, M. Gerwe, J. Czekalla, F. Mattejat

    
  • ·Teenagers suicidal behavior and psychosocial factors

    Page :253-253

    A. Jaras, V. Arbaciauskas, D. Gudiene, O. Jankuviene, B. Burba, V. Grigaliuniene

    
  • ·Executive function in chinese children with bipolar disorder

    Page :253-254

    W.D. Ji, H.F. Chang, Y. Li, B.Y. Guo, D.L. Yang

    Résumé Résumé Plan Plan
  • ·Ziprasidone does not exacerbate mania or worsen depression during treatment of bipolar mania: An analysis of pooled clinical trial data

    Page :254-254

    I. Lombardo, F. Rappard, A. Jina, F. Mandel

    
  • ·Is there a coleration between alexithymia and frontal lobe dysfunction?

    Page :254-254

    D. Kountouris, A. Bougioukou

    
  • ·ADHD bibliometric study over the last 25 years (i): Analysis of the production and dispersion of the scientific literature

    Page :254-254

    F. Lopez-Munoz, F.J. Quintero-Gutierrez, P. Garcia-Garcia, C. Alamo

    
  • ·ADHD bibliometric study over the last 25 years (ii): correlation with social-health parameters

    Page :254-255

    F. Lopez-Munoz, F.J. Quintero-Gutierrez, P. Garcia-Garcia, C. Alamo

    Résumé Résumé Plan Plan
  • ·Sub syndromal mood disorders in artists

    Page :255-255

    F. Manoudi, F. Asri, I. Tazi

    
  • ·Bipolar depression comorbid with diabetes mellitus - a therapeutical challenge. Case report

    Page :255-255

    G. Marian, I.A. Dan, B.E. Ionescu, D. Spinu

    
  • ·Peripheral brain-derived neurotrophic factor (BDNF) in patients with unipolar depression or with bipolar I and II disorders

    Page :255-255

    V. Martiadis, P. Monteleone, V. Iodice, C. Serritella, M. Fabrazzo, M. Maj

    
  • ·A survey exploring characteristics of bipolar patients referred to a specialist tertiary centre in UK

    Page :256-256

    J. Mayoral van Son, I.N. Ferrier, J. Artal, J.L. Vazquez Barquero

    
  • ·Progressive grey matter loss in patients with bipolar disorder

    Page :256-256

    A.M. McIntosh, T.W.J. Moorhead, J. McKirdy, J.E.D. Sussmann, J. Hall, E.C. Johnstone, S.M. Lawrie

     
  • ·Quality of life in bipolar mood disorder

    Page :256-256

    R.S. Macrea, I.V. Miclutia, M. Crisan

    
  • ·How common is bipolar disorder not otherwise specified diagnosis in hospitalized patients?

    Page :256-257

    S. Guloksuz, E.T. Oral

    Résumé Résumé Plan Plan
  • ·Behavioral disorders at adolescent with primary cerebral dysfunction

    Page :257-257

    O. Pilyavskaya, N. Butorina, D. Verbovetskaya

    
  • ·Suicidal risk in bipolar disorder patients

    Page :257-257

    M. Pompili, A. Grispini, P. Girardi, R. Tatarelli

    
  • ·Social networks of patients with bipolar affective disorder.

    Page :257-257

    M. Poradowska-Trzos, D. Dudek, W. Datka, A. Zieba

    
  • ·A perception of social support in the aspect of a cognitive style of patients with affective disorders.

    Page :257-258

    M. Poradowska-Trzos, D. Dudek, W. Datka, A. Zieba

    Résumé Résumé Plan Plan
  • ·Efficacy of ziprasidone in dysphoric mania: Pooled analysis of two double-blind studies

    Page :258-258

    S. Stahl, I. Lombardo, A. Loebel, F. Rappard, F. Mandel

    
  • ·Does cannabis use impact on treatment outcome in bipolar illness?A longitudinal analysis

    Page :258-258

    I. van Rossum, M. Boomsma, D. Tenback, C. Reed, J. van Os

    
  • ·Behavioral activation and inhibition systems in bipolar i euthymic patients and its influence in subsequent episodes

    Page :258-258

    J. Salavert, X. Caseras, R. Torrubia, N. Ramírez, E. Del Moral, B. Arranz, L. San

    
  • ·The co-occurrence of bipolar and substance-related disorders

    Page :259-259

    G.L. Santana, Y.P. Wang

    
  • ·Selective mutism: The power of words

    Page :259-259

    V. Santos, V. Domingues

    
  • ·The efficacy and side effect profile of lamotrigine in acute mania: A double-

    Page :259-259

    G. Sharma, M. Kumar, D. Ram

    
  • ·The suicidal archetype of bipolar patient: An analysis of 206 hospital admissions.

    Page :259-259

    J.T.S.F. Serra, C.S.S. Silva, J.G. Santos, O.S.N. Neves

    
  • ·The depression prevalence and psychosocial need satisfaction in teenagers

    Page :260-260

    Z. Sooky, K.H. Sharifi, Z. Tagharrobi

    
  • ·Comorbidity of adult attention deficit hyperactivity disorder in adult patients with bipolar disorder: prevalence and clinical correlates

    Page :260-260

    L. Tamam, G. Karatas, N. Ozpoyraz

    
  • ·The features of emotion regulation in a clinical sample of youth in hungary. Pilot study of ‘feelings and me' questionnaire.

    Page :260-260

    Z. Tamas, J. Gadoros

    
  • ·Automutilation behavior and suicidal ideation in adolescent with bipolar disorder

    Page :260-261

    J.H. Tang, G.H. Wang, X.P. Wang, Z.C. Liu, C. Shu, L. Xiao

    Résumé Résumé Plan Plan
  • ·Maniacal type of bipolar affective disorder and sexual dysfunction

    Page :261-261

    N.F. Valeeva

    
  • ·Oxcarbazepine as a mood stabiliser.

    Page :261-261

    E.M. VanGent

    
  • ·Augmenting antidepressant psychopharmacological approach with cognitive-behavioural therapy in bipolar depression

    Page :261-261

    D. Vasile, O. Vasiliu, D. Ojog, M. Vasile, M. Sarmache, M. Terpan

    
  • ·Double-blind comparison of addition of acanthopanax senticosus versus fluoxetine to lithium for treatment of adolescent patients with bipolar depression

    Page :261-262

    S.H. Weng, J.H. Tang, G.H. Wang, X.P. Wang

    Résumé Résumé Plan Plan
  • ·Response- and remission rates as efficacymarker of monotherapy with atypical neuroleptics in the treatment of acute mania

    Page :262-262

    S. Eppendorfer, S. Wilhelm, C. Nicolay, H.P. Hundemer

    
  • ·Preventing bipolar relapse: Which factors are associated with different mood stabilizer therapy?

    Page :262-262

    S. Wilhelm, A. Schacht, A. Minarzyk, A. Liebeskind, H. Grunze

    
  • ·Preventing bipolar relapse: In which way do patients with mixed episodes differ?

    Page :262-263

    S. Wilhelm, A. Schacht, A. Minarzyk, A. Liebeskind, H. Grunze

    Résumé Résumé Plan Plan
  • ·Attention deficit hyperactivity disorder and bipolar disorder: comorbidities and psychosocial impairment

    Page :263-263

    D. Bicer, C. Dedeoglu, K. Kora, Y. Yazgan

    
  • ·The effect of quetiapine monotherapy on subjective estimates of sleep in acute mania

    Page :263-263

    B.H. Yoon, W.M. Bahk, D.I. Jon, K.J. Min, A. Bae, Y.H. Sea, K.J. Kim

    

• Poster Session 2: ECT

  • ·Are the ect machines with high dosage (>576mc) advantageous? A preliminary study

    Page :263-263

    A.A. Alabi, G. Kungiri

    
  • ·Self-evaluation of the cognitive effects of ECT

    Page :264-264

    E.L. Brakemeier, R. Berman, J. Prudic, H.A. Sackeim

    
  • ·Deep brain stimulation in treatment-refactory major depressive disorder: Preliminary results in three patients

    Page :264-264

    L. Gabriels, P. Cosyns, B. Nuttin

    
  • ·New electromagnetic (quantum) therapeutic tools (specially) in depression, schizophrenia, parkinson's disease and dementia

    Page :264-264

    E.M. Goncalves

    
  • ·A rare case of dissociative fugue with unsually prolonged amnesia successfully resolved by ECT

    Page :264-265

    K. Kosidou, S. Lindholm

    Résumé Résumé Plan Plan
  • ·rTMS added to usual treatment for older patients with depression

    Page :265-265

    R.V. Milev, G. Abraham, G. Hasey

    
  • ·Demographic and clinical predictors for the efficacy of electroconvulsive therapy

    Page :265-265

    Z. Spiric, R. Samardzic, G. Mandic-Gajic, J. Antonijevic, T. Maric, V. Petrovic

    
  • ·The changes of brain electrical activity after cerebellar rtms revealed by loreta (low resolotion brain electromagnetic tomography)

    Page :265-266

    B. Tislerova, M. Kopecek, J. Audrlicky, P. Sos, M. Brunovsky, J. Horacek

    Résumé Résumé Plan Plan  
  • ·Efficacy of modified electroconvulsive therapy combined with antipsychotic medication in treatment-refractory schizophrenia

    Page :266-266

    Z.H. Yi, Q.H. Xu, G.H. Sheng, GJ. Wu, H.Y. Deng, L.P. Zhu

    

• Poster Session 2: ANXIETY, STRESS RELATED, IMPULSE AND SOMATOFORM DISORDERS

  • ·Anxiety levels in east and west: 18 arab countries, germany, spain, U.K., and U.S.A.

    Page :266-266

    Ahme Abdel-Khalek

    
  • ·Cyproheptadine effect on combat related PTSD nightmares

    Page :266-266

    G.H. Ahmadzadeh, A. Farhat, G.H. Assadolahi, G. Mahmodi

    
  • ·Subjective sleep quality and aggression in antisocial personality disorder

    Page :266-267

    A. Algul, U.B. Semiz, M.A. Ates, M. Cetin, S. Ebrinc, C. Basoglu, H. Gunay, C. Gunes, C.O. Noyan, O. Yilmaz

    Résumé Résumé Plan Plan
  • ·Psychological consequences of erectile dysfunction in yemeni adult men

    Page :267-267

    M. Almalmi, A. Aliriani, T. Albadani

    
  • ·Waiting for kidney transplantation from living or cadaveric donor: Impact on transplant representations

    Page :267-267

    M. Ammor, A. Durrbach, B. Charpentier, P. Lang, F. Advenier, S. Amidi, A. Dezamis, P. Hardy, B. Falissard, E. Corruble

    
  • ·Suicidality and religiosity in breast cancer patients

    Page :267-268

    B. Aukst-Margetic, M. Jakovljevic, B. Margetic, M. Samija, M. Biscan

    Résumé Résumé Plan Plan
  • ·Anxiety and bruxist behaviour in the patients with temporomandibular joint disorder

    Page :268-268

    T. Badel, S. Kocijan Lovko, J. Panduric, M. Marotti, J. Keros, J. Kern

    
  • ·Relationship between anxiety and hostility among teachers

    Page :268-268

    A.A. Bayani, A.M. Kocheki

    
  • ·A randomized, open-label comparison of paroxetine (rexetine) and cognitive-behavioral therapy in management of panic disorder

    Page :268-268

    A.E. Bobrov, I.N. Agamamedova, N.A. Kuznetsova

    
  • ·Relationship between psychotrauma and multiple sclerosis

    Page :268-269

    M. Bras, R. Gregurek, V. Milunovic, I. Busic, B. Kalenic

    Résumé Résumé Plan Plan
  • ·Alexithymia correlates with physical quality of life after percutaneous transluminal coronary angioplasty

    Page :269-269

    E. Bui, P. Birmes, L. Cailhol, R. Klein, L. Schmitt

    
  • ·Psychiatric diagnoses and fibromialgia: Who takes care of these patients?

    Page :269-269

    X. Cardona, F. Sastre, M. Martin-Baranera, N. Olona

    
  • ·Stress related disorders: Hypothalamic-pituitary-adrenal axis dysfunctions.

    Page :269-269

    M. Catena, S. Gorini Amedei, L. Faravelli, F. Rotella, A. Scarpato, A. Palla, A. Veltri, M. Picchetti, R. Paggini, G. Ciampa, C. Faravelli

    
  • ·Comorbidity of adult attention deficit hyperactivity disorder and its relation to executive functions in patients with antisocial personality disorder

    Page :270-270

    M. Cetin, U.B. Semiz, M.S. Iyisoy, C. Basoglu, A. Ates, S. Ebrinc

    
  • ·Psychiatrists and occupational stress

    Page :270-270

    A. Chiorean, A. Mihai, M. Stoica, I. Marculescu, I. Papava

    
  • ·The nocebo effect: How stress modulates pain

    Page :270-270

    M. Sigaudo, S. Vighetti, F. Benedetti, L. Colloca

    
  • ·Use of medical services in the Factitious Disorder

    Page :270-271

    A. De Cos Milas, V. Gomez Macias, M.L. Catalina Zamora

    Résumé Résumé Plan Plan
  • ·Adaptative disorder: Relationship between RAHE and PHQ in primary care

    Page :271-271

    L. de Ugarte Postigo, M. Catalina Zamora, J. Iglesias, M. Magariños, P. Garcia-Parajua

    
  • ·The forecasting of chronical forms of PTSD

    Page :271-271

    I.V. Dorovskih, A.S. Zakovryashin, G.U. Maltsev, O.V. Senko, A.A. Kozlov

    
  • ·Conversion disorder misdiagnosed as epilepsy for 12 years, treated successfully with fluoxetine - Case report

    Page :271-271

    F. Elezi, A. Braho, E. Sotiri, D. Dobi

    
  • ·Endothelial damage markers in panic disorder and its evolution after the treatment

    Page :271-272

    O. Fernandez-Torre, A. Herran, M.T. Garcia-Unzueta, M.L. Ramirez, B. Rodriguez-Cabo, M. Carrera, F. Hoyuela, A. Ayestaran, J.L. Vazquez-Barquero, J.A. Amado

    Résumé Résumé Plan Plan
  • ·Social support and psychological consequences in females exposed to war trauma

    Page :272-272

    M. Klaric, T. Franciskovic

    
  • ·Dissociative disorders and dissociative symptoms among veterans of Iraq-Iran combat

    Page :272-272

    A.G. Nejad

    
  • ·Factitious disorder with psychological symptoms: Learning to be ill

    Page :272-272

    V. Gomez Macias, A. De Cos Milas, M.L. Catalina Zamora

    
  • ·Risperidone treatment for chronic PTSD

    Page :272-273

    G.B. Grbesa, M.B. Simonovic, T.M. Milovanovic

    Résumé Résumé Plan Plan
  • ·The spiritual approach in the group psychotherapy treatment of psychotraumatized persons in post-war Bosnia and Herzegovina

    Page :273-273

    M. Hasanović, I. Pajević, O. Sinanović

    
  • ·The influence of religiosity on mental stabylity of war veterans

    Page :273-273

    I. Pajević, O. Sinanović, M. Hasanović

    
  • ·PTSD, depression, anxiety, and substance misuse among of medical and phylosphy university students in Bosnia-Herzegovina after 1992-95 war

    Page :273-274

    O. Sinanovic, M. Hasanovic, E. Babajic, M. Salkic, J. Mujanovic, A. Begic, Z. Music

    Résumé Résumé Plan Plan
  • ·PTSD among adolescents from three different geographical settings in Bosnia-Herzegovina after 1992-95 war

    Page :274-274

    M. Hasanovic, O. Sinanovic, S. Pavlovic

    
  • ·Four years of day hospital treatment of psycho-traumatized persons in post-war Bosnia and Herzegovina

    Page :274-274

    E. Avdibegovic, M. Hasanovic, Z. Selimbasic, I. Pajevic, O. Sinanovic, A. Kopric

    
  • ·Prevention of mental health problems among future doctors: A controlled group intervention study among medical students in Bergen

    Page :274-274

    M. Holm, R. Tysssen, B. Haver

    
  • ·Ethnotherapeutic approach in psychosocial assistance to adolescents in refugee camps: The experience of Chechnya

    Page :274-275

    K.A. Idrisov

    Résumé Résumé Plan Plan
  • ·The quality of life of the patients who underwent surgical treatment on oncological pathology of thyroid gland

    Page :275-275

    S.A. Igumnov, I.V. Grigorieva

    
  • ·Type of trauma in posttraumatic stress disorder female patients

    Page :275-275

    N. Jovanovic, A. Bokic Sabolic, M. Rojnic Kuzman, J. Grubisin, V. Medved, L.J. Hotujac

    
  • ·Prison psychosis or simulation: a case report

    Page :275-275

    M.F. Kammoun, J. Ben Thabet, J. Masmoudi, T. Dumoulin, A. Jaoua, J.L. Garrigou

    
  • ·Indexes of alexithymia and psychopathology in patients with type II diabetes.

    Page :275-276

    S. Kaprinis, D. Kandylis, S. Sokolaki, A. Iakovides

    Résumé Résumé Plan Plan
  • ·The role of early developmental and familial factors in the development of selective mutism: A case-control study

    Page :276-276

    K. Kapornai, S. Okros, E. Kiss, A. Vetro

    
  • ·The stressors of nures of critical care units

    Page :276-276

    M. Aghamohammadi, M. Karimollahi

    
  • ·Pyridoxine (B6) for the treatment of premenstrual syndrome (PMS)

    Page :276-276

    M. Kashanian, R. Mazinani, S.H. Jalalmanesh

    
  • ·The evaluation of the effectiveness of pyridoxine (vitamin B6) for the treatment of premenstrual syndrome

    Page :276-277

    M. Kashanian, R. Mazinani, S.H. Jalalmanesh, S.H. Babayan

    Résumé Résumé Plan Plan
  • ·Contributing factors in the appearance and course of generalized anxiety disorder

    Page :277-277

    A. Chaloudi, K. Katsigiannopoulos, A. Adamopoulou, M. Lombzianidou, M. Markopoulou, D. Dyntsikou, G. Garyfallos

    
  • ·Rational of use of gabapentine in premature ejaculation

    Page :277-277

    M.H. Khan, H.R. Chaudhry, M. Masood, M.G. Butt, T. Ali

    
  • ·Somatoform syndromes at the anxiety-depressive disorders.

    Page :277-277

    A.S. Kim

    
  • ·The phenomenon of "magic thinking" as a criteria of shizotypal disorder

    Page :277-278

    E.V. Klembovskaya

    Résumé Résumé Plan Plan
  • ·Depression in children who experienced severe war trauma

    Page :278-278

    N. Kravic, I. Pajevic, M. Hasanovic

    
  • ·Psychotherapy and pharmacotherapy efectiveness on brain neuroplasticity in patients suffering from anxiety disorders

    Page :278-278

    K. Krysta, M. Matuszczyk, A. Klasik, Z. Pilarz, J. Przybylo, I. Krupka-Matuszczyk

    
  • ·Women mental health after 40: Age-related stress

    Page :278-278

    M.A. Kulygina

    
  • ·Randomized crossover trial studying the effect of music on examination anxiety

    Page :278-279

    H.L. Lai

    Résumé Résumé Plan Plan
  • ·Music appreciation and intervention on stress reduction: a randomized crossover trial

    Page :279-279

    H.L. Lai

    
  • ·Reation of panic disorder and somatic illnesses

    Page :279-279

    M. Latas, S. Adnadjevic

    
  • ·Preliminary results evaluating cognitive function in elderly from double-blind, placebo-controlled trial of pregabalin in generalized anxiety disorder (gad)

    Page :279-280

    M.M. Carrasco, F. Baldinetti, T. Leon, F. Mandel, L. Pauer, K. Chatamra

    Résumé Résumé Plan Plan
  • ·Pregabalin for the treatment of generalized anxiety disorder (GAD): Efficacy and safety in elderly patients

    Page :280-280

    J. Bobes Garcia, S. Montgomery, F. Baldinetti, T. Leon, F. Mandel, L. Pauer, K. Chatamra

    
  • ·A case control study of the psychiatric status of elderly versus younger trauma victims.

    Page :280-280

    H.M. Livingston, D.Z. Gillis, M.G. Livingston

    
  • ·Can IBS (irritable bowel syndrome) be conceptualized as an anxiety disorder and what treatment implications would that have?

    Page :280-280

    B. Ljotsson, S. Andreewitch

    
  • ·Clinical outcome of multimodal rehabilitative care for young patients with multiple drug abuse

    Page :280-281

    F. Loehrer, R. Sotho-Loewenthal, H.J. Kunert

    Résumé Résumé Plan Plan
  • ·Impaired abstraction and symbolization abilities in subjects with panic disorder

    Page :281-281

    F. Mancuso, P. Bucci, R. Zamboli, E. Plaitano, A. Mucci, S. Galderisi, M. Maj

    
  • ·Alexithymia and emotional stimuli processing in panic disorder

    Page :281-281

    F. Mancuso, R. Zamboli, R.M. De Santo, M. Chieffi, A. Mucci, S. Galderisi, M. Maj

    
  • ·A relationship between social anxiety and oxytocin.

    Page :281-282

    D. Marazziti, S. Baroni, M. Catena, M. Picchetti, M. Carlini, G. Giannaccini, A. Lucacchini, L. Dell'Osso

    Résumé Résumé Plan Plan
  • ·Prevalence of anxiety disorders in earthquake effected areas

    Page :282-282

    M. Masood, H. Burki, M. Masood

    
  • ·Burnout syndrome: A comparative study

    Page :282-282

    A. Matos Pires, M. Sá Pessoa

    
  • ·Social anxiety and depersonalization

    Page :282-282

    M. Michal, J. Wiltink, M.E. Beutel

    
  • ·Sleep disorders in children with learning difficulties

    Page :282-283

    A. Michopoulou, B. Belesioti, V. Goula, X. Tokatlidou, A. Pantazopoulou

    Résumé Résumé Plan Plan
  • ·Fear as a state and trait in patients with brain injury after surgical treatment.

    Page :283-283

    E. Mojs, E.G. Gajewska

    
  • ·Coping behaviour in medical residents

    Page :283-283

    P. Morales, O. Granada, C. Galan, J.J. Lopez-Ibor

    
  • ·Psychodermatology-A review of the relationship between dermatology and psychiatry

    Page :283-283

    L. Motherway

    
  • ·9/11 PTSD among urban primary care patients in nyc: A longitudinal examination

    Page :283-284

    Y. Neria, M. Olfson, R. Gross, M. Gamerrof, J. Manetti-Cusa, M. Weissman

    Résumé Résumé Plan Plan
  • ·System of immunity in posttraumatic stress disorders

    Page :284-284

    V.B. Nikitina, T.P. Vetlugina, E.M. Epanchintseva, V.Y. Semke

    
  • ·Social anxiety disorder and temperament: Excitatory and inhibitory mechanisms on primary motor cortex in patients and healthy controls

    Page :284-284

    S. Pallanti

    
  • ·Distinct patterns of premorbid social functioning in first-episode psychosis: Relationship to initial presentation

    Page :284-285

    M.A. Parrilla-Escobar, R. Perez-Iglesias, J.M. Pelayo-Teran, G. Pardo-Garcia, M.L. Ramirez-Bonilla, J.L. Vazquez-Barquero, B. Crespo-Facorro

    Résumé Résumé Plan Plan
  • ·Melatonin effect on sleep during benzodiazepine withdrawal- A double blind clinical trial

    Page :285-285

    E. Peles, R. Bar-Hamburger, T. Hetzroni, S. Schreiber, M. Adelson

    
  • ·Pemphigus and skin disease: A comparison of the incidence of stressful life events and personality disorders

    Page :285-285

    F. Rossano, E. Ruocco, F. Perris, A. Baroni, M. Fabrazzo, F. Catapano, M. Maj

    
  • ·Non-complicated pregnancy, anxiety and depression

    Page :285-285

    J. Petkovic, E. Tupkovic

    
  • ·Burnout syndrome among general practitioners and anesthesiologists

    Page :285-286

    N. Petrovic Stefanovic, B. Pejuskovc, D. Lecic Tosevski, I. Perunicic

    Résumé Résumé Plan Plan
  • ·Brain 18FDG pet in panic disorder during the treatment with CBT or antidepressants

    Page :286-286

    J. Prasko, J. Horacek, R. Zalesky, M. Kopecek, T. Novak, B. Paskova, L. Skrdlantova, O. Belohlavek, C. Hoschl

    
  • ·Nocturnal panic in first stages of panic disorder: Clinical differences between nocturnal vs Non-nocturnal panickers

    Page :286-286

    B. Rodriguez-Cabo, A. Herran, M.L. Ramirez, M. Carrera, F. Hoyuela, O. Fernandez-Torre, A. Ayestaran, D. Sierra-Biddle, J.L. Vazquez-Barquero

    
  • ·Correlation between the Wender-Utah rating scale and impulsivity, personality, anxiety and depression psychometric scales

    Page :286-287

    R. Rodriguez-Jimenez, G. Ponce, P. Carretero, M. Aragues, A. Bagney, C. Muñoz-Ruiperez, M.A. Jimenez-Arriero

    Résumé Résumé Plan Plan
  • ·Headache in psychiatric patients

    Page :287-287

    M. Roque, A. Cabral, V. Domingues, H. Rita, L. Sousa

    
  • ·Mental health of war veterans in military forces of Serbia

    Page :287-287

    R. Samardzic, Z. Spiric, G. Mandic-Gajic, M. Radovanovic, N. Bjelica, A. Eror

    
  • ·Posttraumatic stress reactions of children whose parents suffered from posttraumatic stress disorder

    Page :287-287

    Z. Selimbasic, E. Avdibegovic, O. Sinanovic

    
  • ·Psychopathological disorders in the period of burn disease late sequelae in children and teenagers

    Page :287-288

    I. Shadrina

    Résumé Résumé Plan Plan
  • ·Psychopathology of hospital endocrinological patients - Two -year retrospective study

    Page :288-288

    Z.B. Stankovic, I.D. Ilic, V.P. Bojic, Lj.J. Popovic

    
  • ·The postponed mourning in Bosnian refugees: "I'll cry tomorrow"

    Page :288-288

    A.B. Sutovic

    
  • ·Subjective sleep quality and aggression in antisocial personality disorder

    Page :288-288

    A. Algul, U.B. Semiz, M.A. Ates, M. Cetin, S. Ebrinc, C. Basoglu, H. Gunay, C. Gunes, C.O. Noyan, O. Yilmaz

    
  • ·Traumatic stress in delinquent adolescent girls

    Page :288-289

    N.F. Valeeva

    Résumé Résumé Plan Plan
  • ·Nonbenzodiazepine versus benzodiazepine hypnotic efficiency analysis in older people

    Page :289-289

    D. Vasile, O. Vasiliu, M. Vasile, M. Sarmache, M. Terpan

    
  • ·The problems of individual dynamics of stress-related disorders

    Page :289-289

    D.Y. Veltishchev, K.B. Kovalevskaya, O.F. Seravina, G.S. Bannikov

    
  • ·A psychophysiological investigation of emotional processing in subjects with panic disorder

    Page :289-289

    U. Volpe, A. Mucci, F. Centanaro, E. Merlotti, S. Galderisi

    
  • ·Assessment of exposure and resistance to emotional stress

    Page :289-290

    J. Suliburska, G. Duda, Z. Krejpcio, R.W. Wojciak

    Résumé Résumé Plan Plan
  • ·The complex therapy of anxiety-depressive disorders at adolescents

    Page :290-290

    I.V. Zabozlaeva, F.F. Belikov

    
  • ·Increased risk of mortality after an acute coronary syndrome among patients with comorbid anxiety and depression

    Page :290-290

    B.D. Thombs, R.C. Ziegelstein, D.E. Stewart, S.E. Abbey, S.L. Grace

    
  • ·The effects of therapeutic touch on anxiety and cardiac dysrhythmia in cardiac catheterization clients

    Page :290-290

    M. Zolfaghari, M. Haztati, G.H.R. Sameh

    

• Poster Session 2: OBSESSIVE-COMPULSIVE DISORDERS

  • ·Gambling and suicidal behaviours: A Swiss study in a treatment center in Switzerland

    Page :291-291

    M. Andronicos, M. Rihs-Middel, S. Gougler, J. Battisti, C. Zumwald, L. Aufrere, O. Simon, J. Besson

    
  • ·Young adults: What about gambling disorders?

    Page :291-291

    J. Battisti, M. Rihs-Middel, M. Andronicos, S. Gougler, O. Simon, J. Besson

    
  • ·Long-term treatment of obsessive-compulsive disorder: A prospective follow-up study

    Page :291-291

    F. Catapano, F. Perris, F. Rossano, L. Magliano, M. Maj

    
  • ·Seeking out candidate endophenotypes for OCD. Neurocognitive findings in unaffected relatives.

    Page :291-292

    S.R. Chamberlain, N. Fineberg, N. del Campo, L. Menzies, A.D. Blackwell, E.T. Bullmore, T.W. Robbins, B.J. Sahakian

    Résumé Résumé Plan Plan
  • ·Relapse prevention in patients with obsessive-compulsive disorder (OCD)

    Page :292-292

    N. Fineberg, O. Lemming, B. Tonnoir, D. Stein

    
  • ·The treatment of obsessive-compulsive disorder with escitalopram

    Page :292-292

    D.J. Stein, B. Tonnoir, E.H. Reines, E.W. Andersen, N. Fineberg

    
  • ·Amis subito: Assessment, measurement, intervention and studies for the prevention of suicidal behaviour in individuals, inclined to gamble excessively

    Page :292-293

    S. Gougler, M. Rihs-Middel, M. Andronicos, J. Battisti, N. Cornuz, L. Aufrere, O. Simon, J. Besson

    Résumé Résumé Plan Plan
  • ·Venlafaxine extended release as a treatment option after SSRI-s nonresponse and intolerance in obsessive-compulsive disorder:Case report

    Page :293-293

    D.R. Josifovic-Kostic, D.B. Kostic

    
  • ·Atypical antipsychotics and obsessive compulsive symptoms in schizophenia: Literature review

    Page :293-293

    M. Oumaya, S. Friedman, L. Vera, J.D. Guelfi, F. Rouillon

    
  • ·Clinical characteristics and treatment response in obsessive-compulsive disorder (OCD) with poor insight: A 3-year prospective follow-up study

    Page :293-293

    F. Perris, F. Rossano, V. Cioffi, F. Catapano, M. Maj

    
  • ·Topiramate in OCD comorbid with impulsive behaviour disorders

    Page :293-294

    R. Ramos Rios, S. Martinez Formoso, M. Arrojo Romero, P. Ecenarro Tome, A. Arauxo Vilar

    Résumé Résumé Plan Plan
  • ·The prevention of gambling bahavior in switzerland

    Page :294-294

    M. Rihs-Middel, M. Preisig, M. Andronicos, S. Gougler, J. Battisti, L. Aufrère, C. Zumwald, O. Simon, J. Besson

    
  • ·White matter abnormalities in obsessive-compulsive disorder: A diffusion tensor imaging study

    Page :294-294

    Y. Saito, K. Nobuhara, G. Okugawa, K. Takase, A. Tajika, T. Sugimoto, H. Kurokawa, K. Ikeda, S. Sawada, T. Kinoshita

    
  • ·Feasibility and acceptability of short message service (SMS) text messaging to support adherence in patients receiving quetiapine: A pilot study

    Page :294-295

    D. Volcke, P. Snoeck, T. Festjens, J. Kowalski, R. Jones, S. Van Hoorde

    Résumé Résumé Plan Plan
  • ·The Cape Town consensus statement regarding the diagnosis and treatment of obsessive-compulsive disorder

    Page :295-295

    J. Zohar, H.G.M. Westenberg, D.J. Stein, E. Hollander

    

• Poster Session 2: ORGANIC MENTAL DISORDERS AND MEMORY AND COGNITIVE DYSFUNCTIONS

  • ·Multiple presenting neuropsychiatric symptoms confound diagnosis of sporadic Creutzfeldt-Jakob disease

    Page :295-295

    C.G. Chung, A.O. Alao

    
  • ·Validation of the modified mini- mental state examination (3ms) in a German population

    Page :295-295

    P. Alexopoulos, K. Nadler, B. Cramer, S. Herpertz, A. Kurz

    
  • ·Variability among physicians on diagnosis and therapeutic approach of patients with Alzheimer disease plus cerebrovascular disease (ad+cvd)

    Page :295-296

    M. Anton, P. Gil, D. Sanchez-Matienzo, C. Bas

    Résumé Résumé Plan Plan
  • ·Decreased platelet vesicular monoamine transporter binding capacity in tourette syndrome

    Page :296-296

    D.H. Ben-Dor, S. Zimerman, Y. Sever, N. Roz, A. Apter, M. Rehavi, A. Weizman

    
  • ·Neuropsychological differentiation of adults with attention deficit disorder and autism spectrum disorders

    Page :296-296

    I. Bloemen, W. Verbeeck, S. Tuinier

    
  • ·Chronic psychotic disorder and cognitive decline associated with low-dose interferon-α treatment of hepatitis c: A case report

    Page :296-296

    W. Drozdz, A. Borkowska, M. Wilkosc, M. Tomaszewska, W. Halota, M. Pawlowska, D. Dybowska, J.K. Rybakowski

    
  • ·Neuropsychical symptoms due to cerebrovascular changes

    Page :297-297

    B. Burba, D. Gudiene, V. Grigaliuniene, O. Jankuviene, A. Jaras

    
  • ·A study on the polymorphism of IL-1Ra86bp,IL-1βexon5 gene and cognitive function in han chinese with TS

    Page :297-297

    H.F. Chang, W.D. Ji, Y. Li, B.Y. Guo, D.L. Yang

    
  • ·Alzheimer's or alzheimer-perusini's disease?

    Page :297-297

    G.L. Conte, M. Pomponi

    
  • ·General paralysis a case report

    Page :297-298

    M. Darghal

    Résumé Résumé Plan Plan
  • ·Apathy correlates with dopamine uptake in neurodegenerative diseases. a spect study with partial volume effect correction

    Page :298-298

    R. David, M. Koulibaly, J. Darcourt, P.H. Robert

    
  • ·Atomoxetine improved response inhibition in adults with ADHD

    Page :298-298

    N. del Campo, S.R. Chamberlain, J. Dowson, U. Muller, L. Clark, T.W. Robbins, B.J. Sahakian

    
  • ·Psychotic epizode of multiple drug user after acute anticholinergic intoxication - a case report

    Page :298-298

    N. Dostanic, M. Stankovic

    
  • ·Specific characteristics of prefrontal cortex functions in multiple sclerotic patients

    Page :298-299

    H. Ekhtiari, P. Jangouk, A. Behzadi, A. Mokri, A. Jannati, H. Safaei, M. Sahraian, J. Lotfi

    Résumé Résumé Plan Plan
  • ·Evoked far-field potentials originating from the brainstem - new diagnostic possibilities for alzheimer's disease?

    Page :299-299

    A.J. Fallgatter, F. Metzger, A.C. Ehlis, M.J. Herrmann, J. Langer, T. Polak

    
  • ·Cognitive effects of a prolonged-release formulation of galantamine (PRC) in patients with alzheimer's disease (AD) - an open-label phase-IIIb-study

    Page :299-299

    M. Gerwe, B. Ibach, J. Czekalla, H.J. Moeller

    
  • ·Cognitive function in patients with alzheimer's dementia and concomitant cerebrovascular disease treated with galantamine - a one year open-label phase-IIIb-study

    Page :299-300

    B. Ibach, M. Gerwe, S. Schwalen, M. Riepe

    Résumé Résumé Plan Plan
  • ·Safety and efficacy of inhibitors of cholinesteraseduring the treatment of DAT-long-term follow

    Page :300-300

    D. Ignjatovic, M. Ignjatovic, M. Kniskova, R. Hruby, T. Baska

    
  • ·Clinical and expert assessment of emotional state and cognitive functions of patients with cerebrovascular diseases

    Page :300-300

    S.A. Igumnov

    
  • ·Cognitive dysfunctions and depressive symptoms in graves-basedow disease

    Page :300-300

    K. Jablkowska, K. Nowakowska, A. Borkowska

    
  • ·Auditory processing disorders in children with learning disabilities

    Page :301-301

    V. Iliadou, S. Kaprinis, K. Apalla, A. Kritsi, V. Bizeli, D. Kandylis

    
  • ·The influence of genetic polymorphisms on white matter lesion load in dementia

    Page :301-301

    P. Kelemen, H. Kölsch, R. Heun, R. Seitz, B. Krumm, L. Frölich, F. Hentschel

    
  • ·White matter lesion (WML) load and clock drawing test (CDT): a comparison of two diagnostic tools in dementias

    Page :301-301

    P. Kelemen, M. Damian, R. Seitz, L. Frölich, F. Hentschel

    
  • ·The occurrence of psychiatric disorders in patients with traumatic brain injury

    Page :301-302

    S. Koponen

    Résumé Résumé Plan Plan
  • ·Mutually related depression and dementia syndromes in elderly patients

    Page :302-302

    L. Kuklova, R. Jirak, A. Nawka, J. Raboch

    
  • ·Early psychical disorders at children with epilepsy

    Page :302-302

    E. Malinina, I. Zabozlaeva, N. Kvyatkovskaya

    
  • ·An attempt of factorial analysis of the typological formation of non-psychotic disturbances after brain damage

    Page :302-303

    S.P. Margaryan

    Résumé Résumé Plan Plan
  • ·Dopamine agonists and pathological gambling in parkinson disease

    Page :303-303

    I. Menendez, G. Moris

    
  • ·Asian cultural influences on dementia in a developed country: a Singapore perspective

    Page :303-303

    K.W. Ng, C.H. How, L. Tan, L.L. Ng, W.K. Tay

    
  • ·peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may induce working memory disturbances in chronic hepatitis c (CHC) patients

    Page :303-303

    T. Pawelczyk, D. Strzelecki, A. Pawelczyk, J. Rabe-Jablonska

    
  • ·Attention abnormalities in chronic hepatitis c (CHC) patients during peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may persist after treatment discontinuation

    Page :303-304

    T. Pawelczyk, D. Strzelecki, A. Pawelczyk, J. Rabe-Jablonska

    Résumé Résumé Plan Plan
  • ·Normal and pathological aging of attention in huntington's disease and normal elderly subjects

    Page :304-304

    C.S. Peretti, F. Ferreri, F. Blanchard, S. Bakchine, A. Dobrescu, V.A. Chouinard, G. Chouinard

    
  • ·Carotid doppler ultrasound modifications in alzheimer disease

    Page :304-304

    C. Radut, A. Tiugan, A. Andritoiu

    
  • ·Spanish validation of the adult ADHD self-report scale-version 1.1

    Page :304-305

    J.A. Ramos-Quiroga, R. Bosch, S. Valero, N. Saez, M. Nogueira, N. Gómez, I. Martinez, M. Casas

    Résumé Résumé Plan Plan
  • ·Effect of cerebral white matter changes on clinical response to cholinesterase inhibitors in dementia

    Page :305-305

    M.E. Devine, J.A. Saez Fonseca, R.W. Walker, T. Sikdar, T. Stevens, Z. Walker

    
  • ·Six years experience with acetylcholinesterase inhibitors in a clinical setting

    Page :305-305

    J.A. Saez Fonseca, D. Cutinha, K.K. Shanker, Z. Walker

    
  • ·Adult ADHD, fact and myth

    Page :305-305

    M.D. Sigal

    
  • ·Assessment of competence in dementia in europe. an initiative of the european consensus network (EDCON)

    Page :305-306

    G. Stoppe, L. Maeck

    Résumé Résumé Plan Plan
  • ·Representative follow up investigations of primary care physicians competence for the management of memory disorders in Germany

    Page :306-306

    G. Stoppe, S. Haak, A. Knoblauch, L. Maeck

    
  • ·Active allothetic place avoidance task: evaluation of new and promising behavioral approach to testing spatial cognitive abilities of rodents.

    Page :306-306

    A. Stuchlik, L. Rehakova, D. Cinkova, V. Helesic, L. Rezacova, K. Vales

    
  • ·Fearing insanity… charles bonnet syndrome - case study

    Page :306-306

    V. Teixeira Sousa, A. Costa, M. Mota, R. Grangeia, A. Pacheco Palha

    
  • ·The use of non-stimulant drugs in the treatment of adult ADHD

    Page :306-307

    W. Verbeeck, S. Tuinier

    Résumé Résumé Plan Plan
  • ·The disturbed parent-child communication after parental separation and its impact on the child's psychosocial adjustment

    Page :307-307

    A. Beka

    
  • ·Forensic-psychiatric meaning of paranoiac conditions with personality disorders

    Page :307-307

    S.V. Danilova

    
  • ·Intervention strategies for stalking victims

    Page :307-307

    H. Dressing, E. Schiefelbein, P. Gass

    
  • ·Assessing the therapeutic process with the forensic operationalized therapy/risk evaluation system (FOTRES)

    Page :307-308

    J. Endrass, C. Danielsson, F. Urbaniok

    Résumé Résumé Plan Plan
  • ·Out-patient care to schizophrenic patients having antisocial records

    Page :308-308

    G. Fastovtsov, S. Oskolkova

    
  • ·The use of risperidone long-acting injection (RLAI) in a high secure hospital

    Page :308-308

    S.D. Gibbon, M. Gahir, B. Huckstep

    
  • ·Criteria of appointment of compulsory treatment for patients with mental disorders with limited diminished responsibility

    Page :308-308

    V.V. Gorinov

    
  • ·Pathological intoxication - a question of law and psychiatry

    Page :308-309

    P. Gottlieb

    Résumé Résumé Plan Plan
  • ·Coercive measures used during hospitalization. Eunomia - final results in the Czech Republic

    Page :309-309

    L. Kalisova, J. Raboch, E. Kitzlerova, T.W. Kallert, Team Eunomia

    
  • ·Violence, substance abuse and active symptoms in schizophrenia - overview of forensic wards in Portugal

    Page :309-309

    E. Leite, J. Ribeiro, S. Fonseca

    
  • ·Property offences in dissocial personality disorder and kleptomania

    Page :309-309

    O.V. Leonova, B.V. Shostakovich

    
  • ·Criminal agressive-violent and gomcidal behaviour of children and adolescents

    Page :309-310

    E.V. Makushkin, V.D. Badmaeva

    Résumé Résumé Plan Plan
  • ·Factors of adaptation of imprisoned in Russia

    Page :310-310

    D.A. Malkin

    
  • ·Psychiatric services for undocumented immigrants in the USA

    Page :310-310

    B. Ng

    
  • ·Monitoring research on act on medical care and treatment for insane or quasi-insane persons who caused serious incidents in Japan

    Page :310-311

    H. Noguchi, T. Oakada, A. Kikuchi, Y. Mino, M. Sano, F. Hisanaga, K. Yoshikawa

    Résumé Résumé Plan Plan
  • ·Objectification of the diminished responsibility criteria

    Page :311-311

    I.M. Oushakova

    
  • ·Do psychiatric patients improve their competence to consent involuntary hospitalisation after an admission?

    Page :311-311

    M.P. Presa, D.F. Fraguas, S.T. Terán, E.C. Chapela, J.P. De La Peña, A.C. Calcedo, F.G. García

    
  • ·Nature and nurture influence later-life violence: serotonergic genes and childhood adversity

    Page :311-311

    A. Reif, M. Roesler, C.M. Freitag, M. Schneider, C. Kissling, A. Eujen, D. Wenzler, C.P. Jacob, P. Retz-Junginger, J. Thome, K.P. Lesch, W. Retz

     
  • ·Evaluating the best interests of the child - a model of multidisciplinary teamwork

    Page :312-312

    J. Sever, R. Finzi, P. Golubchik

    
  • ·Cognitive deficits after traumatic brain injury - does lesion site affect effort?

    Page :312-312

    A. Stevens, P.T. Merten, E. Friedel

    
  • ·Aspects of forensic psychiatric estimation of the influence of totalitarian sects activity on the adherents mental health

    Page :312-312

    V.V. Sushko

    
  • ·Visual arts therapy at turopolje correction institution

    Page :312-313

    E. Susic, B. Svrznjak

    Résumé Résumé Plan Plan

• Poster Session 2: BIOLOGICAL MARKERS AND BRAIN IMAGING

  • ·Renaissance of quantitative electroencephalography (QEEG) in psychiatry

    Page :313-313

    M. Brunovsky, J. Horacek, M. Bares, M. Kopecek, B. Tislerova, P. Sos, V. Krajca, C. Hoschl

    
  • ·Forensic evaluation of psychiatric disorders in epilepsy

    Page :313-313

    M.V. Usyukina

    
  • ·Diminished responsibility: some current issues in Russia

    Page :313-313

    V.V. Vandish-Bubko

    
  • ·Endophenotypic measures of altered inhibitory brain processes in ADHD

    Page :313-314

    A.J. Fallgatter, C.G. Baehne, M.M. Plichta, M.M. Richter, K.P. Lesch, A.C. Ehlis

    Résumé Résumé Plan Plan
  • ·Paired associate learning in subjects at risk for psychosis: fMRI study

    Page :314-314

    P. Fusar-Poli, M.R. Broome, P. Matthiasson, J. Woolley, L. Johns, P. Tabraham, E. Bramon, L. Valmaggia, S. Williams, S. Brammer, X. Chitnis, P. McGuire

    
  • ·Age-related decline in 5-HT2A and 5-HTU sites in the rhesus monkey hypothalamus

    Page :314-314

    E.K. Hamlyn, D.E. Roberts, J.A. Pugh, D.L. Rosene

    
  • ·The WHO (Ten) well-being index as a screening instrument for major depression in a population-based sample

    Page :314-315

    A. Hansson, P. Hillerås, Y. Forsell, I. Lundberg

    Résumé Résumé Plan Plan
  • ·The effect of low-frequency rTMS on regional brain metabolism (PET) in auditory hallucinations as the background for neuronavigated rTMS

    Page :315-315

    J. Horacek, M. Brunovsky, M. Klirova, T. Novak, L. Skrdlantova, M. Kopecek, F. Spaniel, C. Hoschl

    
  • ·Inhibin b as a possible marker of antipsychotic induced sexual dysfunction in schizophrenic men

    Page :315-315

    L. Janu, S. Rackova

    
  • ·Novel evidence for the involvement of the mirror neuron system in emotional processing

    Page :315-316

    J. Kinross, S. Frangou, V. Kumari

    Résumé Résumé Plan Plan
  • ·Increase of prefrontal cortex blood flow during trail making test

    Page :316-316

    M. Kubo, Y. Kitamura, K. Kinugasa, M. Okamoto

    
  • ·Circadian rhythm of malondialdehyde formation in healthy subjects

    Page :316-316

    A.L. Morera, P. Abreu, M. Henry, A. Garcia-Hernandez, F. Guillen-Pino, A. Intxausti, A. Orozco, E. Díaz-Mesa, F. Trujillo, J. Monzon, C.D. Díaz-Melian, R. Gracia

    
  • ·The medium latency auditory evoked response in attention deficit disorder and hyperactivity

    Page :316-316

    S. Mourente-Diaz, M. Dominguez-Santos, C. Morla-Boveda, J. Otero-Costas

    
  • ·Orexin-a, body weight, and physical activity relationships in the rhesus monkey

    Page :316-317

    D.E. Roberts, D.L. Rosene

    Résumé Résumé Plan Plan
  • ·Neurochemical markers for aggression-related personality traits

    Page :317-317

    R. Anckarsater, A. Forsman, K. Blennow, H. Anckarsater

    
  • ·Time course of emotional responses: the effects of subjective ratings of emotional intensity and voluntary supression

    Page :317-317

    E. Stefanopoulou, S. Argyropoulos, S. Frangou

    
  • ·The effect of personality dimensions on subjective and objective measures of emotional reactivity

    Page :317-318

    E. Stefanopoulou, S. Argyropoulos, S. Frangou

    Résumé Résumé Plan Plan
  • ·The study of brain function in first-episode schizophrenia by functional MRI

    Page :318-318

    C. Shu, G.H. Wang, H.L. Wang, J.H. Tang

    
  • ·Pharmacogenetics of weight gain and obesity following clozapine treatment

    Page :318-318

    O. Yevtushenko, C. Lafferty, V. Aziz, A. Tyson, N. Jamil, G.P. Reynolds

    
  • ·MEG investigation of abnormal semantic priming in schizophrenia

    Page :318-318

    D. Vistoli, E. Brunet-Gouet, B. Houze, M.C. Hardy-Bayle

    
  • ·Working memory and executive function: relation to psychiatric candidate genes

    Page :318-319

    M. Wilkosc, A. Borkowska, M. Tomaszewska, M. Skibinska, M. Dmitrzak-Weglarz, A. Szczepankiewicz, J. Hauser, J.K. Rybakowski

    Résumé Résumé Plan Plan

• Poster Session 2: DIAGNOSIS AND CLASSIFICATION ISSUES

  • ·Doctor, can one see worms in a scan? Clinical case of headache attributed to psychotic disorder

    Page :319-319

    A. Cabral, M. Roque, V. Domingues, A. Craveiro, H. Rita, L. Sousa

    
  • ·Does actigraphy differentiate ADHD subtypes?

    Page :319-319

    M.M. Dabkowska, D. Pracka, T. Pracki

    
  • ·Schizoafective disorder: diagnostic difficulties - about two clinical cases

    Page :319-320

    I. Domingues, S. Timóteo, I. Costa, C. Silveira, R. Curral, A. Palha

    Résumé Résumé Plan Plan
  • ·A model for analysis of non verbal parameters in n-dimensional space

    Page :320-320

    V.V. Enatescu, V.R. Enatescu

    
  • ·Psychiatric morbidity of employed mothers 6-weeks and one year after childbirth: A prospective study of adaptation

    Page :320-320

    M.L. Imaz, P. Navarro, M. Garriz, C. Ascaso, C. Aguado, E. Gelabert, L. García

    
  • ·Bibliometric analysis about the diagnostic criteria used in psychiatry (1980-2005)

    Page :320-320

    P. Garcia-Garcia, F. Lopez-Munoz, G. Rubio, C. Alamo

    
  • ·Prediction of violent behavior in acute psychiatric inpatients

    Page :320-321

    U. Groleger, A. Logar, Z. Muidza, V. Novak-Grubic

    Résumé Résumé Plan Plan
  • ·Psychiatric diagnosis, clinical scales and impulsivity: a pilot study

    Page :321-321

    U. Groleger, M. Derganc, A. Kogoj, K.B. Strukelj

    
  • ·Diagnostic, clinical magnificence of somatoform syndrome

    Page :321-321

    A.S. Kim

    
  • ·Adjustment disorders as stress-related disorders: Prevalences from a representative community survey

    Page :321-321

    A. Maercker, S. Forstmeier, A. Enzler-Donatsch

    
  • ·Usefulness of the eeg investigation to diagnose TIC disorders in children and adolescents.

    Page :321-322

    J. Mlodzikowska-Albrecht, M. Zarowski, B. Steinborn, E.H. Mojs

    Résumé Résumé Plan Plan
  • ·Symptomatology of TIC disorder in children and adolescents.

    Page :322-322

    M. Zarowski, J. Mlodzikowska-Albrecht, E. Mojs, B. Steinborn

    
  • ·Psychiatric disorders in a palliative care unit

    Page :322-322

    P.S. Muniz, A.E. Nardi, F.C. Campos

    
  • ·Different cut-off points for different trimesters? the use of edinburgh postnatal depression scale and beck depression inventory to screen depression during pregnancy in Taiwan

    Page :322-322

    K.P. Su, C.H. Chiu, C.L. Huang, C.M. Pariante

    
  • ·Psychiatric comorbidity and socio-demographic profile of adults with attention deficit hyperactivity disorder

    Page :323-323

    D. Bicer, C. Dedeoglu, Y. Yazgan

    
  • ·Medical criteria of disability in psychiatric practice

    Page :323-323

    O. Zaytsev, G. Prieb

    
  • ·"Ego-dystonic" delusions in psychotic patients

    Page :323-323

    J. Zislin, V. Kuperman, R. Durst

    
  • ·Smoking and mental disorders: associations derived from longitudinal data over 20 years

    Page :323-324

    V. Ajdacic-Gross, K. Landolt, J. Angst, A. Gamma, W. Rossler

    Résumé Résumé Plan Plan
  • ·Medical morbidity in psychiatric (de-)institutionalized patients

    Page :324-324

    B. Michailidou, G.D. Giaglis, G.F. Angelidis

    
  • ·Lifetime risk and age-of-onset of mental disorders in the Belgian general population

    Page :324-324

    A. Bonnewyn, R. Bruffaerts, K. Demyttenaere

    
  • ·Migration and mental disorders in an outpatient setting

    Page :324-324

    A. Corominas, M. Cavero

    
  • ·Transgenerational transmission of agressive behaviour

    Page :324-325

    D. Degmecic, I. Pozgain, P. Filakovic, K. Dodig-Curkovic, M. Grgic

    Résumé Résumé Plan Plan
  • ·Suicidal ideation in Viennese secondary school pupils

    Page :325-325

    K. Dervic, T. Akkaya-Kalayci, N.D. Kapusta, M. Kaya, E. Merl, E. Vogel, M. Aysel, E. Pellegrini, M.H. Friedrich

    
  • ·Adolescent general health in Tehran

    Page :325-325

    H. Emami, M. Ghazinour, H. Rezaishiraz

    
  • ·Prevalence and behavioral correlates of enuresis in preschool children

    Page :325-326

    A. Erdogan, H. Akkurt, G. Aydogan, N. Kucuk Boettjer, E. Yurtseven, G. Can, N. Atasoy, N. Konuk, L. Atik

    Résumé Résumé Plan Plan
  • ·Revolving door and human resources in a community mental health system

    Page :326-326

    G. Pardo-Castillo, A. Fontalba-Navas, D. Gutierrez-Castillo, F. Del Ojo-Garcia, E. Avanesi-Molina, A. Higueras-Aranda, J.L. Martinez-Gonzalez, M.I. Rodriguez-Idigoras, J.M. Pena-Andreu

    
  • ·Suicide in south Tyrol

    Page :326-326

    G. Giupponi, S. Perin, R. Pycha

    
  • ·Actual treatment for elderly patients with depression

    Page :326-326

    J.L. Hernandez Fleta, M.E. Terres Ruiz, T. Sanchez-Araña Moreno, A. Salesansky Davidovsky, E. Zerek Benitez, A. Dominguez Santana

    
  • ·Sudden infant death syndrome and psychiatric disorders

    Page :326-327

    L.M. Howard, G. Kirkwood

    Résumé Résumé Plan Plan
  • ·Temperament and character assessed with cloninger inventory of 174 undergraduated medical students at University of Nancy 1, France

    Page :327-327

    F.A. Jumelle, S. Boini, V. Adnet

    
  • ·Heavy use of inpatient psychiatric services: an analysis from a systemic view point

    Page :327-327

    U.M. Junghan, M. Pfammatter, W. Tschacher

    
  • ·Some aspects of adolescents' risk behavior related to drug, alcohol and tobacco in Sarajevo, Bosnia and Herzegovina

    Page :327-327

    I.L. Licanin, A.R. Redzic, M.S. Spremo, E.I. Ibrahimagic

    
  • ·Patients with suicidal ideation in primary care: Clinical characteristics

    Page :327-328

    P. Martinez-Alfonso, P. Garcia-Parajua, J. Iglesias, L. de Ugarte, M. Magarinos, J.J. Carballo, L. Giner, E. Baca

    Résumé Résumé Plan Plan
  • ·Psychological scales predict psychiatric hospitalizations - The Northern Finland 1966 birth cohort

    Page :328-328

    J. Miettunen, J. Veijola, M. Isohanni, T. Paunio, D. Lichtermann, N. Freimer, L. Peltonen, M.R. Järvelin, M. Joukamaa

    
  • ·Prevalence of postnatal psychiatric morbidity: a preliminary analysis

    Page :328-329

    P. Navarro, L.L. Garcia-Esteve, C. Ascaso, J. Aguado, R. Martin-Santos, E. Gelabert, A. Plaza, M.L. Imaz, S. Subira

    Résumé Résumé Plan Plan
  • ·Profile of males who have committed suicide in the capital of Serbia in period 1997-2005

    Page :329-329

    G. Nikolic-Balkoski, V. Pavlicevic, L.J. Leposavic, S. Milovanovic, N. Laskovic, J. Barisic-Rojnic

    
  • ·EPIA-epidemiology of Gad and Sad in Slovakia

    Page :329-329

    V. Novotny, J. Pecenak, A. Heretik, A. Heretik, A. Ritomsky

    
  • ·Internalising and externalising problems in adolescence - general and dimension-specific effects of familial loadings and preadolescent temperament traits

    Page :329-329

    J. Ormel

    
  • ·Prevalence of agitation-hostility during acute episodes in patients with schizophrenia

    Page :329-330

    J. Orta-Rodriguez, Y. Riesgo, P. Vieitez, B. Alonso

    Résumé Résumé Plan Plan
  • ·Bullying in Serbia elementary schools - facts and future ideas

    Page :330-330

    M. Pejovic Milovancevic, V. Ispanovic Radojkovic, S. Popovic Deusic

    
  • ·Netherlands study of depression and anxiety (NESDA): examining the long-term course of affective disorders

    Page :330-330

    B.W. Penninx, J.H. Smit, F.G. Zitman, W. Nolen, A.T. Beekman, R. van Dyck

    
  • ·Suicide and fatal alcohol poisoning in Belarus between 1970 and 2005

    Page :330-330

    Y. Razvodovsky

    
  • ·What happens to patients seen only once by psychiatric services? Findings from a follow-up study

    Page :330-331

    A. Rossi, F. Amaddeo, M. Sandri, A. Marsilio, M. Bianco, M. Tansella

    Résumé Résumé Plan Plan
  • ·Mental disorder and women

    Page :331-331

    A. Shahbazi, S.M. Sadathashemi, B. Behnam

    
  • ·The epidemiology of common mental disorders in adolescents: The Epirus school project

    Page :331-331

    P. Skapinakis, S. Mpellos, G. Mihalis, T. Gkatsa, V. Mavreas

    
  • ·Characteristics of no shows in the netherland study of depression and anxiety (Nesda)

    Page :331-332

    J.H. Smit, A.R. Draisma, T. Zandbelt, W.A. Nolen, E. de Beurs

    Résumé Résumé Plan Plan
  • ·Sexual activities of adolescents from Serbian language speaking area

    Page :332-332

    M. Stankovic, S. Miljkovic, D. Krasic, S. Stankovic, O. Milojkovic, M. Mitkovic

    
  • ·The structure and prevalence of mental disorders in patients of mental health and diagnostic centers in Armenia

    Page :332-332

    S.H. Sukiasyan, S.P. Margaryan, N.G. Manasyan, A.A. Babakhanyan, A.L. Kirakosyan, M.M. Ordyan, A.N. Pogosyan

    
  • ·Concurrent substance abuse and recent homelessness among patients with schizophrenia in The Hague, The Netherlands

    Page :332-332

    E.S. Valencia, A. van Hemert, A. van der Plas

    
  • ·Comorbidity of anxiety and depression

    Page :333-333

    P. Van Oppen, J.H. Smit, A.J.L.M. Van Balkom, F. Zitman, W.A. Nolen, A.T. Beekman, R. Van Dyck, B.W. Penninx

    
  • ·Transcultural aspects of non-psychotic disorders prevalence rate in Buryatia

    Page :333-333

    N.A. Vasilyeva

    
  • ·Prevalence of overweight and obesity, and relationship to physical activity among Norwegian women (18-65) in 1991 and 2004

    Page :333-333

    E. Vedul-Kjelsaas, K.G. Gotestam

    
  • ·Incident sexual dysfunction disorders in clinically significant depression in a UK representative patient population

    Page :333-334

    M.E. Villamil, D.J. Webb, G.K. Quartey

    Résumé Résumé Plan Plan

• Poster Session 2: CHILD PSYCHIATRY

  • ·Musical hallucinations revisited

    Page :334-334

    P. Varela Casal, M. Perez Garcia, I. Espiño Diaz, R. Ramos Rios, M. Tajes Alonso, J. Lopez Moriñigo, S. Martinez Formoso, M. Arrojo Romero

    
  • ·Viennese transcultural outpatient clinic for child psychiatry

    Page :334-334

    T. Akkaya-Kalayci, K. Dervic, M.H. Friedrich

    
  • ·Clinical benefit of switching patients with schizophrenia to once-daily quetiapine sustained release

    Page :334-335

    S. Ganesan, V. Agambaram, F. Randeree, I. Eggens, M.M. Schmidt, D. Meulien

    Résumé Résumé Plan Plan
  • ·Posttraumatic stress disorder among schizoaffective and bipolar patients

    Page :335-335

    D.I. Ilies, C.E. Coatu, R.S. Moldovan, G.G. Roth

    
  • ·The pitfalls and caveats in the implementation of an early intervention service for psychotic patients in a rural region.

    Page :335-335

    R.B. Laport

    
  • ·The difficult to diagnose autism spectrum disorders in preschoolers and the early intervention program, "let's get started"

    Page :335-335

    J. Perlov

    
  • ·Self-reported medical comorbidity and resulting interactions with health care providers in US patients with schizophrenia or bipolar disorder

    Page :335-336

    C. Stave, F. Rappard, R. McIntyre, C. O'Brien

    Résumé Résumé Plan Plan
  • ·Musical hallucinations induced by tramadol

    Page :336-336

    M. Tajes Alonso, R. Ramos Rios, J.D. Lopez Moriñigo, I. Espiño Diaz, M. Perez Garcia, P. Varela Casal, S. Martinez Formoso, M. Arrojo Romero, M. Páramo Fernández

    
  • ·Quality of life in patients with schizophrenia: why do physician and patient perspectives differ?

    Page :336-336

    P.M. Wehmeier, M. Kluge, A. Schacht, K. Helsberg, W. Schreiber

    
  • ·Pregabalin for the treatment of generalized anxiety disorder (GAD) in elderly patients: efficacy as a function of baseline symptom severity

    Page :336-337

    L. Agüera-Ortiz, F. Baldinetti, T. Leon, F. Mandel, L. Pauer, K. Chatamra

    Résumé Résumé Plan Plan
  • ·Use of antipsychotic depot medication in the elderly in UK

    Page :337-337

    J. Caballer, J. Ferran

    
  • ·Suicide attempts in over 60 years old patients

    Page :337-337

    A. Fontalba, M.L. Barrigon, M. Anguita

    
  • ·Chronic pain, depression and opioids misuse in elderly people. A case report.

    Page :337-337

    E. Fontova, M.V. Trasovares, M. Ferrer, C. Roncero, M. Casas

    
  • ·Depression and its pharmacological approach in Spanish nursing home

    Page :337-338

    R. Lopez Mongil, J.A. Lopez Trigo, J. Castrodeza Sanz, T. Leon Colombo, S. Tamames GÓmez, C. Hernan Garcia, C. Rodriguez Gay, J.L. Elguero Angulo, S. Marban Garcia, G. De La Cruz Gonzalez

    Résumé Résumé Plan Plan
  • ·Analysis of symptomology in neuropsychiatric patients with dementia

    Page :338-338

    R. Lopez Mongil, J.A. Lopez Trigo, J. Castrodeza Sanz, T. Leon Colombo, S. Tamames Gonzalez, C. Hernan Garcia, C. Rodriguez Gay, J.L. Elguero Angulo, S. Marban Garcia, G. Gomez De La Cruz

    
  • ·Adequate use of psychotropic agents at healthcare facility for elderly in Japan

    Page :338-338

    H. Misawa, Y. Hamasaki, M. Ochiai

    
  • ·Depression and the elderly

    Page :338-339

    E. Panagoulias, K. Dailianis, D. Malidelis, P. Papadopoulos

    Résumé Résumé Plan Plan
  • ·Mental status and elderly

    Page :339-339

    M. Saberian, S. Hajiaghajani, R. Ghorbanif

    
  • ·Relationship of subjective sleep quality, daytime sleepiness, and depression to the quality of life in patients with parkinson's disease

    Page :339-339

    U.B. Semiz, M. Cetin, M.G. Senol, O. Noyan, A. Ates, C. Basoglu, S. Ebrinc

    
  • ·Sexuality in the older person

    Page :339-339

    P. Teixeira, T. Salgado

    
  • ·The impact of perceived support on the daily activities and depression of institutionalised elderly people with impaired vision

    Page :339-339

    J. Zycinska

    

• Poster Session 2: OTHER TOPICS

  • ·Self-reported consequences and needs for support associated with abuse in female users of psychiatric care

    Page :340-340

    A.I. Bengtsson-Tops, D. Tops

    
  • ·Are women different from men? Some mental health issues

    Page :340-340

    V. Domingues, A.S. Cabral, M. Santos

    
  • ·Alopecia and metilphenidato: two clinical cases

    Page :340-340

    J.L. Fernandez, H. Sancho, A. Rojo, T. Lorenzo, C. Cinos

    
  • ·Themes in cultural competence: Ritual cleansing and medicine noncompliance

    Page :340-341

    K.R. Kaufman, D.L. Kaufman

    Résumé Résumé Plan Plan
  • ·Telepsychiatry in Denmark

    Page :341-341

    D. Mucic

    
  • ·Open access E-journals: research workshop

    Page :341-341

    D. Saltman, M. Norton

    
  • ·Plane crazy: a case series of psychiatric presentations at the airport

    Page :341-341

    L. Tan, C.H. How, K.W. Ng, P.S. Ong, W.K. Tay